{"meta":{"query_hash":"89014c6b0aca","filters":{"venue":"Regular and Young Investigator Award Abstracts"},"cohort_total":145,"direct_labels_cover":0,"predictions_cover":145,"exported":145,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/89014c6b0aca","api":"https://metacan.xera.ac/api/v1/cohort?venue=Regular+and+Young+Investigator+Award+Abstracts"},"results":[{"id":"W3100538981","doi":"10.1136/jitc-2020-sitc2020.0379","title":"379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD8; Medicine; T-cell receptor; Internal medicine; Antigen; Cancer; T cell; Gastroenterology; Oncology; Immunology; Immune system","score_opus":0.05083607555745884,"score_gpt":0.29174663320772787,"score_spread":0.24091055765026903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100538981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96535105,0.0025182539,0.0010505336,0.00063585176,0.000117331525,0.0017677891,0.010713454,0.000095116695,0.017750686],"genre_scores_gemma":[0.9671536,0.0014386288,0.0012874188,0.0009462998,0.00010018093,0.0010238178,0.018060522,0.000062185725,0.009927367],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996426,0.00011582924,0.00003203085,0.000047544658,0.00009497879,0.00006699381],"domain_scores_gemma":[0.99963105,0.00008760576,0.00005712142,0.000027911994,0.00003724193,0.0001590084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008312513,0.00040397936,0.000607916,0.00017873103,0.00028498872,0.0008003062,0.00024567146,0.00054710265,0.009161918],"category_scores_gemma":[0.0006825455,0.00013114454,0.00071763544,0.00024449982,0.00026235185,0.0003737135,0.00021290561,0.0011786596,0.0013788254],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4685028,0.018756106,0.023940397,0.0011039054,0.0011872537,0.0010025171,0.0002449608,0.006661091,0.12305488,0.0012950259,0.028872149,0.32537887],"study_design_scores_gemma":[0.09476595,0.62967765,0.09426986,0.000189366,0.0017791641,0.002306387,0.00016435233,0.0035016115,0.06646082,0.0015914913,0.10517959,0.00011377808],"about_ca_topic_score_codex":0.0008434701,"about_ca_topic_score_gemma":0.002052281,"teacher_disagreement_score":0.009161918,"about_ca_system_score_codex":0.0007850422,"about_ca_system_score_gemma":0.0008189744,"threshold_uncertainty_score":0.030649662},"labels":[],"label_agreement":null},{"id":"W3101543312","doi":"10.1136/jitc-2020-sitc2020.0727","title":"727 Increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"TIGIT; Cancer research; Antibody; Cytokine; Hepatocellular carcinoma; Proinflammatory cytokine; Tumor microenvironment; Immune system; Biology; Medicine; Molecular biology; Immunology; T cell; Inflammation","score_opus":0.022493175923070513,"score_gpt":0.2240064407249474,"score_spread":0.2015132648018769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101543312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915075,0.0001935388,0.000070131544,0.000030211108,0.0000042466504,0.0000060494917,0.00017421323,0.000008807081,0.0003620917],"genre_scores_gemma":[0.9991953,0.0000659586,0.00006657738,0.00002287105,0.0000065022114,0.000009723562,0.00035140384,0.0000020964558,0.00027955347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999509,0.000007913147,0.000004413727,0.000011019947,0.000009385272,0.000016337903],"domain_scores_gemma":[0.99985087,0.000018748444,0.000047427795,0.000008522242,0.000013214874,0.00006114466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011926171,0.00018446364,0.0002323432,0.00032112136,0.00019036832,0.00018873267,0.00008486322,0.00021716351,0.0012175691],"category_scores_gemma":[0.00018557152,0.00010985311,0.00019345575,0.00025309966,0.00013327505,0.00009057634,0.000112235706,0.00028401654,0.0002122736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061598886,0.00027379958,0.942531,0.000042753432,0.0001346595,0.00070194463,0.00006701785,0.00012910148,0.04290211,0.00004062114,0.000570335,0.006446803],"study_design_scores_gemma":[0.00005093504,0.0005174961,0.9949704,0.000004175686,0.00004421229,0.0009071125,0.0000584702,0.00032881726,0.0026362075,0.0000311531,0.00044676004,0.000004233241],"about_ca_topic_score_codex":0.0010631501,"about_ca_topic_score_gemma":0.0013957674,"teacher_disagreement_score":0.0012175691,"about_ca_system_score_codex":0.00016175944,"about_ca_system_score_gemma":0.0001536494,"threshold_uncertainty_score":0.0040732026},"labels":[],"label_agreement":null},{"id":"W3102487262","doi":"10.1136/jitc-2020-sitc2020.0597","title":"597 In situ vaccination with oncolytic vesicular stomatitis virus improves anti-tumor immune response and outcome in bladder cancer","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Oncolytic virus; Vesicular stomatitis virus; Immune system; Medicine; Vaccination; Cancer; Vesicular Stomatitis; Bladder cancer; Virus; Virology; Immunology; Internal medicine","score_opus":0.01603602895359507,"score_gpt":0.27865911129045634,"score_spread":0.26262308233686127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102487262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972692,0.00090575137,0.00063453626,0.00006924337,0.00005420217,0.000030725707,0.00023064994,0.000056636996,0.00074900856],"genre_scores_gemma":[0.99717784,0.0004998762,0.00054754724,0.00006349542,0.00001180087,0.000035931993,0.00041473258,0.000012263885,0.0012364778],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998957,0.000014709592,0.000011745798,0.000018281244,0.000020917732,0.000038635233],"domain_scores_gemma":[0.99994755,0.000006241058,0.000013624147,0.00000700213,0.0000073716974,0.00001818523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013358206,0.00020612865,0.00040024577,0.00017406733,0.00010721105,0.00028570255,0.0001495234,0.00029312316,0.0012333028],"category_scores_gemma":[0.00007879399,0.000091272224,0.00028758522,0.00011412129,0.00017967097,0.00015589343,0.00012429195,0.000642752,0.00025845403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010265704,0.0005332249,0.0006313441,0.000082696526,0.000012606258,0.000029331846,0.000023307815,0.00013856038,0.99165756,0.0000666304,0.00020813652,0.0055900444],"study_design_scores_gemma":[0.0001555615,0.013220931,0.014541721,0.000019219297,0.000067283756,0.00038914123,0.00007410897,0.0022162294,0.96557295,0.00008985205,0.0036419195,0.0000110477495],"about_ca_topic_score_codex":0.00063409825,"about_ca_topic_score_gemma":0.00053352216,"teacher_disagreement_score":0.0012333028,"about_ca_system_score_codex":0.00022832786,"about_ca_system_score_gemma":0.00020626784,"threshold_uncertainty_score":0.0041258335},"labels":[],"label_agreement":null},{"id":"W3103244011","doi":"10.1136/jitc-2020-sitc2020.0351","title":"351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Oncology; Immunotherapy; Head and neck squamous-cell carcinoma; Chemotherapy; Internal medicine; Head and neck cancer; Head and neck; Radiation therapy; Surgery; Cancer","score_opus":0.04785480680630224,"score_gpt":0.2749732537829019,"score_spread":0.22711844697659964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103244011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870608,0.0045817513,0.00022350883,0.0008409918,0.00046446567,0.0013770316,0.0012210846,0.00007645131,0.004154026],"genre_scores_gemma":[0.99198675,0.0017396489,0.00067695975,0.0010860934,0.00027028943,0.00075551047,0.0012547038,0.000016730644,0.0022132776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999634,0.00015823601,0.000028085075,0.000050920633,0.000037248858,0.00009140408],"domain_scores_gemma":[0.99944264,0.0001206089,0.00007959318,0.000026723812,0.000026068557,0.0003043426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009399237,0.00057489384,0.0016602435,0.00039916704,0.00028710882,0.0010187998,0.0005770821,0.0008999685,0.007958237],"category_scores_gemma":[0.0006994385,0.00031752454,0.0016305961,0.00029899058,0.0005114945,0.0009701784,0.00038648394,0.0022226698,0.000891497],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92333305,0.012801018,0.0017257698,0.00050492445,0.0010826645,0.00008805598,0.00005101638,0.0008026363,0.0075745,0.00018070308,0.0025017897,0.04935399],"study_design_scores_gemma":[0.49434596,0.47451732,0.018066736,0.00012621951,0.0019464458,0.0002071545,0.000096500655,0.00224566,0.0027081978,0.00036556888,0.005330724,0.000043589436],"about_ca_topic_score_codex":0.0017194811,"about_ca_topic_score_gemma":0.0055246754,"teacher_disagreement_score":0.007958237,"about_ca_system_score_codex":0.0010988582,"about_ca_system_score_gemma":0.0015984717,"threshold_uncertainty_score":0.026622951},"labels":[],"label_agreement":null},{"id":"W3103606205","doi":"10.1136/jitc-2020-sitc2020.0307","title":"307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Pritzker School of Medicine; American Society of Hematology","keywords":"Vemurafenib; Internal medicine; Medicine; Atezolizumab; Hazard ratio; Oncology; Progression-free survival; Melanoma; Pembrolizumab; Immunotherapy; Cancer research; Cancer; Overall survival; Metastatic melanoma; Confidence interval","score_opus":0.00991258563327047,"score_gpt":0.21943228970482428,"score_spread":0.20951970407155382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103606205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968809,0.0009569397,0.00013084506,0.00022013317,0.00006855277,0.00019081523,0.0007319091,0.000018586381,0.0008013661],"genre_scores_gemma":[0.99660265,0.00036145272,0.00028433264,0.00044525234,0.00012013424,0.0002189029,0.0014757871,0.000007107031,0.000484353],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99965084,0.00017217633,0.000022782035,0.000057169033,0.000030846295,0.000066138935],"domain_scores_gemma":[0.9995758,0.00007084593,0.00010103287,0.000052511426,0.00002916022,0.00017057794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013747036,0.0005611978,0.001259735,0.00015478344,0.00026217607,0.0007117881,0.00036102723,0.0005106766,0.0021762995],"category_scores_gemma":[0.00060010294,0.0002846688,0.0015209009,0.00021266377,0.00030918996,0.00034135295,0.00025245664,0.001092993,0.00046896175],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8315962,0.010299853,0.061841816,0.00044212234,0.00303867,0.0002495746,0.00009447566,0.0015487641,0.027269462,0.00022423177,0.0077970386,0.055597764],"study_design_scores_gemma":[0.45998493,0.19768913,0.31768113,0.00013614832,0.005201667,0.0007746153,0.00015164721,0.005009988,0.006068602,0.0008308642,0.0063340426,0.00013730646],"about_ca_topic_score_codex":0.0005968795,"about_ca_topic_score_gemma":0.001994019,"teacher_disagreement_score":0.0021762995,"about_ca_system_score_codex":0.00043969663,"about_ca_system_score_gemma":0.000724222,"threshold_uncertainty_score":0.0072804093},"labels":[],"label_agreement":null},{"id":"W3103926827","doi":"10.1136/jitc-2020-sitc2020.0155","title":"155 iPSC-derived NK cells mediate robust anti-tumor activity against glioblastoma","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Cancer research; Immunotherapy; Adoptive cell transfer; NK-92; Cytotoxicity; Perforin; Biology; Immunology; Interleukin 21; Immune system; CD8; T cell; In vitro","score_opus":0.03077527250515736,"score_gpt":0.25573247412130745,"score_spread":0.2249572016161501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103926827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844677,0.0019517643,0.003820289,0.00020036305,0.0001574003,0.0001346957,0.0021110007,0.00024760957,0.006909154],"genre_scores_gemma":[0.9887078,0.0010757162,0.0028883773,0.0002525201,0.000035371388,0.00013965288,0.0031159644,0.000057732654,0.0037268926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981374,0.000020976027,0.00004092487,0.000028631346,0.00005451903,0.000041278272],"domain_scores_gemma":[0.99993217,0.000013463866,0.000015873635,0.000011072392,0.000012498476,0.000014977631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014087073,0.00038362772,0.0003214347,0.00023448387,0.00009909988,0.0003509896,0.00024168861,0.0003430211,0.002957201],"category_scores_gemma":[0.00013417543,0.00012386766,0.00031553104,0.0001808935,0.00016864696,0.00017745946,0.00022612434,0.0008301246,0.0013083172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002797088,0.00013448659,0.00020189233,0.00010392159,0.000010613293,0.00006497085,0.000026759562,0.00025249252,0.9936168,0.00017253292,0.0004679258,0.0046678907],"study_design_scores_gemma":[0.00005377324,0.0004408228,0.0021060777,0.000014334478,0.00002677599,0.00014995331,0.000028534821,0.0006693749,0.9913258,0.00007615848,0.0051021627,0.0000061626547],"about_ca_topic_score_codex":0.000320225,"about_ca_topic_score_gemma":0.00036377262,"teacher_disagreement_score":0.002957201,"about_ca_system_score_codex":0.00022359964,"about_ca_system_score_gemma":0.00023876173,"threshold_uncertainty_score":0.009892821},"labels":[],"label_agreement":null},{"id":"W3104499934","doi":"10.1136/jitc-2020-sitc2020.0498","title":"498 Downregulation of CD5 in CD8+ T tumour-infiltrating lymphocytes associates with increased level of activation and exhaustion","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"CD5; CD8; T cell; Molecular biology; T-cell receptor; CD28; Biology; Cytotoxic T cell; Cancer research; Flow cytometry; Chemistry; Immunology; Antigen; Immune system; In vitro; Biochemistry","score_opus":0.04433985947392986,"score_gpt":0.2528445104636845,"score_spread":0.20850465098975463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104499934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928457,0.0008083136,0.0030084362,0.000112950496,0.00003130184,0.000028341843,0.0011787522,0.00009047094,0.0018956923],"genre_scores_gemma":[0.9898052,0.00039947615,0.0025909753,0.00014987546,0.000017343884,0.00009492083,0.0016756584,0.000033063632,0.005233467],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998203,0.000020030871,0.000021150563,0.00004180274,0.000043004267,0.0000538075],"domain_scores_gemma":[0.9999069,0.000013783107,0.00002581704,0.000010881012,0.000015074407,0.00002756599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085219384,0.00017336354,0.00012877052,0.00024268178,0.00013711321,0.00025236473,0.00013244967,0.00021878918,0.003559937],"category_scores_gemma":[0.00006483504,0.00009766473,0.00017188674,0.000120379584,0.00014384421,0.000101937614,0.00012954051,0.0004853043,0.00079558435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109347966,0.000017352831,0.00047218546,0.00001567161,0.0000020081866,0.000026685833,0.000010043653,0.000016246428,0.99874395,0.00003145673,0.00004551138,0.00050954754],"study_design_scores_gemma":[0.000012713272,0.0002425549,0.020294946,0.000006207789,0.00001026363,0.00019624479,0.00004807342,0.0005541954,0.97663975,0.00003827239,0.0019522773,0.000004566057],"about_ca_topic_score_codex":0.0005831123,"about_ca_topic_score_gemma":0.0008078187,"teacher_disagreement_score":0.003559937,"about_ca_system_score_codex":0.0001931196,"about_ca_system_score_gemma":0.0000765555,"threshold_uncertainty_score":0.011909187},"labels":[],"label_agreement":null},{"id":"W3104819140","doi":"10.1136/jitc-2020-sitc2020.0428","title":"428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Vismodegib; Internal medicine; Clinical endpoint; Interim analysis; Basal cell carcinoma; Progression-free survival; Oncology; Surgery; Gastroenterology; Randomized controlled trial; Chemotherapy; Adverse effect; Basal cell","score_opus":0.02856484540316573,"score_gpt":0.270789013981223,"score_spread":0.2422241685780573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104819140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94055367,0.003117868,0.0065189674,0.0014397188,0.0006062997,0.009351023,0.023584086,0.0004857221,0.014342713],"genre_scores_gemma":[0.94861275,0.00065914675,0.008932723,0.0022294929,0.0002400268,0.013429812,0.01922468,0.0002096344,0.006461651],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9969215,0.0018859401,0.00014837149,0.00032985597,0.00032117238,0.0003931347],"domain_scores_gemma":[0.9975247,0.0008588855,0.00070732686,0.00037231905,0.00018680803,0.00035002062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077166897,0.0011810052,0.0017025216,0.00036058627,0.00042631474,0.0012474955,0.0005448989,0.0008523693,0.0077599273],"category_scores_gemma":[0.0043354975,0.000485398,0.0037333746,0.00033210238,0.00039295343,0.0005932746,0.0004315696,0.0021982947,0.0011296872],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8557347,0.008406758,0.021639619,0.000831515,0.004830241,0.00028336077,0.00013054567,0.007008335,0.016007258,0.0008216046,0.02400035,0.06030567],"study_design_scores_gemma":[0.39308736,0.4099294,0.106651925,0.00020137835,0.008972457,0.00083598145,0.00015988701,0.014606158,0.024162387,0.0033445682,0.037898604,0.00015001198],"about_ca_topic_score_codex":0.0003422427,"about_ca_topic_score_gemma":0.0011395154,"teacher_disagreement_score":0.0077599273,"about_ca_system_score_codex":0.00072868384,"about_ca_system_score_gemma":0.002147507,"threshold_uncertainty_score":0.040810227},"labels":[],"label_agreement":null},{"id":"W3105595935","doi":"10.1136/jitc-2020-sitc2020.0054","title":"54 Patient stratification using clinical proteomics – validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Biomarker; Biomarker discovery; Quantitative proteomics; Multiplex; Selected reaction monitoring; Proteomics; Repeatability; Reproducibility; Computational biology; Chemistry; Biology; Mass spectrometry; Bioinformatics; Tandem mass spectrometry; Chromatography; Biochemistry","score_opus":0.0894014995236722,"score_gpt":0.3655048005106565,"score_spread":0.27610330098698427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105595935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704856,0.0028077604,0.022015749,0.00044307637,0.00006375947,0.00040775855,0.001300914,0.00035793512,0.0021173975],"genre_scores_gemma":[0.97080594,0.0006289931,0.025352977,0.0005492855,0.000043634875,0.00022672792,0.0012435239,0.000026821233,0.0011221346],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993206,0.00017088084,0.00006207046,0.00018583998,0.00019677196,0.00006381594],"domain_scores_gemma":[0.9997018,0.00008217112,0.00008201814,0.00003779264,0.00007335601,0.000022824712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016057388,0.00043752522,0.00023936165,0.0006051187,0.00023184906,0.0007487661,0.000246304,0.0005414743,0.0009071706],"category_scores_gemma":[0.0010838438,0.00016455598,0.00023053837,0.00033220625,0.00031274577,0.00019288129,0.00023221187,0.0003992527,0.00044926384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011970057,0.0002446006,0.07284912,0.00016530283,0.00011030347,0.00034583017,0.00014877689,0.0014799115,0.87287116,0.0002919543,0.0017096561,0.04858631],"study_design_scores_gemma":[0.000105865416,0.0014592014,0.18598038,0.00006546145,0.00017736289,0.0021879694,0.00016823254,0.013437609,0.7859242,0.00050635345,0.009926033,0.00006138027],"about_ca_topic_score_codex":0.0008874844,"about_ca_topic_score_gemma":0.001330927,"teacher_disagreement_score":0.0016057388,"about_ca_system_score_codex":0.0003564597,"about_ca_system_score_gemma":0.00032107267,"threshold_uncertainty_score":0.008492053},"labels":[],"label_agreement":null},{"id":"W3105826467","doi":"10.1136/jitc-2020-sitc2020.0075","title":"75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Generalizability theory; Blockade; CTLA-4; Cancer; Cancer therapy; Medicine; Oncology; Internal medicine; Immunology; Immune system; Mathematics; T cell; Receptor; Statistics","score_opus":0.02573454979681641,"score_gpt":0.2777691241262219,"score_spread":0.2520345743294055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105826467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9330944,0.0037991088,0.040509555,0.0011914992,0.000146138,0.00035406888,0.015239415,0.0007209001,0.0049448675],"genre_scores_gemma":[0.9884659,0.00018363039,0.0041118353,0.00043455302,0.00006407995,0.00018494994,0.0061559505,0.00011856012,0.0002804912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9857486,0.006568808,0.0015857965,0.0039401464,0.0016932182,0.00046343167],"domain_scores_gemma":[0.9496941,0.03656404,0.0039213337,0.007494854,0.0019683295,0.00035736596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02935154,0.0004311512,0.0007298687,0.0023704658,0.00040525262,0.002057728,0.0006368294,0.0006724089,0.003031672],"category_scores_gemma":[0.051419307,0.00028911594,0.0022541785,0.0026125284,0.0012860561,0.0008056728,0.0016509404,0.000708657,0.0005630087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002471807,0.00010806009,0.8959882,0.0005385719,0.004830839,0.00019226647,0.0004924669,0.011995335,0.011074807,0.00080659613,0.0026280652,0.06887301],"study_design_scores_gemma":[0.00014253918,0.0009074978,0.96152693,0.000106397616,0.0017228238,0.00042370267,0.0004063052,0.016656138,0.005299037,0.004729852,0.008020425,0.00005838922],"about_ca_topic_score_codex":0.0026644394,"about_ca_topic_score_gemma":0.002181778,"teacher_disagreement_score":0.02935154,"about_ca_system_score_codex":0.0006899001,"about_ca_system_score_gemma":0.00073520915,"threshold_uncertainty_score":0.15522766},"labels":[],"label_agreement":null},{"id":"W3113081454","doi":"10.1136/jitc-2020-sitc2020.0265","title":"265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Interim analysis; Interim; Avelumab; Cohort; Urothelial carcinoma; Oncology; Medicine; Internal medicine; Political science; Bladder cancer; Immunotherapy; Cancer; Clinical trial","score_opus":0.01670594694064256,"score_gpt":0.26632339166413244,"score_spread":0.24961744472348987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113081454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878512,0.0013793978,0.0010525222,0.00037102343,0.000110537985,0.0018993067,0.0048262617,0.0001711251,0.0023386725],"genre_scores_gemma":[0.974312,0.00081522914,0.003118678,0.0009086042,0.00011554151,0.0024003524,0.014168085,0.00009467556,0.004066854],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99931717,0.0003450237,0.000028161825,0.000089162786,0.00007945351,0.00014102926],"domain_scores_gemma":[0.9991903,0.00012508627,0.00016817098,0.00012217558,0.0000652689,0.0003289966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025386359,0.0012950179,0.0015472856,0.00031856517,0.0003857496,0.0010456229,0.00060744514,0.0008142867,0.0033549087],"category_scores_gemma":[0.0009485462,0.00048129426,0.0021662414,0.00030417278,0.00052040716,0.00051822717,0.00034141657,0.002481664,0.001063169],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81283313,0.029904447,0.020497873,0.00039868383,0.0028211984,0.00024584998,0.0001809102,0.005994941,0.051513407,0.00024129954,0.008915768,0.066452496],"study_design_scores_gemma":[0.3418844,0.5628791,0.062252186,0.000049230865,0.0022072128,0.00057421863,0.000105416686,0.004092428,0.015433537,0.0004529816,0.0099936435,0.00007557538],"about_ca_topic_score_codex":0.00086390617,"about_ca_topic_score_gemma":0.0016687926,"teacher_disagreement_score":0.0033549087,"about_ca_system_score_codex":0.0008408265,"about_ca_system_score_gemma":0.0013833203,"threshold_uncertainty_score":0.013425767},"labels":[],"label_agreement":null},{"id":"W3113360743","doi":"10.1136/jitc-2020-sitc2020.0020","title":"20 Quantification of sBCMA in human plasma using a high-throughput mass spectrometry workflow for exploratory, CAP/CLIA or regulated studies","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Chemistry; Chromatography; Mass spectrometry; Peptide; Selected reaction monitoring; Tandem mass spectrometry; Biochemistry","score_opus":0.1380512454315843,"score_gpt":0.3556764921383321,"score_spread":0.21762524670674777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113360743","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27162537,0.0066144806,0.6793558,0.0014433395,0.00053808175,0.0036263517,0.010528144,0.013711559,0.0125568025],"genre_scores_gemma":[0.36169952,0.0035194713,0.6114476,0.0019858764,0.00021472639,0.0044695223,0.007459661,0.0008769981,0.008326664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770194,0.00035591953,0.0001419679,0.0006424845,0.0010044442,0.00015318976],"domain_scores_gemma":[0.9991548,0.00016680575,0.00015890402,0.00012338183,0.0003222227,0.000073974086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029451682,0.0012724227,0.00065635686,0.0015859199,0.0009020594,0.0012903885,0.001047984,0.0013704664,0.0024650767],"category_scores_gemma":[0.0018458869,0.00051772525,0.0009221226,0.0009070064,0.0006992172,0.0006624483,0.0010268204,0.0011640559,0.0027175338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000328571,0.00017506247,0.001785071,0.0003363558,0.00009313934,0.00021000546,0.00013761452,0.000649622,0.9732737,0.0009283548,0.002289338,0.019793166],"study_design_scores_gemma":[0.000060619757,0.0005254808,0.006096623,0.00008454617,0.000071850845,0.00087819545,0.00007076605,0.016642988,0.95119953,0.0010529851,0.023239814,0.00007652115],"about_ca_topic_score_codex":0.0015624326,"about_ca_topic_score_gemma":0.0022083141,"teacher_disagreement_score":0.0029451682,"about_ca_system_score_codex":0.0009587041,"about_ca_system_score_gemma":0.0021026626,"threshold_uncertainty_score":0.015575707},"labels":[],"label_agreement":null},{"id":"W3211713559","doi":"10.1136/jitc-2021-sitc2021.459","title":"459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Pembrolizumab; TIGIT; Medicine; Internal medicine; Oncology; Lung cancer; Antibody; Phases of clinical research; Chemotherapy; Immunotherapy; Cancer; Immunology","score_opus":0.013459531560581944,"score_gpt":0.2621275120378249,"score_spread":0.24866798047724298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211713559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826066,0.0022695672,0.00078474695,0.00074396125,0.0005567694,0.007812671,0.0024203258,0.00016873785,0.0026365847],"genre_scores_gemma":[0.9808843,0.0016192702,0.002134827,0.0020625386,0.00039978855,0.0058307154,0.0030243557,0.00006246431,0.0039816727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992895,0.00031858424,0.00003357113,0.00011483336,0.000075842836,0.00016754077],"domain_scores_gemma":[0.999169,0.00010028632,0.00012011564,0.000073776384,0.00008069167,0.00045625662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021207065,0.0016318167,0.0029118834,0.00048429088,0.00073731755,0.0015394805,0.0011388052,0.0021064307,0.005298207],"category_scores_gemma":[0.0009995935,0.0010418826,0.0030382553,0.00038241493,0.0011038533,0.0010274182,0.00039678637,0.0048875944,0.0014219343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8671164,0.082906365,0.0020303365,0.00050528906,0.001608176,0.00010015525,0.0001581117,0.0011301909,0.02041328,0.00014826343,0.0028811626,0.02100226],"study_design_scores_gemma":[0.74049366,0.24994102,0.0042085676,0.000024502442,0.000545901,0.00008334641,0.000039330764,0.00076934876,0.0020600685,0.00013329074,0.0016668758,0.00003417448],"about_ca_topic_score_codex":0.0025222867,"about_ca_topic_score_gemma":0.0055251606,"teacher_disagreement_score":0.005298207,"about_ca_system_score_codex":0.0015746872,"about_ca_system_score_gemma":0.0030997368,"threshold_uncertainty_score":0.017724216},"labels":[],"label_agreement":null},{"id":"W3212221590","doi":"10.1136/jitc-2021-sitc2021.587","title":"587 Inducing mismatch repair deficiency in combination with anti-CTLA4 therapy is highly effective against non-immunogenic neuroblastoma tumors","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Neuroblastoma; Cancer research; Immunotherapy; Medicine; Melanoma; DNA mismatch repair; Tumor-infiltrating lymphocytes; Flow cytometry; Nivolumab; Antibody; MLH1; Cancer; Oncology; Immunology; Internal medicine; Biology; Cell culture; Colorectal cancer","score_opus":0.010589970114445417,"score_gpt":0.24355012770787968,"score_spread":0.23296015759343425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212221590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265385,0.0022116404,0.00084566924,0.00018909016,0.0001420153,0.000101310405,0.00045847188,0.00016471848,0.0032332505],"genre_scores_gemma":[0.9931625,0.0017203476,0.0011063778,0.00016147712,0.000038444152,0.00010759845,0.00085687864,0.00001889733,0.0028274448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988997,0.00001776027,0.000012428866,0.000016056241,0.000029997464,0.000033817814],"domain_scores_gemma":[0.9999298,0.000008997272,0.000013533737,0.000008466369,0.0000057532916,0.000033486547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013979488,0.00030993755,0.00049657124,0.00024320478,0.00011302995,0.00022586448,0.0003038189,0.00024531825,0.0014874211],"category_scores_gemma":[0.000069430076,0.000120701996,0.00025457426,0.0001297269,0.00018653748,0.00014863623,0.00014861852,0.00076425413,0.00035862275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001974645,0.0013806677,0.0005784891,0.00014701902,0.000043010597,0.00011891246,0.000022866512,0.00029519296,0.97695506,0.00019315392,0.0008151176,0.017475834],"study_design_scores_gemma":[0.0010304183,0.017926874,0.011272408,0.000039708648,0.00011469594,0.00073001185,0.00004698353,0.0019793003,0.95594645,0.0001291109,0.01076839,0.000015774836],"about_ca_topic_score_codex":0.0005886893,"about_ca_topic_score_gemma":0.0012340583,"teacher_disagreement_score":0.0014874211,"about_ca_system_score_codex":0.00017699288,"about_ca_system_score_gemma":0.00026592994,"threshold_uncertainty_score":0.0049759746},"labels":[],"label_agreement":null},{"id":"W3212274217","doi":"10.1136/jitc-2021-sitc2021.374","title":"374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Sanofi","keywords":"Pembrolizumab; Aflibercept; Medicine; Oncology; Internal medicine; Cancer; Bevacizumab; Immunotherapy; Chemotherapy","score_opus":0.010628406773812712,"score_gpt":0.26602352087909115,"score_spread":0.25539511410527843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212274217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877089,0.002187852,0.00033327908,0.0010480114,0.00024869788,0.0033483712,0.0012795731,0.00006079662,0.0037845436],"genre_scores_gemma":[0.98870903,0.00155013,0.0011857413,0.0012470168,0.00020843121,0.0019644455,0.0022263152,0.00001507977,0.0028939077],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997701,0.00008810863,0.00001386193,0.00003877107,0.000023615403,0.000065633954],"domain_scores_gemma":[0.9997358,0.000030901032,0.000031079246,0.000012114712,0.00001756108,0.00017252774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080016284,0.00093548256,0.0010462328,0.0002901141,0.00039393388,0.0007303398,0.00056107325,0.0008701373,0.005015036],"category_scores_gemma":[0.00038754093,0.00043149124,0.0010753584,0.00025160576,0.0005964288,0.0005185911,0.00023334577,0.0024479772,0.0009279061],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7646522,0.053244885,0.009236126,0.00088072364,0.0013441786,0.00037441932,0.00030308275,0.0024638479,0.05589086,0.000460154,0.008600445,0.102549106],"study_design_scores_gemma":[0.63812286,0.337227,0.013806564,0.000037978592,0.00045349234,0.00023288219,0.00007631068,0.0011055417,0.0034109782,0.00023854492,0.0052635917,0.000024237506],"about_ca_topic_score_codex":0.0018694648,"about_ca_topic_score_gemma":0.004911193,"teacher_disagreement_score":0.005015036,"about_ca_system_score_codex":0.0012868403,"about_ca_system_score_gemma":0.0018315911,"threshold_uncertainty_score":0.016776979},"labels":[],"label_agreement":null},{"id":"W3212494582","doi":"10.1136/jitc-2021-sitc2021.036","title":"36 Digital Whole Slide Image (WSI) scoring is equivalent to microscope glass slide scoring for evaluation of programmed death-ligand 1 (PD-L1) expression across multiple tumor indications","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Concordance; Medicine; Digital pathology; Digital image analysis; Nuclear medicine; Cutoff; Pathology; Internal medicine; Computer science; Computer vision; Physics","score_opus":0.03299134903457568,"score_gpt":0.3410151725997529,"score_spread":0.3080238235651772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212494582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63510364,0.0019309769,0.31464738,0.0006032531,0.0005283578,0.0015779746,0.0046274615,0.005484971,0.035495896],"genre_scores_gemma":[0.61855644,0.0009922531,0.36171523,0.00023380031,0.00010078139,0.00078421924,0.0030529958,0.0005204568,0.0140438005],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978733,0.00046103203,0.00035537872,0.00036464463,0.0008539906,0.000091743575],"domain_scores_gemma":[0.99793565,0.00041422687,0.00036514486,0.00048650592,0.0007000416,0.000098457334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020279817,0.0004976616,0.0002781959,0.0021985655,0.00027441463,0.0010265651,0.00055802846,0.00029011743,0.01291088],"category_scores_gemma":[0.0021357932,0.0004547817,0.00036137726,0.0010356323,0.00078132434,0.0006284763,0.0005674509,0.00037525716,0.002758757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010714554,0.00018177535,0.10658248,0.0005960034,0.00013252895,0.00058157183,0.0002758921,0.00081262685,0.70692235,0.00242625,0.007411043,0.17300606],"study_design_scores_gemma":[0.00007452477,0.0008228896,0.34405786,0.000090502705,0.00018530675,0.006245321,0.0005062926,0.02140489,0.5920547,0.0015025767,0.03293467,0.00012038183],"about_ca_topic_score_codex":0.0013252824,"about_ca_topic_score_gemma":0.0046205022,"teacher_disagreement_score":0.01291088,"about_ca_system_score_codex":0.0004731308,"about_ca_system_score_gemma":0.0004690836,"threshold_uncertainty_score":0.043191195},"labels":[],"label_agreement":null},{"id":"W3212495819","doi":"10.1136/jitc-2021-sitc2021.302","title":"302 Characterization of TIGIT and PVR expression in colorectal liver metastases","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Institut Du Cancer de Montréal; Bristol-Myers Squibb","keywords":"TIGIT; Immune system; Cancer research; Immune checkpoint; Immunotherapy; Medicine; Metastasis; Cancer; Immunology; Internal medicine","score_opus":0.014115980077505693,"score_gpt":0.2360600032502943,"score_spread":0.2219440231727886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212495819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973175,0.0003633005,0.0010000179,0.000022367307,0.00000322812,0.00002391745,0.0005721731,0.000030751235,0.0006667078],"genre_scores_gemma":[0.99607915,0.00018193749,0.001271341,0.00004084595,0.0000053799113,0.00004419496,0.0012196077,0.000015392367,0.0011421959],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999442,0.000004840906,0.0000033445713,0.000012970884,0.000017463022,0.000017219687],"domain_scores_gemma":[0.9999343,0.0000092990795,0.000020115514,0.000004095864,0.000009692918,0.000022442748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058835718,0.00012503563,0.000101304926,0.00028779448,0.000080629776,0.00016012158,0.00006600159,0.00017490554,0.0013310036],"category_scores_gemma":[0.000098665485,0.00006225913,0.00010149337,0.00015648021,0.00010995434,0.000054197342,0.00008533861,0.00018387678,0.00041595133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006953164,0.0000049469336,0.001356644,0.000009712339,0.0000014433462,0.00004805979,0.000009741271,0.000019664083,0.998044,0.0000106393345,0.000014365081,0.00041126536],"study_design_scores_gemma":[0.000037185433,0.0006962578,0.2472774,0.00001119502,0.000023721044,0.0027210196,0.00022730057,0.0030235872,0.7425894,0.00011246187,0.003270032,0.000010466611],"about_ca_topic_score_codex":0.0007317656,"about_ca_topic_score_gemma":0.00074985897,"teacher_disagreement_score":0.0013310036,"about_ca_system_score_codex":0.00012700816,"about_ca_system_score_gemma":0.000085870604,"threshold_uncertainty_score":0.004452646},"labels":[],"label_agreement":null},{"id":"W3212553475","doi":"10.1136/jitc-2021-sitc2021.466","title":"466 Use of a 27-gene immuno-oncology (IO) assay to associate response to single-agent immune checkpoint inhibitor (ICI) therapy in advanced-stage NSCLC patients from a large Canadian cohort","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncology; Medicine; Internal medicine; Lung cancer; Cancer; Targeted therapy; Biomarker; Breast cancer; Immunotherapy; Immunohistochemistry; Biology","score_opus":0.02346754772782018,"score_gpt":0.2608376512464363,"score_spread":0.23737010351861615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212553475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005413,0.00037611608,0.00045412238,0.00016205951,0.000023513958,0.00014592265,0.006386273,0.000033109154,0.0023646727],"genre_scores_gemma":[0.99217767,0.00024627312,0.0009556955,0.0002680842,0.00001591903,0.000095178206,0.004407985,0.000017716504,0.0018154411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936527,0.00004259182,0.000028102038,0.00018859396,0.00022768436,0.00014774196],"domain_scores_gemma":[0.99889684,0.00006923538,0.0001381524,0.00006836379,0.0006374251,0.00019002696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006324295,0.0003343758,0.00036567455,0.0010272425,0.0011195814,0.00077222945,0.0006222884,0.0003935525,0.0013966484],"category_scores_gemma":[0.0009895769,0.00022683629,0.0005634868,0.0013074235,0.000455518,0.00013584903,0.0003272135,0.000546564,0.0004429507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038717763,0.00007579969,0.9843322,0.00003568695,0.00006375321,0.00018451139,0.00035810485,0.00017465773,0.0045776432,0.000064766326,0.0019134374,0.007832205],"study_design_scores_gemma":[0.000024638945,0.00020001875,0.99322814,0.000009045663,0.000052349515,0.00035325933,0.000372714,0.0006983868,0.0010989603,0.000018528592,0.003925237,0.000018691053],"about_ca_topic_score_codex":0.7731179,"about_ca_topic_score_gemma":0.83855957,"teacher_disagreement_score":0.2268821,"about_ca_system_score_codex":0.006810131,"about_ca_system_score_gemma":0.0053792126,"threshold_uncertainty_score":0.45643646},"labels":[],"label_agreement":null},{"id":"W3212850110","doi":"10.1136/jitc-2021-sitc2021.597","title":"597 The role of CCL20 in mediating regulatory T cell infiltration and resistance to radiotherapy in head and neck squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"CCL20; Radioresistance; Cancer research; Chemokine; Head and neck squamous-cell carcinoma; Cetuximab; Tumor microenvironment; Head and neck cancer; Medicine; Radiation therapy; Immune system; Immunology; Chemokine receptor; Antibody; Internal medicine; Tumor cells; Monoclonal antibody","score_opus":0.008062825554022547,"score_gpt":0.22243572269095008,"score_spread":0.21437289713692753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212850110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960526,0.0018592752,0.00024681448,0.00007821894,0.000021689151,0.00003214906,0.00024323392,0.000030836643,0.0014351049],"genre_scores_gemma":[0.9975298,0.0006214689,0.00021683906,0.00006733768,0.000019058458,0.00003448659,0.00035257326,0.0000047192434,0.0011537733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999299,0.000011014904,0.0000044833955,0.0000068805243,0.00001360425,0.000034129367],"domain_scores_gemma":[0.99995327,0.0000074019536,0.000008371817,0.0000037059585,0.000010238483,0.0000169826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109231376,0.00017715768,0.00016757619,0.00021593583,0.00016424293,0.0002044139,0.00012384476,0.00019588677,0.0021501377],"category_scores_gemma":[0.000081638194,0.00006979685,0.00023591775,0.00012732549,0.00015203621,0.00012431352,0.00009150744,0.0002132205,0.00035746256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090298423,0.00017619188,0.006260754,0.00011399739,0.000009339751,0.0003821438,0.00004255098,0.00012142994,0.9875425,0.00013318357,0.0003478699,0.00396709],"study_design_scores_gemma":[0.0002712061,0.0029386368,0.19526626,0.000043316108,0.000082095336,0.0020323724,0.00037253267,0.0027852717,0.785953,0.0002175622,0.01001478,0.000022967395],"about_ca_topic_score_codex":0.0015148246,"about_ca_topic_score_gemma":0.001344868,"teacher_disagreement_score":0.0021501377,"about_ca_system_score_codex":0.00032988278,"about_ca_system_score_gemma":0.0002761774,"threshold_uncertainty_score":0.0071929693},"labels":[],"label_agreement":null},{"id":"W3212914573","doi":"10.1136/jitc-2021-sitc2021.509","title":"509 A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD8; Immunotherapy; Refractory (planetary science); Cytotoxic T cell; Cancer; Internal medicine; Oncology; Cancer immunotherapy; Dosing; Immune system; Cancer research; Immunology; Chemistry; Biology; In vitro","score_opus":0.018619486975963523,"score_gpt":0.28676740589623634,"score_spread":0.2681479189202728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212914573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845084,0.0015108366,0.0010577205,0.000678968,0.00019343595,0.005976517,0.0024311324,0.0002447156,0.0033983712],"genre_scores_gemma":[0.9756187,0.0016632503,0.0036084088,0.002194109,0.0002057352,0.0054808958,0.0052991537,0.000089523855,0.0058402475],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99961275,0.00017560032,0.000016213207,0.00005483582,0.000042909116,0.00009772205],"domain_scores_gemma":[0.9994629,0.00007761666,0.00006229119,0.000057942958,0.000041620635,0.00029768323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013600781,0.0014944467,0.0014755032,0.00042582472,0.00051439955,0.00074807217,0.0010199007,0.0012864941,0.005209862],"category_scores_gemma":[0.00054077443,0.0005578325,0.0011033277,0.0003031485,0.0008515335,0.0006337019,0.0003415805,0.0025747223,0.0013914985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40428346,0.25026733,0.010408447,0.0011107196,0.0011311818,0.0008659376,0.00045152567,0.004850471,0.14171436,0.0005105326,0.017883746,0.16652226],"study_design_scores_gemma":[0.26081708,0.70981216,0.009291735,0.000033819168,0.00028323653,0.00045951887,0.00007306667,0.0018090784,0.010448313,0.00020821311,0.006720019,0.000043647837],"about_ca_topic_score_codex":0.0018595353,"about_ca_topic_score_gemma":0.0045135343,"teacher_disagreement_score":0.005209862,"about_ca_system_score_codex":0.0011037261,"about_ca_system_score_gemma":0.002497431,"threshold_uncertainty_score":0.017428756},"labels":[],"label_agreement":null},{"id":"W3214232282","doi":"10.1136/jitc-2021-sitc2021.353","title":"353 Identification of potential response predictors to maveropepimut-S (DPX-Survivac), a novel T cell activating immunotherapy, in patients with advanced recurrent ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunotherapy; CD8; Immune system; T cell; Antigen; Ovarian cancer; Oncology; Immunohistochemistry; Cancer research; Cancer; Cyclophosphamide; Internal medicine; Chemotherapy; Immunology","score_opus":0.00683929153160976,"score_gpt":0.22010438966044987,"score_spread":0.21326509812884012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214232282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929893,0.00027132558,0.00006804877,0.000018695042,0.0000032855387,0.000013418524,0.00010674745,0.0000046504665,0.00021485698],"genre_scores_gemma":[0.9994734,0.00006462173,0.00009579317,0.00002356543,0.0000074453997,0.000012630952,0.00020448917,0.0000011165336,0.00011703639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999329,0.000014762995,0.0000058423843,0.000017972554,0.000011285906,0.000017191991],"domain_scores_gemma":[0.99987257,0.000031728137,0.000035484998,0.000007611798,0.000017047743,0.000035568784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018965302,0.000134399,0.00026161625,0.00028201175,0.00012620303,0.00024898007,0.00009349147,0.00024129121,0.00068935595],"category_scores_gemma":[0.00032497357,0.000072503026,0.00017271824,0.00023320588,0.00010782416,0.00011394633,0.0000955054,0.00022079784,0.00014696144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050117993,0.00032894494,0.93125373,0.000060124465,0.00007147744,0.00044768685,0.00016016915,0.00040197076,0.035598546,0.000033811597,0.00052670727,0.02610499],"study_design_scores_gemma":[0.0001146148,0.0036735528,0.9863667,0.000008738219,0.00009262539,0.0009190467,0.00013537431,0.0021036314,0.004958237,0.000068384885,0.0015508712,0.000008350202],"about_ca_topic_score_codex":0.00067049236,"about_ca_topic_score_gemma":0.0008209003,"teacher_disagreement_score":0.00068935595,"about_ca_system_score_codex":0.00015934798,"about_ca_system_score_gemma":0.00014668507,"threshold_uncertainty_score":0.0023061037},"labels":[],"label_agreement":null},{"id":"W3214459545","doi":"10.1136/jitc-2021-sitc2021.538","title":"538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melanoma; Refractory (planetary science); Internal medicine; Gastroenterology; Nuclear medicine; Urology; Surgery; Oncology; Cancer research; Biology","score_opus":0.013254783814050257,"score_gpt":0.2431491939966965,"score_spread":0.22989441018264622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214459545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777234,0.001832781,0.0002748761,0.00021976545,0.000030373696,0.00006956011,0.013509731,0.00007162739,0.0062678084],"genre_scores_gemma":[0.98454446,0.00036969435,0.00019546083,0.00019480243,0.000033319804,0.000057597987,0.013059896,0.00001004621,0.0015346389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985504,0.000024637135,0.00001492973,0.00003370633,0.00003824319,0.000033377146],"domain_scores_gemma":[0.99949396,0.00008453714,0.00022444152,0.000034419976,0.00007512911,0.00008737849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034739662,0.000160653,0.00036712273,0.0003440129,0.00017150285,0.00038949022,0.00018504499,0.00031216463,0.0031477981],"category_scores_gemma":[0.00053743616,0.00008263755,0.00044522394,0.00035140142,0.00008325585,0.00030004597,0.00016795867,0.00043162555,0.00047772814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026120713,0.0003889562,0.8561895,0.00024772793,0.00067888945,0.00047705267,0.00011689302,0.0021376307,0.008551008,0.00013621146,0.0071288,0.097826764],"study_design_scores_gemma":[0.0005275385,0.004617874,0.9836717,0.00003086452,0.00043779795,0.00079892913,0.00003385114,0.001041174,0.0018548354,0.00008317589,0.0068819444,0.000020310943],"about_ca_topic_score_codex":0.0021454205,"about_ca_topic_score_gemma":0.004203709,"teacher_disagreement_score":0.0031477981,"about_ca_system_score_codex":0.0004679773,"about_ca_system_score_gemma":0.00027290295,"threshold_uncertainty_score":0.010530472},"labels":[],"label_agreement":null},{"id":"W4308375764","doi":"10.1136/jitc-2022-sitc2022.0059","title":"59 DetermaIO (IO score) is associated with efficacy of ICI monotherapy in advanced NSCLC patients: a retrospective BC Cancer study","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Medicine; Cohort; Oncology; Retrospective cohort study; Chemotherapy; Cancer; Combination therapy; PD-L1; Immunotherapy","score_opus":0.013312479880391408,"score_gpt":0.25634213303346753,"score_spread":0.24302965315307612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308375764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974311,0.0005090265,0.00014464007,0.000021516878,0.000008672728,0.000017838765,0.0011612751,0.000004169392,0.00070172444],"genre_scores_gemma":[0.9986539,0.00009175871,0.00007606912,0.000029701838,0.000007865078,0.00001572205,0.00097592606,0.0000031015854,0.00014594932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996351,0.00004978895,0.00004336536,0.00014432365,0.000069950074,0.000057457877],"domain_scores_gemma":[0.999335,0.00009853796,0.00025272023,0.00008882539,0.00011061353,0.000114225826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047714743,0.00016372568,0.00028115668,0.0005373793,0.00033327178,0.00058635615,0.0001950916,0.0003065352,0.0011964781],"category_scores_gemma":[0.00079151156,0.00018626999,0.0005450332,0.0007619649,0.0001973308,0.00021012798,0.0002891992,0.0003303835,0.00028963984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019368464,0.000010651122,0.99811447,0.000010693379,0.000068893234,0.0000335706,0.000018342178,0.000027081136,0.00046076957,0.000009159225,0.000119550714,0.0009332065],"study_design_scores_gemma":[0.000008004905,0.000071120914,0.998809,0.000004248041,0.000063624524,0.000196887,0.000052445128,0.00015523219,0.0001664841,0.000016570293,0.00045307557,0.0000033909446],"about_ca_topic_score_codex":0.0036580872,"about_ca_topic_score_gemma":0.0054783085,"teacher_disagreement_score":0.0036580872,"about_ca_system_score_codex":0.00031168255,"about_ca_system_score_gemma":0.00023733231,"threshold_uncertainty_score":0.0072736144},"labels":[],"label_agreement":null},{"id":"W4308377062","doi":"10.1136/jitc-2022-sitc2022.0009","title":"9 A pan-cancer multi-omic immune single-cell atlas for cancer immunotherapy: focus on CD4+ T cells","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute; Society for Immunotherapy of Cancer; Parker Institute for Cancer Immunotherapy; AstraZeneca; Bristol-Myers Squibb","keywords":"Immunotherapy; Cancer immunotherapy; T cell; Immune system; Computational biology; CD8; Metadata; Cancer; Transcriptome; Biology; Computer science; Immunology; Gene expression; World Wide Web; Gene; Genetics","score_opus":0.020840147660867253,"score_gpt":0.24210162126527568,"score_spread":0.22126147360440843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308377062","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036342077,0.009252248,0.06649049,0.0030340815,0.0011355849,0.0004546023,0.83268934,0.02042402,0.030177474],"genre_scores_gemma":[0.06266934,0.003979183,0.08695592,0.0024800864,0.00033885863,0.00114555,0.8320281,0.0019648937,0.008438053],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99872017,0.00021548088,0.00010538359,0.0003915998,0.00037439555,0.00019295716],"domain_scores_gemma":[0.99841225,0.00026215648,0.00019853219,0.00039459087,0.0005108353,0.00022163607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018898814,0.00070198375,0.0010820477,0.0033561687,0.0012179948,0.0029198215,0.0013621288,0.001020286,0.016017975],"category_scores_gemma":[0.0024740114,0.00046698935,0.0013274559,0.004926803,0.0003981229,0.0010461845,0.0028834506,0.0012060358,0.009272143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013181783,0.000102226244,0.0320021,0.009788249,0.00141114,0.0007230468,0.00088213786,0.0070180455,0.2212042,0.02052952,0.5400855,0.16493562],"study_design_scores_gemma":[0.000092009504,0.00011883691,0.03322303,0.00054747885,0.00044171172,0.0006592183,0.00032567108,0.0041558896,0.03265517,0.00873412,0.9189578,0.00008909494],"about_ca_topic_score_codex":0.00583415,"about_ca_topic_score_gemma":0.012435415,"teacher_disagreement_score":0.016017975,"about_ca_system_score_codex":0.0014041469,"about_ca_system_score_gemma":0.004003821,"threshold_uncertainty_score":0.05358547},"labels":[],"label_agreement":null},{"id":"W4308378248","doi":"10.1136/jitc-2022-sitc2022.0234","title":"234 Bead-bound antibody-activation of T cells provides sub-optimal metabolic programming and tumour control compared to dendritic cell-activated T cells","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"CD28; T cell; Biology; Cell biology; Cytotoxic T cell; Antigen; Dendritic cell; Cancer research; CD8; Molecular biology; Immunology; Biochemistry; Immune system; In vitro","score_opus":0.018158421451222675,"score_gpt":0.27313632410871636,"score_spread":0.2549779026574937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308378248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537635,0.00055827055,0.0022097742,0.00006109359,0.000022871413,0.000017579623,0.0002760318,0.00005660783,0.0014213995],"genre_scores_gemma":[0.99650395,0.0002509799,0.0017618431,0.000056469915,0.000008473587,0.000020423651,0.00032292202,0.000022891776,0.0010520632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998387,0.000022862305,0.000011991696,0.00003223155,0.000036001948,0.000058087982],"domain_scores_gemma":[0.99994075,0.000011986322,0.000018091283,0.0000048221127,0.000008188848,0.000016134574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008476149,0.00022038582,0.00019982609,0.00007598624,0.00008679413,0.0003738598,0.00014050007,0.00023828325,0.0015235584],"category_scores_gemma":[0.00007587813,0.00009618805,0.00018582791,0.00013215296,0.0001630895,0.00011802044,0.00011189535,0.00051222934,0.0004824458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028041276,0.000029441608,0.00013775159,0.00002499866,0.0000025267454,0.000011836029,0.0000059284625,0.000102425416,0.9983535,0.000037727314,0.00004344006,0.00097014866],"study_design_scores_gemma":[0.00001928007,0.0003403804,0.0014292803,0.0000022902977,0.000009135854,0.000057487796,0.000012311833,0.0006504518,0.9965833,0.000024296038,0.0008688171,0.0000030189951],"about_ca_topic_score_codex":0.00035000005,"about_ca_topic_score_gemma":0.000718523,"teacher_disagreement_score":0.0015235584,"about_ca_system_score_codex":0.00018922331,"about_ca_system_score_gemma":0.00017168789,"threshold_uncertainty_score":0.005096793},"labels":[],"label_agreement":null},{"id":"W4308378595","doi":"10.1136/jitc-2022-sitc2022.0052","title":"52 Digital pathology training effectiveness for the evaluation of PD-L1 expression in multiple tumor indications","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Digital pathology; Concordance; Medicine; Digital image analysis; Test (biology); Medical physics; Artificial intelligence; Computer science; Pathology; Computer vision; Internal medicine","score_opus":0.04122079206106776,"score_gpt":0.3111353124665198,"score_spread":0.26991452040545205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308378595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828468,0.0005806861,0.005884757,0.0002045028,0.00008028816,0.00028439908,0.0004949208,0.0003270789,0.009296525],"genre_scores_gemma":[0.9895865,0.00016395489,0.00729078,0.0000726581,0.00003318298,0.00016849907,0.0004950806,0.000057969366,0.002131484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934316,0.002715238,0.0005602606,0.0011731539,0.0017888205,0.00033095438],"domain_scores_gemma":[0.98041946,0.012577589,0.0027017025,0.0015394101,0.0018260614,0.00093586574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010444376,0.0003908363,0.00032327065,0.0011084165,0.0003869981,0.0010383318,0.0005250616,0.00040815986,0.00873376],"category_scores_gemma":[0.019652786,0.00025077234,0.00071401236,0.0004591518,0.00050707994,0.00072281435,0.0010865736,0.00034151977,0.0014656857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010601273,0.0019735598,0.4850702,0.0005643709,0.00034819375,0.00017295666,0.0009084112,0.0032177868,0.03710774,0.00034279175,0.004823613,0.4548691],"study_design_scores_gemma":[0.00011422532,0.006196847,0.93274885,0.00011719636,0.00039736502,0.0004777843,0.00043731355,0.014019366,0.039784107,0.00018426817,0.0054471334,0.00007555977],"about_ca_topic_score_codex":0.0016424553,"about_ca_topic_score_gemma":0.0030748039,"teacher_disagreement_score":0.010444376,"about_ca_system_score_codex":0.00077271677,"about_ca_system_score_gemma":0.00041858453,"threshold_uncertainty_score":0.055235803},"labels":[],"label_agreement":null},{"id":"W4308381384","doi":"10.1136/jitc-2022-sitc2022.1350","title":"1350 AI/ML-driven discovery of Collagen Triple Helix Repeat-Containing 1, CTHRC1, a novel proteoglycan for disruption of stromal barriers and enhancement of immunotherapy responses in desmoplastic tumors","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Centre for Phenogenomics","funders":"","keywords":"Stromal cell; Cancer-Associated Fibroblasts; Cancer research; Tumor microenvironment; Breast cancer; Cancer immunotherapy; Pancreatic cancer; Medicine; Immunotherapy; Cancer; Immune system; Immunology; Internal medicine; Tumor cells","score_opus":0.010093382535066147,"score_gpt":0.2456134219118275,"score_spread":0.23552003937676136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308381384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788542,0.0019724453,0.010369202,0.0003876086,0.00008400383,0.00019757598,0.003952971,0.00028296106,0.0038991119],"genre_scores_gemma":[0.9637783,0.0016135297,0.021358361,0.0002810046,0.000034305296,0.00011822858,0.0059478353,0.00006362553,0.0068046423],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99992,0.000008088732,0.0000041106323,0.000016229238,0.000036874662,0.000014721274],"domain_scores_gemma":[0.99994826,0.0000060580574,0.000016439655,0.000003328478,0.000009848007,0.000016047503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018556727,0.00021263662,0.00013306274,0.00022695462,0.00012299493,0.00025551408,0.00012837882,0.00015801362,0.0010863624],"category_scores_gemma":[0.00007556474,0.00007814299,0.00016527176,0.00015851148,0.00012217098,0.000075893906,0.00009567421,0.0002988008,0.00033095034],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044844994,0.000014544896,0.00015953639,0.000020940195,0.0000025577372,0.00002200396,0.0000032308692,0.00010107903,0.9981364,0.000067597844,0.00013055162,0.0012967936],"study_design_scores_gemma":[0.000014747026,0.00022129898,0.00337657,0.0000035388373,0.000012550074,0.00016690957,0.000012883062,0.0020023626,0.98908114,0.000043816843,0.0050605047,0.0000037269647],"about_ca_topic_score_codex":0.000696613,"about_ca_topic_score_gemma":0.0014409092,"teacher_disagreement_score":0.0010863624,"about_ca_system_score_codex":0.00034278195,"about_ca_system_score_gemma":0.00027965903,"threshold_uncertainty_score":0.0036342144},"labels":[],"label_agreement":null},{"id":"W4308383460","doi":"10.1136/jitc-2022-sitc2022.1185","title":"1185 Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nuvation (Canada); Zymeworks (Canada)","funders":"","keywords":"Immune system; TLR7; Purine; Pharmacology; Antibody; Peripheral blood mononuclear cell; Splenocyte; In vitro; Chemistry; Cytokine; Cancer research; Immunology; Biology; Biochemistry; Toll-like receptor; Innate immune system","score_opus":0.020887112292559094,"score_gpt":0.3131224107280727,"score_spread":0.2922352984355136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308383460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907691,0.0012854902,0.0047127567,0.000051993266,0.000021956394,0.00012144227,0.00030669078,0.00006342977,0.0026672506],"genre_scores_gemma":[0.99148273,0.0008204721,0.006109299,0.000045427765,0.0000074693535,0.000076468525,0.00028699733,0.000015657191,0.0011554642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999087,0.000023873261,0.000008202286,0.000015361053,0.000022388387,0.000021379698],"domain_scores_gemma":[0.9999379,0.000009737881,0.000022136792,0.000004356387,0.000012133003,0.000013629773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016304596,0.00027269433,0.00015888887,0.00014438413,0.00008462516,0.00016731993,0.00016094187,0.00023747582,0.0011078692],"category_scores_gemma":[0.00011955206,0.00009384992,0.00015114798,0.0001456709,0.000084849875,0.00013976236,0.000121172976,0.00022782444,0.00041335967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000235436,0.00010237836,0.00016506817,0.00008688249,0.000008717302,0.000075022144,0.000016483762,0.0008898423,0.9922645,0.0001506151,0.00012108554,0.0058840984],"study_design_scores_gemma":[0.000024422125,0.0010080662,0.00041182872,0.0000057850516,0.000008399062,0.000083705185,0.000009019673,0.0010928664,0.9948585,0.000016518154,0.002475711,0.0000051720644],"about_ca_topic_score_codex":0.0001725584,"about_ca_topic_score_gemma":0.0003955978,"teacher_disagreement_score":0.0011078692,"about_ca_system_score_codex":0.00016439255,"about_ca_system_score_gemma":0.00012953902,"threshold_uncertainty_score":0.0037062168},"labels":[],"label_agreement":null},{"id":"W4308385775","doi":"10.1136/jitc-2022-sitc2022.0750","title":"750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Gastroenterology; Oncology; Cancer; Immunotherapy","score_opus":0.010732607277661305,"score_gpt":0.2477301152551453,"score_spread":0.23699750797748398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308385775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637858,0.003573238,0.0018582195,0.0018436048,0.00047604926,0.01061314,0.0063227164,0.0005868185,0.01094046],"genre_scores_gemma":[0.9477923,0.0035928327,0.0064391834,0.0046765176,0.00034870498,0.010325547,0.010111268,0.0001717081,0.016541954],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99944633,0.0001947575,0.000020204765,0.00009764932,0.000076942,0.00016401931],"domain_scores_gemma":[0.99944264,0.00004891954,0.000056779107,0.000033683304,0.0000419832,0.0003759678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013973468,0.0020938455,0.0016872237,0.000717882,0.00074609334,0.001570763,0.0014316133,0.002449277,0.0066200574],"category_scores_gemma":[0.00052191433,0.0009182255,0.0012343685,0.0004562361,0.0010682971,0.0010913393,0.0003423432,0.005715627,0.0024734547],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22275682,0.29327795,0.0050250264,0.0012940454,0.0015572293,0.00067015237,0.000474895,0.005894072,0.260356,0.0011690445,0.031730954,0.17579377],"study_design_scores_gemma":[0.28543022,0.67344606,0.009808149,0.000058252208,0.00045215458,0.0005156843,0.000098967954,0.001800607,0.017595563,0.00041660032,0.010300613,0.000077100434],"about_ca_topic_score_codex":0.0026037276,"about_ca_topic_score_gemma":0.009569752,"teacher_disagreement_score":0.0066200574,"about_ca_system_score_codex":0.0019591658,"about_ca_system_score_gemma":0.0028318495,"threshold_uncertainty_score":0.022146285},"labels":[],"label_agreement":null},{"id":"W4308395446","doi":"10.1136/jitc-2022-sitc2022.1196","title":"1196 Streamlining T cell engager development with a diverse panel of fully human CD3-binding antibodies, bispecific engineering technology, and an integrated discovery engine","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"CD3; Bispecific antibody; Antibody; Flow cytometry; T cell; Chemistry; Molecular biology; Cancer research; Biology; Computational biology; Monoclonal antibody; Antigen; Immunology; Immune system","score_opus":0.030233380629322352,"score_gpt":0.2584438281147855,"score_spread":0.22821044748546315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308395446","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44232178,0.002272271,0.52569187,0.0010113169,0.00025695583,0.00097238197,0.0022101002,0.0048856195,0.020377677],"genre_scores_gemma":[0.4932708,0.0017339971,0.48515388,0.0007344986,0.00006911504,0.00074512453,0.00270529,0.00042074293,0.01516657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970764,0.000035421737,0.000027055434,0.000053785738,0.00012574455,0.000050396753],"domain_scores_gemma":[0.99989724,0.00002210406,0.000019683957,0.000012893245,0.000026977956,0.000021151223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052750326,0.00041721752,0.00027498454,0.00036169108,0.00015695617,0.0006132407,0.00033201787,0.00029930315,0.004342549],"category_scores_gemma":[0.000271944,0.00020393658,0.00030952768,0.0002056216,0.0001707796,0.0003309336,0.0004008439,0.00074913225,0.0023625651],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007259957,0.000080878526,0.00031556122,0.00005715359,0.00000903191,0.000050280054,0.000017692091,0.00066982745,0.9727423,0.0010474842,0.0014358631,0.023501309],"study_design_scores_gemma":[0.000022660935,0.0002239993,0.0005860035,0.000007816844,0.00000989781,0.00019999131,0.000012833013,0.006313366,0.97383267,0.0002904356,0.018490167,0.0000102517815],"about_ca_topic_score_codex":0.00046141227,"about_ca_topic_score_gemma":0.0010114416,"teacher_disagreement_score":0.004342549,"about_ca_system_score_codex":0.0004171336,"about_ca_system_score_gemma":0.0003465495,"threshold_uncertainty_score":0.014527321},"labels":[],"label_agreement":null},{"id":"W4308396193","doi":"10.1136/jitc-2022-sitc2022.0936","title":"936 Assessing educational needs for immune-related adverse events curriculum in clinical practice","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; MEDLINE; Curriculum; Family medicine; Oncology; Psychology","score_opus":0.021263464959580085,"score_gpt":0.338515185282241,"score_spread":0.3172517203226609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308396193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886636,0.00013040753,0.00032026463,0.0023690965,0.000056301946,0.0009386656,0.0012784784,0.00006271502,0.0061804433],"genre_scores_gemma":[0.9893477,0.00037123237,0.0037207897,0.0012239008,0.00006451322,0.002323144,0.0011864813,0.000014965858,0.00174725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969894,0.00089349126,0.0005274078,0.0001803497,0.0008262766,0.00058305665],"domain_scores_gemma":[0.97961915,0.006773674,0.0049309405,0.0004612131,0.0034327963,0.004782386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055181454,0.00017851693,0.0002982111,0.0014944851,0.0008447511,0.0011634867,0.0006088423,0.00089336256,0.013104771],"category_scores_gemma":[0.02580822,0.00035007548,0.0005406435,0.0010238732,0.0003131375,0.0011249053,0.0015013161,0.0008817024,0.002144156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010169389,0.0017921618,0.9375883,0.00029542175,0.000021459997,0.00012848656,0.0028149781,0.00015062602,0.0003416637,0.00008687678,0.011088284,0.045590006],"study_design_scores_gemma":[0.000042106367,0.00052787515,0.98825747,0.00017838339,0.000009877734,0.00009106189,0.004430319,0.00057470065,0.00018929796,0.00006965397,0.0056167077,0.000012619364],"about_ca_topic_score_codex":0.005050254,"about_ca_topic_score_gemma":0.009945978,"teacher_disagreement_score":0.013104771,"about_ca_system_score_codex":0.0021010463,"about_ca_system_score_gemma":0.0041573807,"threshold_uncertainty_score":0.043839812},"labels":[],"label_agreement":null},{"id":"W4308396215","doi":"10.1136/jitc-2022-sitc2022.0464","title":"464 Anti-CTLA-4 therapy depletes Tregs and expands ICOS<sup>+</sup> T-cells in neuroblastoma tumors with induced DNA mismatch repair deficiency","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Cytotoxic T cell; CTLA-4; Effector; T cell; Immunology; Biology; Neuroblastoma; Immune system; Cell culture; Genetics","score_opus":0.01719596409556085,"score_gpt":0.2377407066382172,"score_spread":0.22054474254265635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308396215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995355,0.00065952673,0.0013039827,0.00009580764,0.000052470725,0.000056408197,0.00066079915,0.0001141942,0.0017017378],"genre_scores_gemma":[0.99188155,0.00051406206,0.0018480371,0.00010884599,0.000016254431,0.00011175764,0.001090342,0.000039409002,0.0043897536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986017,0.000011316329,0.000019075638,0.00003209268,0.000038666112,0.000038768023],"domain_scores_gemma":[0.99993515,0.000006673385,0.000015501442,0.0000074470286,0.0000055977043,0.000029654697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010496372,0.00027483146,0.00031489757,0.00018599241,0.0001288543,0.0002042933,0.00016436385,0.0002352706,0.0013444858],"category_scores_gemma":[0.00004715381,0.00012711102,0.00024341777,0.000099477555,0.00020544973,0.0001419902,0.00012193856,0.0008201411,0.000418342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001505209,0.00009951452,0.00022730492,0.000023984669,0.0000037088798,0.00004620508,0.000011034467,0.00007098417,0.99821556,0.000047153164,0.00008384591,0.0010201585],"study_design_scores_gemma":[0.000043381144,0.00078407454,0.0031604702,0.000004621426,0.000014918941,0.00023970359,0.0000217874,0.00090107456,0.9926267,0.000025725874,0.0021742652,0.0000031906102],"about_ca_topic_score_codex":0.0010096154,"about_ca_topic_score_gemma":0.0018318266,"teacher_disagreement_score":0.0013444858,"about_ca_system_score_codex":0.0002295971,"about_ca_system_score_gemma":0.00029056447,"threshold_uncertainty_score":0.004497707},"labels":[],"label_agreement":null},{"id":"W4308398250","doi":"10.1136/jitc-2022-sitc2022.0999","title":"999 Investigating the immunomodulatory role of innate lymphoid cells in epithelial ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Innate lymphoid cell; Population; Biology; Immunology; Flow cytometry; Ovarian cancer; Cancer; Innate immune system; Tumor microenvironment; Cancer research; Immune system; Medicine; Genetics","score_opus":0.008682836945489242,"score_gpt":0.18897282713329414,"score_spread":0.1802899901878049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308398250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899519,0.005075232,0.0010887532,0.0002302833,0.000040584706,0.00014227733,0.0010799576,0.000033399006,0.0023576678],"genre_scores_gemma":[0.99197,0.002611538,0.0017624308,0.0004329227,0.000054074557,0.00018369881,0.0015088246,0.000014272361,0.0014622761],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998945,0.000015394595,0.000009050757,0.000020665651,0.00002783096,0.000032549447],"domain_scores_gemma":[0.99993694,0.000011610132,0.000015537658,0.0000060934494,0.0000145415515,0.000015326164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002016505,0.00011798241,0.00022713732,0.00038904973,0.0002154088,0.00040117535,0.00018070111,0.00032313107,0.0020861668],"category_scores_gemma":[0.00014393848,0.00010482339,0.00025287268,0.00032610015,0.00022793743,0.00018350862,0.00024999861,0.0003238339,0.00049046474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001620497,0.00017901986,0.05961172,0.00080201105,0.00003911688,0.00074268854,0.00025107473,0.00027590082,0.90804404,0.0002743258,0.0008525887,0.027307086],"study_design_scores_gemma":[0.00018936924,0.0028452114,0.4953027,0.00017912577,0.00021067723,0.0049509243,0.0022030356,0.0035044893,0.45311713,0.0009600241,0.03650256,0.00003480037],"about_ca_topic_score_codex":0.0004119341,"about_ca_topic_score_gemma":0.00061427697,"teacher_disagreement_score":0.0020861668,"about_ca_system_score_codex":0.00023322168,"about_ca_system_score_gemma":0.00033237637,"threshold_uncertainty_score":0.006978929},"labels":[],"label_agreement":null},{"id":"W4308398717","doi":"10.1136/jitc-2022-sitc2022.0261","title":"261 Evidence for durable anti-tumor responses by TAC-T cells in preclinical models of solid tumors","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cancer research; Flow cytometry; T cell; Antigen; Bone marrow; Immune system; Cytotoxic T cell; Biology; Molecular biology; Immunology; In vitro","score_opus":0.09622014376030799,"score_gpt":0.36606365320160206,"score_spread":0.2698435094412941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308398717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805846,0.0036521894,0.004717647,0.0004323013,0.00022682679,0.00021521168,0.0021229289,0.00037698797,0.007671359],"genre_scores_gemma":[0.9840747,0.0017020277,0.0026798625,0.00031521422,0.00008267493,0.00022694006,0.0035270299,0.000080074766,0.007311456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997477,0.00004274475,0.000022511498,0.000052305422,0.000069443595,0.000065247295],"domain_scores_gemma":[0.9997484,0.000037821734,0.000062785766,0.000041086045,0.000044096174,0.0000657414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030308694,0.000450033,0.00035764236,0.00032806935,0.00017787093,0.0003647764,0.00023920742,0.00041122548,0.0033850006],"category_scores_gemma":[0.00020882694,0.00014549043,0.0003176405,0.00018342708,0.0002892855,0.00023055685,0.00011418607,0.0015492884,0.0011987773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014281094,0.00093156676,0.00043400365,0.00012537812,0.000019559538,0.00012063914,0.000039157578,0.00023715835,0.9896912,0.00018181637,0.00083884236,0.005952386],"study_design_scores_gemma":[0.0002568985,0.016790336,0.0064789983,0.00003409955,0.00007569748,0.001027522,0.000081675855,0.0016647062,0.9645748,0.00019206488,0.008809433,0.0000137821435],"about_ca_topic_score_codex":0.00051990413,"about_ca_topic_score_gemma":0.00057687506,"teacher_disagreement_score":0.0033850006,"about_ca_system_score_codex":0.00021450147,"about_ca_system_score_gemma":0.00028636606,"threshold_uncertainty_score":0.011323988},"labels":[],"label_agreement":null},{"id":"W4308398799","doi":"10.1136/jitc-2022-sitc2022.1130","title":"1130 Investigating macrophage modulation in a murine model of soft tissue sarcoma","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Macrophage; Molecular biology; Immune system; Chemokine; Biology; Immunology; Biochemistry","score_opus":0.01672973063910705,"score_gpt":0.2365844651266673,"score_spread":0.21985473448756027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308398799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924834,0.00170098,0.0034826566,0.0003077629,0.0001318471,0.00024945659,0.0014238511,0.00011453295,0.0033406762],"genre_scores_gemma":[0.9808699,0.0015811869,0.0053714463,0.00033786587,0.00004088269,0.00041736307,0.0014397955,0.000042874814,0.009898736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997341,0.000038406826,0.000027458096,0.000049791033,0.00007491825,0.00007532597],"domain_scores_gemma":[0.9998603,0.000013686285,0.00003787589,0.000014089553,0.000019448496,0.000054638946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025051401,0.00048170827,0.00024150229,0.0005808693,0.0002344537,0.00025934263,0.00021885407,0.0007034832,0.0020573176],"category_scores_gemma":[0.000069070964,0.00018634139,0.00041205445,0.00021078858,0.0003136063,0.00028929848,0.00021268506,0.0012426368,0.0008277474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052872393,0.0004377306,0.00032025058,0.000056810826,0.000005789622,0.00013029762,0.00003872551,0.00013004089,0.99660206,0.00020964262,0.0001357276,0.0014041658],"study_design_scores_gemma":[0.00020128826,0.0076233083,0.005538805,0.000027774691,0.0000440064,0.00067840074,0.00016309092,0.0017294863,0.9765614,0.0002159652,0.00719974,0.00001674796],"about_ca_topic_score_codex":0.00072755764,"about_ca_topic_score_gemma":0.0010225446,"teacher_disagreement_score":0.0020573176,"about_ca_system_score_codex":0.0003161399,"about_ca_system_score_gemma":0.00028414224,"threshold_uncertainty_score":0.006882429},"labels":[],"label_agreement":null},{"id":"W4308399396","doi":"10.1136/jitc-2022-sitc2022.0558","title":"558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Renal cell carcinoma; Fludarabine; Medicine; Clear cell renal cell carcinoma; Internal medicine; Refractory (planetary science); Chimeric antigen receptor; Oncology; Gastroenterology; Cyclophosphamide; Cancer research; Immunotherapy; Chemotherapy; Cancer; Biology","score_opus":0.01358275220468149,"score_gpt":0.24546656095012168,"score_spread":0.23188380874544018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308399396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957711,0.0016062056,0.00023895777,0.00023170811,0.0000321668,0.0002206254,0.0006107881,0.0000371854,0.0012512943],"genre_scores_gemma":[0.99659735,0.0006320971,0.0002890032,0.00027469316,0.000034365556,0.000104701576,0.0014080829,0.000011085654,0.0006486274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99983716,0.000051855677,0.0000094035195,0.000037427006,0.00003076666,0.00003332213],"domain_scores_gemma":[0.99976975,0.000040431878,0.00004317423,0.000021404756,0.000027673197,0.00009762598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005973821,0.00035984433,0.00069941184,0.00010800907,0.00018610044,0.0005120121,0.00023402713,0.00035599867,0.001107798],"category_scores_gemma":[0.00025826704,0.00013968429,0.000545935,0.00017274293,0.00026926497,0.00023231507,0.00014378087,0.000823627,0.00031489998],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33404627,0.0246348,0.11744768,0.0009689358,0.0025947716,0.0005869261,0.00066522445,0.008614424,0.18147501,0.0004981194,0.017038262,0.31142965],"study_design_scores_gemma":[0.198688,0.44016665,0.2935479,0.00010194037,0.0029041287,0.0012086944,0.00024696512,0.008079917,0.03081806,0.00044994286,0.02369869,0.00008919492],"about_ca_topic_score_codex":0.0016485521,"about_ca_topic_score_gemma":0.003364159,"teacher_disagreement_score":0.0016485521,"about_ca_system_score_codex":0.00068855623,"about_ca_system_score_gemma":0.00072074775,"threshold_uncertainty_score":0.004995823},"labels":[],"label_agreement":null},{"id":"W4308400024","doi":"10.1136/jitc-2022-sitc2022.1156","title":"1156 STING activation in sarcoma: assessing translational therapeutic strategies","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Sting; Stimulator of interferon genes; Medicine; Cancer research; Immunotherapy; Soft tissue sarcoma; Combination therapy; Sarcoma; Immune system; Flow cytometry; Pharmacology; Immunology; Internal medicine; Pathology; Innate immune system","score_opus":0.022096676126277227,"score_gpt":0.2623944532731848,"score_spread":0.24029777714690756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308400024","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824525,0.0070157517,0.0012504656,0.0001844319,0.000044036165,0.0001986283,0.00024198215,0.000032866956,0.002786624],"genre_scores_gemma":[0.9925696,0.0039664437,0.0018484833,0.000054496937,0.000030180856,0.0000945528,0.00032306893,0.0000052856694,0.0011078696],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985063,0.00005022211,0.000012620811,0.000015594895,0.00003871515,0.000032181866],"domain_scores_gemma":[0.99990225,0.00001845883,0.00002456362,0.000009322721,0.000012533062,0.000032947497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052579807,0.0003212558,0.0003046772,0.00031976466,0.00011584177,0.00046128038,0.00022102197,0.00034140144,0.0016620655],"category_scores_gemma":[0.00012561187,0.000105222876,0.00026106086,0.00019848601,0.00026065324,0.00033210777,0.00014826805,0.0007117647,0.0002783917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002866665,0.0016934355,0.0017451908,0.00042383495,0.00004249461,0.00007281409,0.000057425943,0.001345431,0.9581079,0.00059701805,0.00028332212,0.032764472],"study_design_scores_gemma":[0.00039179038,0.042980734,0.0073550222,0.00006107726,0.00014617131,0.00032161264,0.000106462336,0.0029985285,0.93781996,0.00017721158,0.007628516,0.000013017525],"about_ca_topic_score_codex":0.00046536454,"about_ca_topic_score_gemma":0.001047966,"teacher_disagreement_score":0.0016620655,"about_ca_system_score_codex":0.00035732595,"about_ca_system_score_gemma":0.0003602432,"threshold_uncertainty_score":0.0055602193},"labels":[],"label_agreement":null},{"id":"W4308400766","doi":"10.1136/jitc-2022-sitc2022.0913","title":"913 Translational analysis of advanced metastatic bladder cancer patients treated with IO combination maveropepimut-S, cyclophosphamide, and pembrolizumab","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ELISPOT; Immune system; Medicine; Immunotherapy; Immunology; Antigen; T cell; Cancer research; Pembrolizumab","score_opus":0.009540570406654516,"score_gpt":0.23996536801863053,"score_spread":0.230424797611976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308400766","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989981,0.00024355177,0.00008397393,0.00003701146,0.000007912675,0.000039771476,0.00018285301,0.000006056533,0.0004006953],"genre_scores_gemma":[0.99867946,0.00011705824,0.00016487685,0.000081172846,0.000014600978,0.000060273884,0.0005142751,0.0000027107517,0.00036551562],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999026,0.000027876424,0.0000070856004,0.000023489103,0.00001783545,0.000021119387],"domain_scores_gemma":[0.99990606,0.000010514254,0.000023262292,0.000007699659,0.000016208596,0.000036295478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024407382,0.0001911885,0.0004528064,0.00015703432,0.00023724927,0.00028146757,0.00010780329,0.00024323101,0.0014884893],"category_scores_gemma":[0.00016991857,0.000116068884,0.00035215684,0.00023973531,0.00020669504,0.00014417227,0.0001241144,0.00033005737,0.00020667122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096405126,0.005791652,0.32480282,0.0004282309,0.00045775864,0.0013512686,0.00041691342,0.0013382657,0.491927,0.00018002692,0.0019687056,0.074932195],"study_design_scores_gemma":[0.0020475057,0.05755217,0.9044097,0.000024509336,0.0005087156,0.0014024604,0.00026595514,0.0024159981,0.02724108,0.00009822011,0.004008565,0.000025093284],"about_ca_topic_score_codex":0.0009812551,"about_ca_topic_score_gemma":0.0013414065,"teacher_disagreement_score":0.0014884893,"about_ca_system_score_codex":0.0003427823,"about_ca_system_score_gemma":0.0004054959,"threshold_uncertainty_score":0.0049794316},"labels":[],"label_agreement":null},{"id":"W4308400784","doi":"10.1136/jitc-2022-sitc2022.1028","title":"1028 IL-12 and IL-27 upregulate CD39 expression on CD8<sup>+</sup> T-cells and differentially affect CD39<sup>+</sup>CD8<sup>+</sup> T-cell effector function","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cytotoxic T cell; CD8; CD28; Biology; T cell; Molecular biology; IL-2 receptor; Tumor-infiltrating lymphocytes; Flow cytometry; Interleukin 21; Cancer research; Immune system; Cell biology; Chemistry; Immunology; In vitro; Biochemistry","score_opus":0.013384548176180563,"score_gpt":0.23369773829873697,"score_spread":0.2203131901225564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308400784","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954497,0.0007502108,0.0007473565,0.00011229816,0.00006555219,0.00002695688,0.00039013513,0.00005134138,0.0024064737],"genre_scores_gemma":[0.99320835,0.00042811866,0.0012624956,0.00013816051,0.000025441783,0.00008371583,0.0006353411,0.000017632035,0.004200712],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998499,0.000023256658,0.00001808198,0.000022799202,0.000031506763,0.00005440087],"domain_scores_gemma":[0.99993396,0.000011634582,0.000014344954,0.0000070955803,0.0000060145026,0.000027066411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006666304,0.00024235989,0.00018168364,0.00013831264,0.00007802765,0.0002447041,0.00010474475,0.00023684496,0.0037379924],"category_scores_gemma":[0.00007287873,0.00008906301,0.00015084073,0.00010171292,0.00016423242,0.00012398358,0.00010504653,0.0005707899,0.0010156487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008181819,0.00016652813,0.00046896155,0.00004764718,0.0000039788256,0.00012980583,0.000016570426,0.000062974585,0.9959948,0.00008398409,0.00014310487,0.002063354],"study_design_scores_gemma":[0.000200206,0.0024055648,0.014946054,0.000017188477,0.000032166397,0.00053992047,0.00014834719,0.0013589453,0.97414386,0.00015997748,0.006037214,0.000010526722],"about_ca_topic_score_codex":0.0001515736,"about_ca_topic_score_gemma":0.00033827775,"teacher_disagreement_score":0.0037379924,"about_ca_system_score_codex":0.0001146713,"about_ca_system_score_gemma":0.00015292194,"threshold_uncertainty_score":0.012504816},"labels":[],"label_agreement":null},{"id":"W4308407496","doi":"10.1136/jitc-2022-sitc2022.1071","title":"1071 Autologous tumor cell immunotherapeutic platform induces stress-correlated immunogenic cell death leading to immune activation within the draining lymph nodes","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Flow cytometry; Immunophenotyping; Cancer research; Immune system; Programmed cell death; Medicine; Apoptosis; Chemistry; Immunology","score_opus":0.022170415442404542,"score_gpt":0.2453659956535131,"score_spread":0.22319558021110858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308407496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906432,0.0006469828,0.0030066804,0.00014172103,0.0000671877,0.0001029169,0.0008725082,0.00018744124,0.004331488],"genre_scores_gemma":[0.9929598,0.00029304437,0.0023556806,0.00012974566,0.000012994002,0.000117440126,0.0010529419,0.000024795148,0.0030536419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986315,0.0000165506,0.000008093874,0.000030936935,0.000041743104,0.000039544644],"domain_scores_gemma":[0.9999691,0.0000046159976,0.0000083288505,0.0000051367642,0.0000039884667,0.000008787068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010607102,0.00025661493,0.00018113395,0.00010918014,0.0001211457,0.00025622742,0.00017859355,0.00024164715,0.0040259566],"category_scores_gemma":[0.00005276708,0.00011207208,0.00014490327,0.00010055086,0.00019355428,0.00013847243,0.00013789137,0.0005913486,0.00082840316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062493206,0.00017412032,0.0004664623,0.000053011907,0.000007397999,0.000045675937,0.000023075301,0.00016204527,0.99367875,0.0002535171,0.0006610138,0.003850069],"study_design_scores_gemma":[0.00012538752,0.0017188991,0.004386203,0.0000062148124,0.000014234438,0.00031043688,0.000034853347,0.001454428,0.9876694,0.00009002132,0.0041861343,0.0000037228522],"about_ca_topic_score_codex":0.00050767575,"about_ca_topic_score_gemma":0.0006567915,"teacher_disagreement_score":0.0040259566,"about_ca_system_score_codex":0.00024682705,"about_ca_system_score_gemma":0.0002544146,"threshold_uncertainty_score":0.013468206},"labels":[],"label_agreement":null},{"id":"W4388042304","doi":"10.1136/jitc-2023-sitc2023.1257","title":"1257 Augmenting post-market surveillance of serious drug-induced adverse events with artificial intelligence (AI)-aggregated case reports: proof-of-concept for PD-1/PD-L1 inhibitors for NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Medicine; Internal medicine","score_opus":0.06243865175087545,"score_gpt":0.37209425398336576,"score_spread":0.30965560223249033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4833061,0.06624377,0.10891384,0.01804941,0.0022644561,0.021694612,0.25053206,0.003625257,0.04537048],"genre_scores_gemma":[0.62834346,0.017079793,0.19678365,0.0044645583,0.0017050434,0.0084260395,0.13928305,0.00032749632,0.0035868876],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97712266,0.009267759,0.0073566493,0.0015480218,0.004295964,0.0004089466],"domain_scores_gemma":[0.81150997,0.10607633,0.044010587,0.014727373,0.021804437,0.0018713258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034643844,0.0005701524,0.00068419287,0.009393592,0.000524937,0.0035130754,0.0012536907,0.0010580703,0.0070779966],"category_scores_gemma":[0.15831241,0.00034631384,0.0019317772,0.0047091143,0.0006560004,0.0021649895,0.0024116635,0.0007868133,0.0018246277],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023107876,0.0006305385,0.3432617,0.026124232,0.0019001667,0.00304379,0.0021548925,0.003754363,0.0041378615,0.005613255,0.083434165,0.52363425],"study_design_scores_gemma":[0.0016231162,0.0022964175,0.36437538,0.0266342,0.0046698716,0.008130312,0.00341994,0.020274466,0.017155694,0.014726238,0.5363129,0.0003814649],"about_ca_topic_score_codex":0.0021766713,"about_ca_topic_score_gemma":0.0037913998,"teacher_disagreement_score":0.034643844,"about_ca_system_score_codex":0.001071982,"about_ca_system_score_gemma":0.0041329963,"threshold_uncertainty_score":0.18321633},"labels":[],"label_agreement":null},{"id":"W4388042466","doi":"10.1136/jitc-2023-sitc2023.1118","title":"1118 The iodinated fluorescein derivative PV-10 enhances the antiviral activity of CD8+ T-Cells by inducing STING dimerization: implications for enhanced vaccine applications","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Bible College","funders":"Alberta Children's Hospital Foundation; Children's Hospital Foundation","keywords":"Cytotoxic T cell; Sting; Adjuvant; CD8; Cytotoxicity; Chemistry; Medicine; Immunology; Immune system; Biology; Molecular biology; Cancer research; Biochemistry","score_opus":0.016271690769014174,"score_gpt":0.2621915126719617,"score_spread":0.24591982190294756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852282,0.0037676508,0.0066760127,0.0003136206,0.00006584021,0.000044403805,0.000234169,0.00010718032,0.00356289],"genre_scores_gemma":[0.9900149,0.0014486682,0.00509816,0.00012967449,0.000015759455,0.000024779321,0.0002646457,0.000013949619,0.0029893618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993825,0.000015598474,0.000003979169,0.000009129392,0.000012508055,0.000020625444],"domain_scores_gemma":[0.99997246,0.000005831104,0.0000075737303,0.000002241587,0.0000033124684,0.000008498759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013001559,0.00018974581,0.000105922234,0.000087049084,0.000053241198,0.00015985736,0.000152931,0.00026777983,0.0021581354],"category_scores_gemma":[0.00007141329,0.00009354979,0.00011467141,0.000079421014,0.00017175634,0.00013088969,0.00007999634,0.00033010897,0.00046843945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009585509,0.000015898046,0.00006804953,0.000025481486,9.46502e-7,0.00001923062,0.000003236609,0.00005198768,0.9984831,0.00005918496,0.000046692654,0.0011303714],"study_design_scores_gemma":[0.000019443258,0.00043619165,0.0010776914,0.0000049977148,0.000004341009,0.00013515758,0.000007859368,0.00075877656,0.9951015,0.00003362417,0.002417173,0.000003201748],"about_ca_topic_score_codex":0.0004064762,"about_ca_topic_score_gemma":0.00048516388,"teacher_disagreement_score":0.0021581354,"about_ca_system_score_codex":0.0002690997,"about_ca_system_score_gemma":0.00014780056,"threshold_uncertainty_score":0.007219672},"labels":[],"label_agreement":null},{"id":"W4388042528","doi":"10.1136/jitc-2023-sitc2023.0689","title":"689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; CD38; Pharmacodynamics; Internal medicine; Multiple myeloma; CD8; Oncology; Refractory (planetary science); Antibody; Monoclonal antibody; Pharmacology; Immunology; Gastroenterology; Bortezomib; Immune system; Pharmacokinetics; Stem cell; Biology; CD34","score_opus":0.014267462257194538,"score_gpt":0.255296573393422,"score_spread":0.24102911113622744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963462,0.0018226426,0.00014241962,0.00019530514,0.000025684289,0.000074785865,0.00032233744,0.00003386717,0.0010367199],"genre_scores_gemma":[0.99842227,0.0003003159,0.0001962339,0.0002282997,0.000044032935,0.000038671198,0.00042995298,0.000008713138,0.00033159714],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99980885,0.00006736035,0.000013898711,0.00003722891,0.000032275617,0.00004037558],"domain_scores_gemma":[0.9997305,0.000063002786,0.0000645959,0.0000142625295,0.000016955466,0.00011073079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004677588,0.00029714854,0.0009248331,0.00024839962,0.0001976313,0.00055489625,0.00019058006,0.00039470164,0.0018980056],"category_scores_gemma":[0.0006584134,0.00014935085,0.0008220193,0.00024103852,0.0001903919,0.0003240371,0.00018300833,0.0009819252,0.0003948915],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4267815,0.013247508,0.11348892,0.00070157845,0.0034808675,0.001563194,0.00045936875,0.00687431,0.15931757,0.0003056841,0.005835525,0.26794398],"study_design_scores_gemma":[0.08382152,0.3303176,0.50128543,0.000101225916,0.0042376444,0.0041640894,0.0003096949,0.015428062,0.040259335,0.00070480077,0.019223325,0.00014724521],"about_ca_topic_score_codex":0.0005999689,"about_ca_topic_score_gemma":0.0012500178,"teacher_disagreement_score":0.0018980056,"about_ca_system_score_codex":0.00052263937,"about_ca_system_score_gemma":0.00033916387,"threshold_uncertainty_score":0.006349504},"labels":[],"label_agreement":null},{"id":"W4388042546","doi":"10.1136/jitc-2023-sitc2023.0601","title":"601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Carboplatin; Atezolizumab; Bevacizumab; Medicine; Internal medicine; Paclitaxel; Oncology; Population; Chemotherapy; Cancer research; Cancer; Immunotherapy; Cisplatin; Nivolumab","score_opus":0.010029377704778903,"score_gpt":0.27238898583694954,"score_spread":0.26235960813217063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875927,0.00035503897,0.00009257285,0.000037427544,0.000007007549,0.000091560774,0.00035939337,0.000007825407,0.0002899737],"genre_scores_gemma":[0.9972313,0.00014082229,0.0002706426,0.0001486909,0.000021427146,0.00014115157,0.0015304881,0.000006606496,0.000508928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967813,0.00012591208,0.000024838451,0.00006312904,0.00006540317,0.000042586424],"domain_scores_gemma":[0.99959916,0.000075326854,0.00011493579,0.000054336993,0.000039934283,0.00011625269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010598277,0.00029856554,0.00052892335,0.00021051381,0.00021572491,0.00054716837,0.0003868413,0.00036563587,0.0016429025],"category_scores_gemma":[0.0007595627,0.00030246167,0.00067192974,0.00021575391,0.00025920718,0.00022860519,0.00029618095,0.00072846125,0.0002793233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33652896,0.008161561,0.49753928,0.00049569854,0.0023335277,0.0002828977,0.0003273319,0.0010319347,0.07470684,0.00019450524,0.0035548012,0.0748426],"study_design_scores_gemma":[0.021984104,0.056488376,0.90650374,0.000034639503,0.0014204924,0.00048400296,0.000099364544,0.0020579908,0.007851298,0.00015259066,0.0028945492,0.000028753906],"about_ca_topic_score_codex":0.00067756994,"about_ca_topic_score_gemma":0.0016367853,"teacher_disagreement_score":0.0016429025,"about_ca_system_score_codex":0.00032387898,"about_ca_system_score_gemma":0.00045906432,"threshold_uncertainty_score":0.0056049824},"labels":[],"label_agreement":null},{"id":"W4388042564","doi":"10.1136/jitc-2023-sitc2023.0695","title":"695 Efficacy and safety of trastuzumab deruxtecan (T-DXd) with durvalumab in patients with non-small cell lung cancer (HER2 altered NSCLC) who progressed on anti-PD1/PD-L1 therapy (HUDSON)","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Clinical endpoint; Oncology; Tremelimumab; Lung cancer; Trastuzumab; non-small cell lung cancer (NSCLC); Adverse effect; Cancer; Immunotherapy; Clinical trial; Nivolumab; Ipilimumab; Breast cancer","score_opus":0.010455952032273884,"score_gpt":0.2406354814381965,"score_spread":0.2301795294059226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979214,0.0008124931,0.0000642465,0.00008652586,0.000024045268,0.000071276394,0.0002652334,0.000012209197,0.0007425506],"genre_scores_gemma":[0.99776554,0.00045958767,0.00019758033,0.00015193861,0.000032718504,0.000055091114,0.0007180253,0.0000066975776,0.00061281334],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999803,0.000084072846,0.000014347672,0.000029045988,0.000022776965,0.000046883863],"domain_scores_gemma":[0.9996915,0.000060522725,0.000062532716,0.000018942865,0.000017615132,0.0001488404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006289584,0.00033850293,0.0008025435,0.00018136397,0.00018185437,0.0005712874,0.00029132227,0.0003731569,0.0014564826],"category_scores_gemma":[0.0006036645,0.00019282226,0.0006917281,0.00024908097,0.00027790005,0.0004140956,0.00024361954,0.0011668897,0.00031703812],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60433346,0.02208881,0.0431793,0.0003805397,0.0013323391,0.0004726202,0.00032316675,0.004473315,0.062433995,0.00021251019,0.003282758,0.25748718],"study_design_scores_gemma":[0.11495508,0.7042704,0.15710971,0.00006457468,0.0009228013,0.00076532183,0.00015125253,0.0040487316,0.011930031,0.0002128443,0.005524097,0.000045125555],"about_ca_topic_score_codex":0.0022327534,"about_ca_topic_score_gemma":0.004917251,"teacher_disagreement_score":0.0022327534,"about_ca_system_score_codex":0.0009933496,"about_ca_system_score_gemma":0.00068108377,"threshold_uncertainty_score":0.007207334},"labels":[],"label_agreement":null},{"id":"W4388042588","doi":"10.1136/jitc-2023-sitc2023.0347","title":"347 Functional characterization of GUCY2C-TAC T cells for the treatment of colorectal cancer using preclinical models","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"In vivo; Cancer research; Receptor; In vitro; Antigen; Cancer; Cancer cell; Colorectal cancer; Cytotoxic T cell; Chemistry; Cell biology; Biology; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.11431374849587565,"score_gpt":0.34841567456806927,"score_spread":0.2341019260721936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867661,0.0013170197,0.0068857903,0.00019653363,0.000059187634,0.00028778004,0.0015002604,0.00012124679,0.0028661273],"genre_scores_gemma":[0.9866194,0.0008341388,0.0060490803,0.00014400185,0.00002038405,0.00029192222,0.002588159,0.000034255634,0.0034187231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986815,0.000025372694,0.000010629313,0.00001952898,0.0000397425,0.000036592366],"domain_scores_gemma":[0.9999279,0.000012770591,0.000012982057,0.0000075504668,0.000018956762,0.000019892148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020612215,0.00037403108,0.000249584,0.00019426871,0.00011865936,0.00022976265,0.00018488042,0.00036612278,0.0014396809],"category_scores_gemma":[0.00011814869,0.000087142274,0.0002564975,0.00015203231,0.00012212334,0.00011197593,0.000065607506,0.00055653264,0.00061385904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018197422,0.00013725253,0.00008109306,0.000033016906,0.000004835875,0.000040177183,0.000013429708,0.000267396,0.99761415,0.00009100181,0.00013119204,0.0014044234],"study_design_scores_gemma":[0.000060585717,0.0026410324,0.0012505712,0.0000052318755,0.000021572032,0.00019213268,0.000019144069,0.0022832192,0.9906741,0.00003229214,0.002814224,0.0000058891246],"about_ca_topic_score_codex":0.0012381338,"about_ca_topic_score_gemma":0.0007165109,"teacher_disagreement_score":0.0014396809,"about_ca_system_score_codex":0.00027740977,"about_ca_system_score_gemma":0.00019417722,"threshold_uncertainty_score":0.004816234},"labels":[],"label_agreement":null},{"id":"W4388042728","doi":"10.1136/jitc-2023-sitc2023.0121","title":"121 Quantifying statistical and systematic uncertainties in predicting clinical outcomes using multiplex immunofluorescence","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Calibration; Multiplex; Poisson distribution; Statistical power; Computer science; Statistics; Statistical hypothesis testing; Microscope; Pattern recognition (psychology); Artificial intelligence; Optics; Mathematics; Physics; Bioinformatics; Biology","score_opus":0.06725253300185183,"score_gpt":0.32539977783584545,"score_spread":0.25814724483399365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042728","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34787607,0.005823583,0.617104,0.0068044798,0.0012830598,0.0005126408,0.0074516735,0.0034216035,0.009723004],"genre_scores_gemma":[0.8817733,0.0013196076,0.107693195,0.0018920522,0.0007051279,0.00047463118,0.0035608602,0.0006277165,0.001953566],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9930779,0.0028426999,0.00045349792,0.00076718203,0.002618417,0.00024032447],"domain_scores_gemma":[0.9743866,0.017226694,0.0024280201,0.0022279522,0.0034848242,0.00024598208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012925405,0.0008726328,0.000592545,0.0015837166,0.00054623716,0.0019084485,0.0011271789,0.0010156947,0.0038054523],"category_scores_gemma":[0.033584986,0.00055411115,0.0010510018,0.0009636529,0.0010104077,0.00080980186,0.0010574829,0.0012751101,0.000812669],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016488074,0.00037408195,0.35965803,0.001295579,0.0016058506,0.0012147444,0.00066259824,0.18927193,0.12713252,0.012735749,0.02371539,0.28068468],"study_design_scores_gemma":[0.0000699973,0.0006038654,0.15684071,0.00034709406,0.00045821,0.0009493843,0.00040081746,0.6104686,0.17731112,0.027182048,0.02500166,0.000366503],"about_ca_topic_score_codex":0.0033890975,"about_ca_topic_score_gemma":0.0042822203,"teacher_disagreement_score":0.012925405,"about_ca_system_score_codex":0.001747176,"about_ca_system_score_gemma":0.0011927094,"threshold_uncertainty_score":0.06835687},"labels":[],"label_agreement":null},{"id":"W4388047619","doi":"10.1136/jitc-2023-sitc2023.0778","title":"778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Cancer; Internal medicine; Oncology; Surgery; Immunotherapy; Cancer research","score_opus":0.04680987990646559,"score_gpt":0.31675635918176015,"score_spread":0.2699464792752946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848316,0.0013900612,0.00050728675,0.000800342,0.00041236047,0.00640967,0.0018893855,0.00015457929,0.0036049618],"genre_scores_gemma":[0.975836,0.0015465039,0.002499647,0.0021922775,0.0004957932,0.0072920676,0.0033179808,0.000073361094,0.0067465208],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995036,0.00025261633,0.000021969245,0.000069895934,0.00005552431,0.000096416006],"domain_scores_gemma":[0.99903595,0.00016633638,0.00016956903,0.000059507074,0.00005371962,0.0005148712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017346926,0.0015330433,0.0018169952,0.00044353312,0.00058727956,0.0010723236,0.0010675809,0.0020025498,0.005738661],"category_scores_gemma":[0.0008730602,0.000657143,0.0016081915,0.00027705135,0.0010586961,0.0009372074,0.00032967023,0.004107145,0.0013321108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8323248,0.08862117,0.0017749707,0.00053219066,0.0006606335,0.00014579916,0.00012133904,0.0012078527,0.037780218,0.00027000386,0.0046970565,0.03186406],"study_design_scores_gemma":[0.60545295,0.3863767,0.003297207,0.000022439239,0.0002446652,0.00008001075,0.00002873207,0.00071339606,0.0022710005,0.0001581345,0.0013284519,0.000026233127],"about_ca_topic_score_codex":0.0015313778,"about_ca_topic_score_gemma":0.005009654,"teacher_disagreement_score":0.005738661,"about_ca_system_score_codex":0.0011029027,"about_ca_system_score_gemma":0.0025114778,"threshold_uncertainty_score":0.019197762},"labels":[],"label_agreement":null},{"id":"W4388047658","doi":"10.1136/jitc-2023-sitc2023.0654","title":"654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cytokine release syndrome; Chimeric antigen receptor; Adverse effect; Refractory (planetary science); Internal medicine; Pharmacokinetics; Immunotherapy; Leukapheresis; T cell; Chemotherapy; Oncology; Gastroenterology; Immunology; Immune system; Cancer; Stem cell","score_opus":0.044519737722509396,"score_gpt":0.3424634879703385,"score_spread":0.2979437502478291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897323,0.00087035197,0.00051438593,0.00043546842,0.000124735,0.0034915304,0.0014931281,0.000084042986,0.0032540779],"genre_scores_gemma":[0.98310167,0.000950674,0.0018223353,0.0013661652,0.00018565347,0.0030984841,0.0040045828,0.00003815133,0.0054323697],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970466,0.00014097488,0.000013952122,0.00004038963,0.000030400477,0.00006961851],"domain_scores_gemma":[0.9995747,0.00006686435,0.000057939826,0.000040343195,0.00002904592,0.00023109939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012599186,0.0008492024,0.0008601312,0.00031760323,0.0003645744,0.0006279638,0.00059043657,0.0008152665,0.005233837],"category_scores_gemma":[0.00045929383,0.0003293357,0.0008644147,0.00027124202,0.0006021079,0.0003729842,0.00020723735,0.0020341403,0.0009908547],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.713187,0.09907936,0.0065657194,0.000632363,0.0010722065,0.00047718425,0.00023076951,0.003205817,0.075433545,0.0005961795,0.0100383395,0.08948157],"study_design_scores_gemma":[0.5176327,0.46264553,0.0058963173,0.000029710034,0.00030286176,0.00019612514,0.000044085187,0.0016166297,0.00784044,0.00033467807,0.0034419147,0.000018975854],"about_ca_topic_score_codex":0.0015895783,"about_ca_topic_score_gemma":0.0025384524,"teacher_disagreement_score":0.005233837,"about_ca_system_score_codex":0.0007367258,"about_ca_system_score_gemma":0.0018346284,"threshold_uncertainty_score":0.017508864},"labels":[],"label_agreement":null},{"id":"W4388047700","doi":"10.1136/jitc-2023-sitc2023.0609","title":"609 Phase 1/2a dose selection of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced solid malignancies","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antibody; Pharmacokinetics; In vitro; Monoclonal antibody; Pharmacology; Receptor; Cancer research; Cell cycle; Medicine; Chemistry; Internal medicine; Immunology; Cancer; Biochemistry","score_opus":0.010168535610960905,"score_gpt":0.27046151261438733,"score_spread":0.2602929770034264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073434,0.0009830631,0.0011489983,0.00023042927,0.000039189585,0.0018968673,0.001346562,0.00015204062,0.0034684702],"genre_scores_gemma":[0.9892117,0.00069156,0.0031815108,0.0003976896,0.000045686636,0.0014889345,0.0017670721,0.00007162289,0.0031442654],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99980646,0.000077040444,0.000008280409,0.000033798584,0.000031413172,0.000042987434],"domain_scores_gemma":[0.9998273,0.000028739545,0.00003071148,0.000020209787,0.000018331388,0.00007464452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006644913,0.0005716008,0.0007300483,0.00035743922,0.0002496968,0.0006452051,0.00035535052,0.0005379044,0.0034924308],"category_scores_gemma":[0.00036193978,0.00025196033,0.00046546035,0.00024822677,0.00031257828,0.00026834133,0.00018885938,0.0013278022,0.00080007594],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18013622,0.07828139,0.014233514,0.00045095728,0.0004613583,0.00032117774,0.00041887278,0.011035392,0.46735218,0.0010419615,0.013055951,0.2332111],"study_design_scores_gemma":[0.08563678,0.6973518,0.04330928,0.000058506066,0.00045820427,0.0007629382,0.00014698032,0.010196752,0.13449372,0.00092992996,0.026584052,0.00007109565],"about_ca_topic_score_codex":0.0011700985,"about_ca_topic_score_gemma":0.0027633759,"teacher_disagreement_score":0.0034924308,"about_ca_system_score_codex":0.0007770901,"about_ca_system_score_gemma":0.0010478576,"threshold_uncertainty_score":0.011683404},"labels":[],"label_agreement":null},{"id":"W4388047770","doi":"10.1136/jitc-2023-sitc2023.0607","title":"607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in the pivotal LUNAR study","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Novocure","keywords":"Medicine; Docetaxel; Internal medicine; Oncology; Lung cancer; Cancer","score_opus":0.019905545277624854,"score_gpt":0.27974167768409136,"score_spread":0.2598361324064665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960891,0.0014367851,0.0001192599,0.00017262356,0.00008430068,0.00053775875,0.0006326125,0.000010869061,0.00091668585],"genre_scores_gemma":[0.9964921,0.0005345959,0.00022649734,0.0003810186,0.00014257964,0.0003513053,0.0009981659,0.000005692503,0.0008681405],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994343,0.00025964543,0.000042129643,0.000085798936,0.0000623831,0.0001156528],"domain_scores_gemma":[0.9993711,0.00009257454,0.00011485326,0.00006436107,0.00004944669,0.0003076712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017519713,0.0006577947,0.0015213094,0.00028515965,0.00042745148,0.00075497635,0.00044210174,0.00072712096,0.0030758611],"category_scores_gemma":[0.000731981,0.00030927517,0.0028128966,0.0003475843,0.0004585644,0.00054628245,0.0003259311,0.0012898713,0.00044904847],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90784985,0.010349688,0.035941783,0.00031384846,0.0024667687,0.0000995026,0.00011846826,0.000541701,0.008962209,0.00013528224,0.0025079004,0.030712925],"study_design_scores_gemma":[0.36702192,0.44426805,0.17042072,0.00010841412,0.005303811,0.00028914114,0.00025123375,0.0017567278,0.0040728915,0.0006860805,0.0057514454,0.00006956426],"about_ca_topic_score_codex":0.0013597284,"about_ca_topic_score_gemma":0.0052238633,"teacher_disagreement_score":0.0030758611,"about_ca_system_score_codex":0.0007040764,"about_ca_system_score_gemma":0.0010236918,"threshold_uncertainty_score":0.010289788},"labels":[],"label_agreement":null},{"id":"W4388047823","doi":"10.1136/jitc-2023-sitc2023.0985","title":"985 PSGL-1 is a novel inhibitor of tumor cell phagocytosis by macrophages","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Phagocytosis; Macrophage; Cell biology; Biology; Immune system; Molecular biology; Myeloid; Chemistry; Immunology; In vitro; Biochemistry","score_opus":0.013055454565177592,"score_gpt":0.22480916438329723,"score_spread":0.21175370981811964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674229,0.013706874,0.0069866567,0.0009172342,0.00023794637,0.00028070537,0.0013391959,0.0004780917,0.008630397],"genre_scores_gemma":[0.980996,0.0053987717,0.0050837635,0.00047356248,0.00008852524,0.00024882602,0.002463749,0.00005100534,0.005195658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998956,0.000019093168,0.000009787745,0.0000135181435,0.000030767576,0.000031246433],"domain_scores_gemma":[0.9999616,0.000006696079,0.000007756277,0.0000045291954,0.0000059058657,0.0000135022465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015375683,0.00041800115,0.00035887928,0.00023687049,0.00020370356,0.00024781626,0.00030394635,0.0002983672,0.002090385],"category_scores_gemma":[0.00008995925,0.00014450231,0.00040109045,0.00019392006,0.0001737299,0.00012681949,0.00018729885,0.00083636324,0.00080839626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007789229,0.00033039218,0.0002162471,0.00014395166,0.000028342409,0.0001234861,0.000019455447,0.00018214036,0.9892909,0.00020083034,0.0010616648,0.0076237004],"study_design_scores_gemma":[0.00052040914,0.002225807,0.004667764,0.000026969508,0.00005066447,0.000584779,0.000024811214,0.002222264,0.9759019,0.00018599948,0.013574579,0.000014144474],"about_ca_topic_score_codex":0.00047097116,"about_ca_topic_score_gemma":0.0007955138,"teacher_disagreement_score":0.002090385,"about_ca_system_score_codex":0.00021746168,"about_ca_system_score_gemma":0.00032602556,"threshold_uncertainty_score":0.0069930553},"labels":[],"label_agreement":null},{"id":"W4388047842","doi":"10.1136/jitc-2023-sitc2023.0544","title":"544 Coordinated blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector memory responses","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; EMD Serono","keywords":"Ovarian cancer; Cancer research; Immune system; Immunotherapy; Tumor microenvironment; Cytotoxic T cell; Cancer; Medicine; Immunology; Cytokine; Biology; Internal medicine","score_opus":0.03204473608297409,"score_gpt":0.30242633622972054,"score_spread":0.27038160014674645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937382,0.0010422412,0.0014356027,0.00017881024,0.000063825675,0.00009891522,0.0010083556,0.00018483198,0.0022491037],"genre_scores_gemma":[0.9930791,0.000761427,0.0017497186,0.00012587692,0.0000214701,0.00014127063,0.0010125141,0.000021456694,0.003087066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998727,0.000013249133,0.000012626145,0.00001800063,0.000029956751,0.00005350166],"domain_scores_gemma":[0.99993145,0.000005962369,0.000018383544,0.0000072193952,0.000007351402,0.000029667033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013457713,0.0003572415,0.00029519707,0.0002603882,0.00014466967,0.0002185344,0.00018782714,0.0002717535,0.0016120708],"category_scores_gemma":[0.000056891473,0.000121012235,0.00025505383,0.00015651499,0.00017543416,0.00018438381,0.00013178927,0.00088947813,0.0003652039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014442093,0.0005022223,0.00037371478,0.00007271434,0.000011898749,0.000055477278,0.000028856044,0.00024923705,0.9914601,0.00009766287,0.00040961037,0.0052942247],"study_design_scores_gemma":[0.00018709166,0.005878713,0.0047285506,0.00000868266,0.000031395408,0.00022457015,0.000044422148,0.0012018264,0.98371375,0.00005216348,0.0039225537,0.0000063624834],"about_ca_topic_score_codex":0.0009938177,"about_ca_topic_score_gemma":0.0019033581,"teacher_disagreement_score":0.0016120708,"about_ca_system_score_codex":0.00024281623,"about_ca_system_score_gemma":0.0002724976,"threshold_uncertainty_score":0.005392909},"labels":[],"label_agreement":null},{"id":"W4388047897","doi":"10.1136/jitc-2023-sitc2023.0912","title":"912 A comparison of 37+ immune populations in whole blood by CyTOF® flow cytometry collected with 4 different preservation reagents","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada); Hospital for Sick Children","funders":"","keywords":"Immune system; Whole blood; Flow cytometry; Mass cytometry; Heparin; Antibody; Multiplex; Medicine; Immunology; Biology; Internal medicine; Bioinformatics; Biochemistry","score_opus":0.030803681376204067,"score_gpt":0.2641109275763721,"score_spread":0.23330724620016804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841903,0.0016605983,0.008726804,0.00015583461,0.00006252064,0.00016941421,0.0014474697,0.00019464063,0.0033924975],"genre_scores_gemma":[0.9661474,0.0014056816,0.019019643,0.0006147643,0.00009501132,0.0005229449,0.0069339597,0.00011225582,0.005148222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993825,0.000105410545,0.000058219615,0.0001785078,0.00019943158,0.00007587153],"domain_scores_gemma":[0.99978584,0.00004862678,0.000046568144,0.000026911996,0.000066613546,0.000025378396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000688079,0.00037075102,0.00024218619,0.00074923085,0.0002743686,0.0005766807,0.00027005296,0.00041737643,0.0034596943],"category_scores_gemma":[0.00040372508,0.00014625659,0.0002296179,0.00038256697,0.00035586735,0.00022621751,0.00023491599,0.00033078346,0.0011261672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012385332,0.00009582155,0.014355555,0.000101415164,0.000032190095,0.000106377396,0.0001721245,0.000078675264,0.97075987,0.00016801528,0.00053301296,0.012358338],"study_design_scores_gemma":[0.00007464299,0.0015246423,0.16369256,0.00007128695,0.0001771158,0.0015779625,0.00029935472,0.0019322875,0.82112634,0.00032619108,0.009164978,0.00003262656],"about_ca_topic_score_codex":0.0006565899,"about_ca_topic_score_gemma":0.0005224997,"teacher_disagreement_score":0.0034596943,"about_ca_system_score_codex":0.00018314886,"about_ca_system_score_gemma":0.0002070878,"threshold_uncertainty_score":0.011573851},"labels":[],"label_agreement":null},{"id":"W4388047947","doi":"10.1136/jitc-2023-sitc2023.0400","title":"400 Preclinical characterization and modelling of allogeneic Vγ9Vδ2 TAC T cells for the treatment of solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Antigen; T cell; Cytotoxic T cell; Cell therapy; Immunotherapy; Chimeric antigen receptor; Immunology; In vivo; Antigen-presenting cell; Biology; Medicine; In vitro; Immune system; Cell biology; Stem cell","score_opus":0.08392283671548659,"score_gpt":0.3301677903857863,"score_spread":0.24624495367029972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876773,0.0008683377,0.0069045103,0.000060645903,0.000026112848,0.00017678521,0.00092993624,0.000052376756,0.0033040033],"genre_scores_gemma":[0.99408555,0.00050342886,0.002815529,0.000024858795,0.000006454349,0.00009964839,0.00096533494,0.000013181698,0.0014860615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990284,0.0000148347535,0.000004986547,0.00001433797,0.00003965491,0.000023256294],"domain_scores_gemma":[0.9999466,0.000009105089,0.000012599436,0.000006051436,0.000010844884,0.000014796321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016826804,0.0002538106,0.000145221,0.0001523507,0.00009796498,0.00030057653,0.0002488958,0.0003131232,0.0013756722],"category_scores_gemma":[0.000085974905,0.000081752085,0.00020100281,0.00013789913,0.00010399633,0.00010477652,0.00006497641,0.00036558651,0.00044642642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038273117,0.000477376,0.00055654533,0.00005544041,0.000006913585,0.00010811336,0.00002292398,0.013254603,0.9815974,0.00033147063,0.00018723654,0.0030191755],"study_design_scores_gemma":[0.00008188057,0.0056486875,0.0017837997,0.0000108345475,0.000023848248,0.00022674305,0.000042383424,0.0334063,0.95434415,0.00016266854,0.004260083,0.000008542833],"about_ca_topic_score_codex":0.0015129197,"about_ca_topic_score_gemma":0.00064505544,"teacher_disagreement_score":0.0015129197,"about_ca_system_score_codex":0.00027993086,"about_ca_system_score_gemma":0.00024193648,"threshold_uncertainty_score":0.0046020746},"labels":[],"label_agreement":null},{"id":"W4388048003","doi":"10.1136/jitc-2023-sitc2023.0312","title":"312 IL7 increases targeted lipid nanoparticle-mediated mRNA protein expression in T cells<i> in vitro</i> and<i> in situ</i> by enhancing T cell translation","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acuitas Therapeutics (Canada)","funders":"","keywords":"Molecular biology; Biology; T cell; mCherry; CD28; CD8; Cell biology; Antigen; Immune system; Green fluorescent protein; Immunology; Biochemistry","score_opus":0.014291793481288098,"score_gpt":0.24408714815614044,"score_spread":0.22979535467485235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98243606,0.0013426507,0.008297984,0.0002227225,0.000115745985,0.00008980636,0.00090497214,0.00023425478,0.0063558505],"genre_scores_gemma":[0.98314697,0.0007691023,0.0064334795,0.00018896293,0.00002360018,0.00013853108,0.0015866383,0.00008279447,0.007630022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997937,0.000040691637,0.000024339275,0.000040849576,0.000050024562,0.000050419745],"domain_scores_gemma":[0.9999001,0.00002841099,0.00002080363,0.0000074030077,0.000021526823,0.000021686557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018306068,0.0003317375,0.00017902165,0.0001961273,0.00011736873,0.0003224694,0.00014432742,0.00038137537,0.003971794],"category_scores_gemma":[0.0000975069,0.00013177143,0.00030405156,0.00015140069,0.00021198862,0.00019262564,0.00014026409,0.0007464202,0.0013252673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014263288,0.000051169896,0.000062292565,0.00004021929,0.0000024332323,0.000023505792,0.000014640693,0.00005447059,0.9988016,0.000054549244,0.000096250944,0.0006561945],"study_design_scores_gemma":[0.000012483025,0.00022660225,0.00046295088,0.0000041448075,0.000004824923,0.000029880575,0.000019877267,0.00047855955,0.99780494,0.0000166109,0.00093686685,0.0000023048678],"about_ca_topic_score_codex":0.0005104985,"about_ca_topic_score_gemma":0.0006718712,"teacher_disagreement_score":0.003971794,"about_ca_system_score_codex":0.0003016062,"about_ca_system_score_gemma":0.00021539051,"threshold_uncertainty_score":0.013286948},"labels":[],"label_agreement":null},{"id":"W4388048048","doi":"10.1136/jitc-2023-sitc2023.0582","title":"582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Tumor microenvironment; Breast cancer; Immune system; Oncology; Internal medicine; Antibody; Triple-negative breast cancer; Cancer; Cancer research; Immunotherapy; Immunology; Nivolumab","score_opus":0.012596636400107528,"score_gpt":0.2596904684011493,"score_spread":0.24709383200104176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965719,0.00096772314,0.0002992124,0.00008170368,0.000030134595,0.00029401193,0.00045110687,0.000025588635,0.0012785274],"genre_scores_gemma":[0.9940445,0.00055669784,0.0009937865,0.0003255214,0.00008018953,0.00047414904,0.002167879,0.000016547036,0.0013407063],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999718,0.00008876373,0.000018466024,0.00006614338,0.00006055626,0.00004803212],"domain_scores_gemma":[0.9997876,0.000045466535,0.000051949228,0.000033564138,0.00002343074,0.000057934983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007645444,0.00032414956,0.0005594307,0.00017816968,0.00015712148,0.0005822628,0.00025992512,0.0004922051,0.0014971189],"category_scores_gemma":[0.00037242088,0.00020561651,0.00038731453,0.00014375852,0.00023619279,0.00029617868,0.00017512831,0.0007389541,0.00037571933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26313588,0.018378753,0.0934913,0.00052818574,0.00096739625,0.0003078244,0.00025377527,0.0024992283,0.44490814,0.00030485852,0.0045332415,0.17069145],"study_design_scores_gemma":[0.055793066,0.30694246,0.41435724,0.000051255796,0.0021540895,0.0011755064,0.00028358074,0.005071896,0.20097409,0.0005771394,0.012522295,0.00009739795],"about_ca_topic_score_codex":0.00029090708,"about_ca_topic_score_gemma":0.00052875327,"teacher_disagreement_score":0.0014971189,"about_ca_system_score_codex":0.0003065501,"about_ca_system_score_gemma":0.0002826532,"threshold_uncertainty_score":0.00500834},"labels":[],"label_agreement":null},{"id":"W4388048115","doi":"10.1136/jitc-2023-sitc2023.0372","title":"372 TAC-T cells persist and remain functional during and after repeated tumor exposure <i>in vitro</i> and <i>in vivo</i>","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Cancer research; In vivo; T cell; Antigen; Flow cytometry; In vitro; Tumor antigen; Biology; Immune system; Immunotherapy; Molecular biology; Immunology; Biochemistry","score_opus":0.012901209380400826,"score_gpt":0.22928253968148246,"score_spread":0.21638133030108164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196166,0.0011514853,0.0026805152,0.00009761756,0.00004557675,0.00003589824,0.00095121417,0.00012805864,0.0029480313],"genre_scores_gemma":[0.9916391,0.00032982486,0.001174497,0.00011788846,0.0000156668,0.0000639413,0.0020090027,0.00003641931,0.004613731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995523,0.00006792155,0.000039883053,0.000084614025,0.00010782769,0.00014735192],"domain_scores_gemma":[0.9997657,0.000035997633,0.000050885974,0.000062577084,0.00004077448,0.000044053682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021967609,0.00037325418,0.00026751368,0.00017941845,0.00017524374,0.0004954897,0.0002104823,0.00035582512,0.0015663577],"category_scores_gemma":[0.0001504909,0.000130697,0.000241239,0.00015463798,0.00024873353,0.00019345539,0.000165795,0.00094926235,0.0010465932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022479586,0.000073959345,0.00039013257,0.000017047498,0.000005434302,0.00005199325,0.000025502546,0.00008458417,0.9976914,0.000080301405,0.00013009059,0.0012247645],"study_design_scores_gemma":[0.000015145518,0.0009954774,0.0052396753,0.0000066327475,0.0000211487,0.0003108176,0.000055682,0.0009254324,0.99025655,0.00005215498,0.0021129788,0.00000831457],"about_ca_topic_score_codex":0.0010464994,"about_ca_topic_score_gemma":0.001143424,"teacher_disagreement_score":0.0015663577,"about_ca_system_score_codex":0.00032025826,"about_ca_system_score_gemma":0.00020853068,"threshold_uncertainty_score":0.0052399635},"labels":[],"label_agreement":null},{"id":"W4388048122","doi":"10.1136/jitc-2023-sitc2023.0738","title":"738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Immunotherapy; Leukapheresis; Chimeric antigen receptor; Cancer research; Radioimmunotherapy; Stem cell; Immunology; Immune system; Antibody; Biology; CD34","score_opus":0.037706947430035526,"score_gpt":0.3355257030615537,"score_spread":0.29781875563151816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98904306,0.00076403224,0.0009835535,0.0003111175,0.00013859247,0.0051907687,0.001391572,0.00009868419,0.0020786484],"genre_scores_gemma":[0.98204744,0.0009226039,0.002446706,0.0010804771,0.00023019302,0.005413456,0.0021531095,0.000042859487,0.005663169],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996537,0.00014259916,0.000014706354,0.000063012376,0.000036682162,0.00008934792],"domain_scores_gemma":[0.9995009,0.00007492206,0.000072348674,0.000044333967,0.00005415308,0.00025349652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012645761,0.0010716986,0.0012897495,0.00031890487,0.00047981855,0.0006466552,0.0006037928,0.0010663632,0.0049258773],"category_scores_gemma":[0.0004736913,0.0004351817,0.0009904238,0.00025845846,0.0007681729,0.000492639,0.00018244557,0.002252894,0.0010637788],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54652065,0.20308593,0.007923618,0.0008074374,0.000826515,0.00072441506,0.00037305147,0.0021072957,0.15447558,0.00044427058,0.008071602,0.074639685],"study_design_scores_gemma":[0.12102784,0.8638402,0.0049416726,0.000014620768,0.0002433411,0.00020248936,0.00005152919,0.00066287833,0.006134918,0.00013917102,0.0027249833,0.000016509553],"about_ca_topic_score_codex":0.0013329408,"about_ca_topic_score_gemma":0.0023293067,"teacher_disagreement_score":0.0049258773,"about_ca_system_score_codex":0.00067994493,"about_ca_system_score_gemma":0.0018130575,"threshold_uncertainty_score":0.016478717},"labels":[],"label_agreement":null},{"id":"W4388048242","doi":"10.1136/jitc-2023-sitc2023.0589","title":"589 RUBY trial post hoc analysis of number needed to treat and incremental costs per outcome of dostarlimab + carboplatin-paclitaxel (CP) vs placebo + CP for primary advanced/recurrent endometrial cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Placebo; Medicine; Internal medicine; Number needed to treat; Population; Post-hoc analysis; Carboplatin; Clinical endpoint; Endometrial cancer; Oncology; Randomized controlled trial; Cancer; Confidence interval; Chemotherapy; Relative risk; Cisplatin","score_opus":0.017014224711491638,"score_gpt":0.2957273220226049,"score_spread":0.27871309731111327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631469,0.004867097,0.006838754,0.0014291045,0.0014293868,0.007085803,0.006924893,0.00029860335,0.007979439],"genre_scores_gemma":[0.9760345,0.0006663016,0.0055066748,0.00080538774,0.00034427352,0.0065678814,0.0027449017,0.0001523446,0.0071777026],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98381436,0.013602381,0.0004272253,0.000807657,0.0005459672,0.00080243865],"domain_scores_gemma":[0.98029786,0.016042529,0.0015932918,0.0008943461,0.0004924395,0.0006795344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02083084,0.0018780152,0.004535221,0.00068933226,0.00025242657,0.0016064988,0.001957382,0.0017998539,0.017590648],"category_scores_gemma":[0.022981945,0.0006918217,0.010960766,0.0005949663,0.001023643,0.0021837926,0.0011315289,0.0047903154,0.0010302224],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95999146,0.0015867858,0.002648597,0.00094014267,0.013762943,0.00010808016,0.000048341968,0.0069665234,0.0008131618,0.0007465522,0.002476842,0.009910386],"study_design_scores_gemma":[0.5159254,0.27012533,0.040106796,0.00058147975,0.04802033,0.00033527028,0.00029867113,0.10254611,0.005842477,0.0053227204,0.010670082,0.00022528115],"about_ca_topic_score_codex":0.0015742539,"about_ca_topic_score_gemma":0.0013323068,"teacher_disagreement_score":0.02083084,"about_ca_system_score_codex":0.001436605,"about_ca_system_score_gemma":0.0021610227,"threshold_uncertainty_score":0.1101653},"labels":[],"label_agreement":null},{"id":"W4388048268","doi":"10.1136/jitc-2023-sitc2023.0838","title":"838 Oncolytic virus induced tumour-infiltrating lymphocytes (TILs) for the treatment of colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Agricultural Research Institute of Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Tumor-infiltrating lymphocytes; Medicine; Adoptive cell transfer; Colorectal cancer; Tumor microenvironment; Cancer research; Immunotherapy; Cancer; Immune system; Immunology; T cell; Internal medicine","score_opus":0.03767717695858579,"score_gpt":0.31901405281430145,"score_spread":0.28133687585571565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9424461,0.015461583,0.029160783,0.0008344991,0.00031423554,0.00092559744,0.0022985877,0.0007659449,0.0077927136],"genre_scores_gemma":[0.95983547,0.006900481,0.023218283,0.0004038353,0.00006313746,0.0005702877,0.0016562726,0.00009316609,0.007259105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999897,0.000020087617,0.000008470114,0.000015455476,0.00003634676,0.000022677708],"domain_scores_gemma":[0.999948,0.000009310939,0.000013205297,0.000005374675,0.000009952741,0.000014214014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019655093,0.00030214005,0.0001800881,0.00031288236,0.000114326824,0.0002201655,0.00015861112,0.00026754098,0.0018515986],"category_scores_gemma":[0.000088359186,0.00008900808,0.00022150337,0.00016428583,0.00015619132,0.00014542053,0.00015218242,0.0006420222,0.00050827855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030458497,0.00012067849,0.00022208324,0.00011259579,0.0000071111303,0.000035467874,0.0000142445015,0.00012816642,0.9874981,0.00013469117,0.00037569678,0.011046614],"study_design_scores_gemma":[0.00010749888,0.002327857,0.0037625446,0.000030331634,0.00002866195,0.00045872226,0.000021534208,0.0011935644,0.9748779,0.00011272944,0.017069334,0.000009306709],"about_ca_topic_score_codex":0.00052028836,"about_ca_topic_score_gemma":0.0009508287,"teacher_disagreement_score":0.0018515986,"about_ca_system_score_codex":0.00023762259,"about_ca_system_score_gemma":0.00033728883,"threshold_uncertainty_score":0.0061941743},"labels":[],"label_agreement":null},{"id":"W4388048272","doi":"10.1136/jitc-2023-sitc2023.0766","title":"766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Nivolumab; Oncolytic virus; Internal medicine; Pharmacokinetics; Gastroenterology; Refractory (planetary science); Pancreatic cancer; Adverse effect; Cancer; Oncology; Urology; Pharmacology; Immunotherapy; Biology","score_opus":0.025696820659456922,"score_gpt":0.33101462625382705,"score_spread":0.3053178055943701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994902,0.0014427637,0.00020622925,0.00023291631,0.00008584281,0.000984337,0.00044942787,0.00004663242,0.001649912],"genre_scores_gemma":[0.9945852,0.00071329717,0.0007634585,0.00037517835,0.00007885121,0.0007561625,0.00077682623,0.000015167454,0.0019358746],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997547,0.00011468759,0.000013779077,0.000039451694,0.00002529497,0.000052058756],"domain_scores_gemma":[0.99971217,0.00005130004,0.000052802236,0.000024038984,0.00001501091,0.00014467681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007720109,0.0006116524,0.0011061071,0.00018668854,0.00026278995,0.0006848984,0.0004103614,0.0007652088,0.003770207],"category_scores_gemma":[0.0003924847,0.00023810974,0.00076721667,0.00023349779,0.00059470633,0.00047499212,0.0001937367,0.0016285504,0.000772005],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7765579,0.035789464,0.0064359233,0.00064902427,0.0007447383,0.00028868407,0.00015182645,0.0026892945,0.062819876,0.00023678673,0.0025396082,0.11109685],"study_design_scores_gemma":[0.3387785,0.63816196,0.009858607,0.00003538429,0.00024705715,0.00030865008,0.000053654734,0.0013735146,0.0075348318,0.00021638721,0.0034040394,0.000027504855],"about_ca_topic_score_codex":0.00069638365,"about_ca_topic_score_gemma":0.0018502746,"teacher_disagreement_score":0.003770207,"about_ca_system_score_codex":0.0006301521,"about_ca_system_score_gemma":0.0011078455,"threshold_uncertainty_score":0.012612581},"labels":[],"label_agreement":null},{"id":"W4388048274","doi":"10.1136/jitc-2023-sitc2023.0277","title":"277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer research; Glioma; Immunotherapy; Chimeric antigen receptor; Tumor microenvironment; Flow cytometry; Immune system; Epidermal growth factor receptor; Antigen; Cytotoxic T cell; Brain tumor; Biology; Immunology; Medicine; Receptor; Pathology; Internal medicine; In vitro","score_opus":0.04880684535185395,"score_gpt":0.3212046304507716,"score_spread":0.27239778509891766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040985,0.0009409403,0.0037044077,0.00022298377,0.00011243358,0.0001620984,0.0013409158,0.00029898115,0.0028074267],"genre_scores_gemma":[0.98832524,0.00087378186,0.0030846745,0.00018210283,0.00003097666,0.00019661602,0.0014400396,0.00008790009,0.0057786983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997069,0.00003589104,0.000032280426,0.000057858368,0.000068051304,0.000098951576],"domain_scores_gemma":[0.9998449,0.000020257692,0.000046510668,0.00002092573,0.000021963713,0.000045409684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028503544,0.00089183176,0.00045261043,0.0005932152,0.00017295901,0.00033964662,0.00038218132,0.0006743068,0.001841175],"category_scores_gemma":[0.00011369497,0.00026547062,0.0004554298,0.00022051804,0.00032110943,0.00035442805,0.00014146867,0.001495068,0.0007522388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048112698,0.00038997442,0.00010839727,0.00004431732,0.000008956926,0.00006887561,0.000035636705,0.0002514886,0.99691653,0.0001810413,0.00021288224,0.0013009621],"study_design_scores_gemma":[0.000077481,0.0023542994,0.0009030725,0.0000071925397,0.000019643865,0.00015587451,0.000027907503,0.0013494635,0.9937542,0.000046256668,0.0012985461,0.0000060813245],"about_ca_topic_score_codex":0.0015236977,"about_ca_topic_score_gemma":0.0017586966,"teacher_disagreement_score":0.001841175,"about_ca_system_score_codex":0.00042943028,"about_ca_system_score_gemma":0.00034704673,"threshold_uncertainty_score":0.006159365},"labels":[],"label_agreement":null},{"id":"W4388048378","doi":"10.1136/jitc-2023-sitc2023.0619","title":"619 First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: updated phase 1 results","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University Health Network","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Oncology; Cancer; Cohort; Toxicity; Adverse effect","score_opus":0.016204629377014217,"score_gpt":0.300082005965044,"score_spread":0.28387737658802975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8603175,0.06598837,0.004162358,0.0035639647,0.0005980948,0.0048410953,0.03310403,0.00065616396,0.026768398],"genre_scores_gemma":[0.90773666,0.024008147,0.008597219,0.006275372,0.00050475297,0.002496092,0.043603733,0.00017573468,0.0066022896],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99952304,0.0001976394,0.00003618023,0.000047804886,0.00013095797,0.000064344706],"domain_scores_gemma":[0.99896395,0.00025601484,0.00032475198,0.00006648811,0.00016755775,0.00022126718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023045582,0.00043680612,0.0008292174,0.0003359293,0.00022116237,0.00095649477,0.0004997491,0.0005439972,0.0033904454],"category_scores_gemma":[0.0013425158,0.00019845877,0.00097248086,0.00039926657,0.00014253375,0.00043823122,0.0002719593,0.001235176,0.00081616506],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090412945,0.009034786,0.03719029,0.003216835,0.0049442095,0.00039995293,0.00026617467,0.005976182,0.044623222,0.0005802096,0.06232107,0.74103415],"study_design_scores_gemma":[0.122760884,0.25983602,0.2878995,0.0012752443,0.010872952,0.0033769088,0.00023318698,0.006716371,0.03270818,0.0022109537,0.27188617,0.00022362926],"about_ca_topic_score_codex":0.00082191126,"about_ca_topic_score_gemma":0.0032697266,"teacher_disagreement_score":0.0033904454,"about_ca_system_score_codex":0.0006015268,"about_ca_system_score_gemma":0.0010259623,"threshold_uncertainty_score":0.012187779},"labels":[],"label_agreement":null},{"id":"W4388048382","doi":"10.1136/jitc-2023-sitc2023.0588","title":"588 Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC) in the RUBY trial: post hoc analysis of the costs of grade ≥3 adverse events (AEs)","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"U.S. National Library of Medicine","keywords":"Placebo; Medicine; Post-hoc analysis; Carboplatin; Internal medicine; Oncology; Urology; Chemotherapy; Cisplatin","score_opus":0.02494451060476337,"score_gpt":0.29188659036916054,"score_spread":0.26694207976439716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710797,0.006867596,0.0027867064,0.0014524751,0.0007862763,0.0043964135,0.0077787708,0.00021211721,0.0046399953],"genre_scores_gemma":[0.9817576,0.0014574344,0.0031220736,0.00079799455,0.0003388489,0.004011153,0.0042951037,0.00008465207,0.004135216],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9938858,0.005164262,0.0001473436,0.00029988398,0.00016032052,0.000342299],"domain_scores_gemma":[0.99625313,0.002427876,0.0005721883,0.0003114878,0.00016582511,0.00026950362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010553546,0.0016481557,0.003219491,0.0003389491,0.00025837173,0.0013826316,0.0013068744,0.0013567035,0.010393335],"category_scores_gemma":[0.0081646815,0.00071952405,0.0112418365,0.0004318336,0.00060132303,0.0013119539,0.0009332897,0.003469426,0.00075946207],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9530699,0.0013348638,0.0030880815,0.0013875146,0.01736434,0.00008873604,0.00004491553,0.007528636,0.00065079704,0.0004843703,0.0030972955,0.011860517],"study_design_scores_gemma":[0.80201006,0.10913674,0.019360013,0.00038981327,0.030967861,0.00016954716,0.00010731014,0.027697455,0.0013230608,0.0017621341,0.006992397,0.000083551065],"about_ca_topic_score_codex":0.002528291,"about_ca_topic_score_gemma":0.003434087,"teacher_disagreement_score":0.010553546,"about_ca_system_score_codex":0.00086676853,"about_ca_system_score_gemma":0.0019638678,"threshold_uncertainty_score":0.055813193},"labels":[],"label_agreement":null},{"id":"W4388048531","doi":"10.1136/jitc-2023-sitc2023.1372","title":"1372 TriTCE Co-Stim: a novel trispecific T cell engager platform, with integrated CD28 costimulation, engineered to widen the therapeutic window for treatment of poorly infiltrated tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"CD28; Cancer research; T cell; CD3; Cytokine; In vivo; Antibody; Immunotherapy; Immunology; Chemistry; Immune system; Medicine; Biology; CD8","score_opus":0.05746762826388186,"score_gpt":0.3030686027193463,"score_spread":0.24560097445546447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665179,0.0010998811,0.022263823,0.00021916583,0.000063666215,0.00009344692,0.000913644,0.00039592638,0.00843251],"genre_scores_gemma":[0.97824806,0.00054612674,0.01199345,0.00017077469,0.00001263764,0.00008668233,0.0009511195,0.00006533349,0.007925996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990547,0.000009367392,0.00000655838,0.000018906938,0.00003756467,0.000022191136],"domain_scores_gemma":[0.9999666,0.0000046241107,0.000011201704,0.000003160975,0.0000065489303,0.000007885391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000911914,0.0002640185,0.00009906058,0.00012579047,0.00010042112,0.00020747975,0.00017635005,0.00027593446,0.0030609886],"category_scores_gemma":[0.000059663453,0.0000961355,0.000117747506,0.000105631836,0.00012835764,0.00018811517,0.00017962609,0.00036273786,0.0009632706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004544304,0.0000157207,0.00011946723,0.000025423891,0.0000024624376,0.000029676465,0.000008169633,0.00015976971,0.9970284,0.000214594,0.00017794133,0.0021729758],"study_design_scores_gemma":[0.000005916839,0.00011318912,0.00030652015,0.0000011320908,0.000003403891,0.00012629374,0.0000060689836,0.0007382787,0.99600464,0.0000181618,0.0026737433,0.0000025856843],"about_ca_topic_score_codex":0.0003246153,"about_ca_topic_score_gemma":0.00062269473,"teacher_disagreement_score":0.0030609886,"about_ca_system_score_codex":0.00023142854,"about_ca_system_score_gemma":0.00021832199,"threshold_uncertainty_score":0.010240078},"labels":[],"label_agreement":null},{"id":"W4388068153","doi":"10.1136/jitc-2023-sitc2023.0126","title":"126 Mapping neuro-oncological cellular landscape of human and mouse brain tumors using imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Human brain; Tumor microenvironment; Pathology; Brain tumor; Flow cytometry; Cancer research; Biology; Medicine; Phenotype; Neuroscience; Immunology; Tumor cells","score_opus":0.024058872493263616,"score_gpt":0.2470022134413314,"score_spread":0.22294334094806778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388068153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85518026,0.0016805661,0.11895712,0.0007492683,0.00010584828,0.00038966077,0.006951365,0.0018745065,0.0141113475],"genre_scores_gemma":[0.80990744,0.0022736995,0.1583766,0.00071285776,0.000043106,0.0007704277,0.009647661,0.0003777932,0.017890446],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997718,0.000028284045,0.000019935966,0.000070644026,0.00007344886,0.000035959903],"domain_scores_gemma":[0.99992085,0.0000133306985,0.000017193277,0.000010940662,0.000024626446,0.000012987874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002970978,0.00035015654,0.00013869285,0.0006810283,0.00025360886,0.0004373615,0.00025229662,0.00046640437,0.00350583],"category_scores_gemma":[0.00011290952,0.00019897982,0.00022264804,0.00031955435,0.0002232392,0.00017132224,0.00018536407,0.00042508694,0.001286766],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030664214,0.00001148572,0.00021339714,0.000020688081,0.0000033111287,0.000015671654,0.000012859569,0.000101848564,0.99771273,0.0001441001,0.00023505744,0.001498066],"study_design_scores_gemma":[0.0000066293105,0.000057140358,0.0035963198,0.000007589844,0.000010436693,0.00013335519,0.000024720559,0.0028241987,0.9867003,0.00010035994,0.00653183,0.0000072486987],"about_ca_topic_score_codex":0.00094707566,"about_ca_topic_score_gemma":0.0017603777,"teacher_disagreement_score":0.00350583,"about_ca_system_score_codex":0.00037415267,"about_ca_system_score_gemma":0.00020297902,"threshold_uncertainty_score":0.0117281675},"labels":[],"label_agreement":null},{"id":"W4388071235","doi":"10.1136/jitc-2023-sitc2023.1490","title":"1490 High-plex co-detection of RNA and protein to explore tumor-immune interactions utilizing RNAscope with imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; RNA; Biology; Molecular biology; Computational biology; Phenotype; Biochemistry","score_opus":0.018451658947243155,"score_gpt":0.2781303994629118,"score_spread":0.25967874051566864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388071235","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20972137,0.0019063144,0.75945675,0.00051830336,0.00034099937,0.0006562907,0.0021664088,0.009319396,0.015914144],"genre_scores_gemma":[0.28965706,0.0018040353,0.6729771,0.0008222902,0.0001651213,0.0023106928,0.004255496,0.0008286071,0.027179677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990237,0.00018849713,0.00005750691,0.00028384125,0.00038383104,0.000062684325],"domain_scores_gemma":[0.99965096,0.0001526594,0.0000346762,0.000043313725,0.00007814089,0.00004018675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012590674,0.00083734846,0.00041317567,0.001242208,0.00033369623,0.0010958429,0.0006738603,0.0009821871,0.01090315],"category_scores_gemma":[0.00049309595,0.00034401144,0.00038602055,0.00042182772,0.00041271804,0.00059799186,0.0005963797,0.0011541124,0.0041988892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004384607,0.00003515613,0.000275949,0.000060413127,0.000009964303,0.000044337958,0.000030526466,0.00020070892,0.99034894,0.00059418747,0.0007039297,0.007652202],"study_design_scores_gemma":[0.000013982118,0.00007940037,0.0014767743,0.000013623462,0.000011986898,0.00017947258,0.000018562943,0.014675448,0.97615266,0.00033893765,0.00702194,0.000017205926],"about_ca_topic_score_codex":0.0002261058,"about_ca_topic_score_gemma":0.0006794047,"teacher_disagreement_score":0.01090315,"about_ca_system_score_codex":0.0005157145,"about_ca_system_score_gemma":0.00043391413,"threshold_uncertainty_score":0.036474645},"labels":[],"label_agreement":null},{"id":"W4388072202","doi":"10.1136/jitc-2023-sitc2023.0594","title":"594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16<sup>+</sup>tumors treated with cell-based vaccine, SQZ-PBMC-HPV","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Peripheral blood mononuclear cell; Medicine; Antigen; CD8; T cell; Immunotherapy; Immunology; Immune system; Internal medicine; Oncology; Biology","score_opus":0.019666628283641647,"score_gpt":0.2677507664605239,"score_spread":0.24808413817688227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388072202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994443,0.000119542645,0.00005851596,0.0000152344055,0.0000039619167,0.00000998133,0.000103011516,0.000003517986,0.00024180379],"genre_scores_gemma":[0.99944264,0.000048166625,0.00004756208,0.000018806404,0.000007419512,0.000009315948,0.000229862,0.0000010294534,0.00019521572],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999107,0.00002009094,0.0000060927205,0.000029742137,0.00001320745,0.000020190744],"domain_scores_gemma":[0.99988174,0.000025260817,0.000022624805,0.000009757115,0.000010089906,0.000050470513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019483209,0.00017745742,0.00036702998,0.00012914238,0.00013335883,0.00025126943,0.00009893191,0.00021867386,0.0014297311],"category_scores_gemma":[0.0001840887,0.00008012712,0.00023148858,0.00010679668,0.00014667667,0.00014638438,0.0001282621,0.00025329448,0.00024238718],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042350147,0.0017249522,0.7856842,0.0001414949,0.00022520329,0.0015411457,0.00022332695,0.00095025764,0.112538405,0.0000707842,0.0013177547,0.053232465],"study_design_scores_gemma":[0.00086936913,0.038416006,0.94250464,0.000013245175,0.00026348903,0.0033764523,0.00016972993,0.0021039334,0.0097710285,0.000083029896,0.0024103136,0.000018752047],"about_ca_topic_score_codex":0.00024237168,"about_ca_topic_score_gemma":0.0004145591,"teacher_disagreement_score":0.0014297311,"about_ca_system_score_codex":0.00020175839,"about_ca_system_score_gemma":0.00014623468,"threshold_uncertainty_score":0.0047829747},"labels":[],"label_agreement":null},{"id":"W4388072441","doi":"10.1136/jitc-2023-sitc2023.0866","title":"866 The effect of butyrophilin 1A1 blockade in combination with radiation treatment in colon and Lewis lung carcinoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioresistance; Cancer research; Lung cancer; Lewis lung carcinoma; Apoptosis; Medicine; CD44; Radiation therapy; Flow cytometry; Pathology; Cell; Biology; Cancer; Internal medicine; Immunology; Metastasis","score_opus":0.008263332487901847,"score_gpt":0.24190241718371935,"score_spread":0.2336390846958175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388072441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922829,0.004000584,0.00031231114,0.00030321168,0.00022775179,0.00009268482,0.00036614775,0.000089172034,0.0023251716],"genre_scores_gemma":[0.9939062,0.0020645596,0.0007015834,0.00019413004,0.000040845018,0.0001073201,0.00051000604,0.0000131783645,0.0024622397],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998673,0.00003649256,0.00001313295,0.000016639264,0.000021103178,0.00004536802],"domain_scores_gemma":[0.99987507,0.000018240811,0.000017635935,0.000012988245,0.00001388829,0.000062119056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002436288,0.00044695058,0.0006544755,0.00033553145,0.00022561007,0.00025338796,0.00024269448,0.00037580437,0.0027575633],"category_scores_gemma":[0.00013627406,0.00018314118,0.0007240422,0.00020626822,0.00024034179,0.00020910388,0.00018345175,0.0009191906,0.00048337702],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011424485,0.0028199712,0.0009217131,0.000603989,0.00010837243,0.0004130867,0.00008663942,0.00048504048,0.9653058,0.00012992232,0.0012396419,0.016461277],"study_design_scores_gemma":[0.002407286,0.08323625,0.020878362,0.000074213654,0.00032454383,0.0010052244,0.00031890144,0.0029896554,0.8765548,0.00015165754,0.01200111,0.000057904683],"about_ca_topic_score_codex":0.0018365138,"about_ca_topic_score_gemma":0.0032881266,"teacher_disagreement_score":0.0027575633,"about_ca_system_score_codex":0.00021515814,"about_ca_system_score_gemma":0.00051675894,"threshold_uncertainty_score":0.009224892},"labels":[],"label_agreement":null},{"id":"W4388074720","doi":"10.1136/jitc-2023-sitc2023.1396","title":"1396 TriTCE CPI: a novel trispecifc T cell engager platform with integrated PD-1/PD-L1 checkpoint inhibition engineered for the treatment of immunosuppressed tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Cancer research; Tumor microenvironment; PD-L1; T cell; Immunotherapy; Immune checkpoint; Cytotoxicity; Cytotoxic T cell; Immune system; Chemistry; Cancer immunotherapy; In vitro; Biology; Immunology; Tumor cells; Biochemistry","score_opus":0.040494279708013003,"score_gpt":0.2694589960541106,"score_spread":0.2289647163460976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388074720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96478635,0.0013977695,0.019170009,0.000249883,0.00010079794,0.00023768019,0.0010053475,0.0005150784,0.012537175],"genre_scores_gemma":[0.9817939,0.0005203951,0.010236787,0.00017337863,0.000014595245,0.00013020901,0.0007947025,0.00004423413,0.0062917215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986684,0.000012860483,0.000008346103,0.000027392607,0.000052623585,0.000031975276],"domain_scores_gemma":[0.9999435,0.000005253763,0.000018674837,0.0000054681786,0.000010174598,0.000016904081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011526604,0.00033134085,0.00012962453,0.00019524549,0.0000961157,0.00028649904,0.00031701606,0.00041946615,0.0024436146],"category_scores_gemma":[0.00010142323,0.00013235358,0.00017121251,0.00014776546,0.0001244949,0.00020963831,0.00020799176,0.0006331378,0.00085062854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100040284,0.00010982991,0.00010539177,0.00003774798,0.0000073694373,0.00006455582,0.000014787047,0.00039173706,0.9935782,0.00033169746,0.00044679875,0.0048117465],"study_design_scores_gemma":[0.000024534165,0.00067829766,0.00038119053,0.0000027698527,0.000006621019,0.00018725735,0.000008190734,0.0019803725,0.9928619,0.000036340913,0.0038245812,0.000008050732],"about_ca_topic_score_codex":0.00035274166,"about_ca_topic_score_gemma":0.000585804,"teacher_disagreement_score":0.0024436146,"about_ca_system_score_codex":0.00028349686,"about_ca_system_score_gemma":0.000182885,"threshold_uncertainty_score":0.008174717},"labels":[],"label_agreement":null},{"id":"W4388076128","doi":"10.1136/jitc-2023-sitc2023.1250","title":"1250 Molecular predictors and mechanisms of immune checkpoint inhibitor-induced myocarditis: a case-control study with translational correlates","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Christie (Canada); McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Jewish General Hospital","keywords":"Myocarditis; Immune system; Peripheral blood mononuclear cell; Medicine; Immune checkpoint; Immunology; Internal medicine; Biology; Immunotherapy; Genetics","score_opus":0.010502649626950758,"score_gpt":0.2293011904421242,"score_spread":0.21879854081517341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388076128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978398,0.0005416472,0.00052674627,0.000052644817,0.000012631612,0.00007908133,0.00028841934,0.0000070447395,0.00065200124],"genre_scores_gemma":[0.99895334,0.00014678157,0.0002478852,0.000048418293,0.00003647284,0.000046911213,0.0003281275,0.0000047864582,0.00018733695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992206,0.00015114766,0.00009775454,0.00034649044,0.00009673846,0.0000872714],"domain_scores_gemma":[0.99934846,0.00015370475,0.00019355456,0.00013728478,0.0000734167,0.000093622766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078712084,0.00042925737,0.000365889,0.0014244547,0.0008842356,0.0006236914,0.0004258385,0.000652871,0.0034707037],"category_scores_gemma":[0.0013913414,0.00041343828,0.0005567237,0.0011234708,0.0005458681,0.0003195824,0.0004540464,0.00036732244,0.00041731974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054828386,0.00029521476,0.9894769,0.000053923166,0.00019716339,0.0028092782,0.00024926284,0.000032982447,0.0030783347,0.00015600181,0.00036219865,0.002740502],"study_design_scores_gemma":[0.0000717521,0.0006741582,0.98821133,0.000029115705,0.000250605,0.008402298,0.00028802542,0.00030288904,0.0004754645,0.00013418026,0.0011441835,0.000015917312],"about_ca_topic_score_codex":0.0024473614,"about_ca_topic_score_gemma":0.0021757197,"teacher_disagreement_score":0.0034707037,"about_ca_system_score_codex":0.0003188833,"about_ca_system_score_gemma":0.00026330535,"threshold_uncertainty_score":0.011610627},"labels":[],"label_agreement":null},{"id":"W4388076165","doi":"10.1136/jitc-2023-sitc2023.1316","title":"1316 Enabling single-cell resolution in spatial transcriptomics for comprehensive cellular profiling with variational autoencoders and optimal transport","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Non-negative matrix factorization; Autoencoder; Pattern recognition (psychology); Artificial intelligence; Deconvolution; Matrix decomposition; Algorithm; Deep learning; Physics","score_opus":0.0248519500191286,"score_gpt":0.22200164790413168,"score_spread":0.19714969788500308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388076165","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02140268,0.00021707207,0.9732872,0.0004809758,0.00008652096,0.000030188945,0.0007482422,0.00138726,0.0023598268],"genre_scores_gemma":[0.34819847,0.0006173354,0.63933873,0.00042033123,0.00008802257,0.0001822677,0.0028916055,0.0011009135,0.0071623423],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999764,0.000055347162,0.000011195708,0.00006849162,0.00007863942,0.000022254899],"domain_scores_gemma":[0.99962175,0.00017817241,0.000033268345,0.000060542632,0.00008280825,0.00002339698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081267976,0.00056593906,0.00035981534,0.00029344807,0.00025302533,0.00074188405,0.0006628367,0.0007223202,0.0044205203],"category_scores_gemma":[0.0014408873,0.00040410322,0.00081981526,0.00032881115,0.0007118434,0.0007113459,0.00075891806,0.0012373133,0.0013851725],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025395947,0.00007426003,0.003291081,0.0003459776,0.00012396002,0.0002900701,0.00020030445,0.5738902,0.24087583,0.03634594,0.011600646,0.13270774],"study_design_scores_gemma":[0.0000036308095,0.000016017835,0.00041833747,0.000007348467,0.0000054425177,0.000025026628,0.000016463091,0.96534914,0.02636033,0.004254328,0.003531903,0.000012035354],"about_ca_topic_score_codex":0.0040838765,"about_ca_topic_score_gemma":0.0062881527,"teacher_disagreement_score":0.0044205203,"about_ca_system_score_codex":0.00080010534,"about_ca_system_score_gemma":0.000726965,"threshold_uncertainty_score":0.014788091},"labels":[],"label_agreement":null},{"id":"W4388077811","doi":"10.1136/jitc-2023-sitc2023.0760","title":"760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Adverse effect; Pharmacokinetics; Internal medicine; Dosing; Toxicity; Response Evaluation Criteria in Solid Tumors; Melanoma; Gastroenterology; Oncology; Pharmacology; Phases of clinical research; Urology; Cancer research","score_opus":0.025246474224272793,"score_gpt":0.30882989092477237,"score_spread":0.2835834167004996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388077811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122167,0.0008940906,0.00085868477,0.000316642,0.00007211145,0.0018344867,0.0020784633,0.00009307846,0.0026307772],"genre_scores_gemma":[0.98583615,0.00054583006,0.0029445144,0.00063951383,0.00009420612,0.0018851308,0.004858711,0.000047359375,0.0031485106],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991647,0.0004452038,0.000060225582,0.00010151798,0.00008759112,0.00014083117],"domain_scores_gemma":[0.9987716,0.0002617883,0.00023640096,0.00016800387,0.00010124546,0.0004608795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022221273,0.0007224621,0.0011369041,0.00034143956,0.0003523101,0.0008114061,0.0005442833,0.0007159567,0.0032705986],"category_scores_gemma":[0.0010212609,0.00036643512,0.0011855514,0.0003205564,0.0006827413,0.00056171906,0.0002362412,0.0022104606,0.00092851627],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56170076,0.07832726,0.014535624,0.00054642936,0.0014521253,0.00045381332,0.0004020387,0.009915027,0.17493255,0.0005235823,0.009798205,0.1474126],"study_design_scores_gemma":[0.14006527,0.8012547,0.022394883,0.000029636978,0.0004604205,0.0004707703,0.00005662866,0.0025120035,0.02535662,0.00033739803,0.007002704,0.00005894607],"about_ca_topic_score_codex":0.0006822915,"about_ca_topic_score_gemma":0.0016075071,"teacher_disagreement_score":0.0032705986,"about_ca_system_score_codex":0.0008546872,"about_ca_system_score_gemma":0.0014118091,"threshold_uncertainty_score":0.011751831},"labels":[],"label_agreement":null},{"id":"W4388081144","doi":"10.1136/jitc-2023-sitc2023.0178","title":"178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Liquid biopsy; Exome sequencing; Tumor-infiltrating lymphocytes; Biopsy; Exome; Transcriptome; Cancer research; Deep sequencing; Medicine; Cancer; Pathology; Computational biology; Immunotherapy; Biology; Mutation; Internal medicine; Gene; Gene expression; Genome; Genetics","score_opus":0.03762420379382995,"score_gpt":0.28809596548987787,"score_spread":0.2504717616960479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388081144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9125157,0.002594127,0.06809771,0.0006908416,0.00018502536,0.0003781792,0.009040282,0.0010398446,0.005458246],"genre_scores_gemma":[0.90876293,0.0011535193,0.072491735,0.0010602018,0.000088583205,0.00046742795,0.011250333,0.00043508975,0.004290199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997569,0.000044425786,0.000019320894,0.00008361568,0.00006710096,0.000028668868],"domain_scores_gemma":[0.9998274,0.000053514952,0.000030588802,0.00002132343,0.000046064102,0.000021145872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048252582,0.00035337763,0.00034226652,0.00044828164,0.00020881518,0.0007887013,0.00026748996,0.00037114407,0.002689272],"category_scores_gemma":[0.0006044901,0.0001519939,0.00033501367,0.00029515938,0.00015826922,0.00016686379,0.00032745596,0.0004622873,0.00095170515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007972396,0.0001100611,0.021300195,0.0002612315,0.000094216404,0.00034996882,0.000091309834,0.003368544,0.8850806,0.00044091707,0.004650076,0.08345564],"study_design_scores_gemma":[0.00016813522,0.0008743749,0.084979154,0.0001130596,0.00025291118,0.0020348933,0.0002787377,0.054546107,0.82105595,0.0022301895,0.033398654,0.00006786996],"about_ca_topic_score_codex":0.00058879843,"about_ca_topic_score_gemma":0.0014637511,"teacher_disagreement_score":0.002689272,"about_ca_system_score_codex":0.0002471841,"about_ca_system_score_gemma":0.00034714982,"threshold_uncertainty_score":0.008996487},"labels":[],"label_agreement":null},{"id":"W4388082927","doi":"10.1136/jitc-2023-sitc2023.1464","title":"1464 Endogenous retroviral protein particles in malignant pleural mesothelioma as potential immunotherapy targets; novel approaches for identification and prioritization","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epitope; Immunotherapy; Computational biology; Genome; Human genome; Gene; Biology; Mesothelioma; Antigen; Cancer; Cancer research; Bioinformatics; Genetics; Medicine; Pathology","score_opus":0.029997622943478876,"score_gpt":0.23102435589482695,"score_spread":0.20102673295134807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388082927","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72420704,0.0022357865,0.26272875,0.00050112157,0.00008454975,0.00023050238,0.001753034,0.0019257874,0.006333541],"genre_scores_gemma":[0.7634588,0.0006036363,0.23143595,0.00016955347,0.000040585513,0.00012017856,0.0021362826,0.00019557647,0.001839458],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.999765,0.00004822611,0.00001453643,0.00006145917,0.000083439285,0.000027413074],"domain_scores_gemma":[0.99980265,0.00008208557,0.000035983314,0.000014320108,0.00004298305,0.000021945829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005236314,0.00045650167,0.00061069126,0.0006538031,0.00027963478,0.0011447356,0.00041712588,0.00043019545,0.0017553663],"category_scores_gemma":[0.00073498423,0.00019698865,0.0006058822,0.00049495505,0.00022538024,0.00034917353,0.0002905747,0.00029625976,0.000454976],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015201357,0.0005287126,0.04734327,0.0009113902,0.00034434642,0.00073343667,0.0001799881,0.27435678,0.40614912,0.007944076,0.004544457,0.25544435],"study_design_scores_gemma":[0.000064148124,0.00014548778,0.0063016405,0.000021161311,0.00006629723,0.0001562083,0.00006766881,0.93538153,0.052497268,0.0025166194,0.0027645193,0.000017513888],"about_ca_topic_score_codex":0.0019136319,"about_ca_topic_score_gemma":0.0040064687,"teacher_disagreement_score":0.0019136319,"about_ca_system_score_codex":0.000497286,"about_ca_system_score_gemma":0.0008978735,"threshold_uncertainty_score":0.0058722496},"labels":[],"label_agreement":null},{"id":"W4388083490","doi":"10.1136/jitc-2023-sitc2023.0783","title":"783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Stand Up To Cancer","keywords":"Ipilimumab; Medicine; Nivolumab; Internal medicine; Immunotherapy; Progression-free survival; Oncology; Melanoma; Progressive disease; Chemotherapy; Cancer research; Cancer","score_opus":0.03118325356358788,"score_gpt":0.29310738592172403,"score_spread":0.26192413235813616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388083490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924143,0.004298791,0.00026842984,0.00037816068,0.000020204807,0.00009139287,0.00047380163,0.000028674924,0.0020261733],"genre_scores_gemma":[0.99631363,0.0016159607,0.00040898428,0.00029992784,0.00004683944,0.000056118362,0.0009614501,0.000009528913,0.00028753284],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997236,0.000093396746,0.00003135436,0.000047260262,0.000050117123,0.00005417563],"domain_scores_gemma":[0.9995235,0.00011783318,0.00011261126,0.000071110466,0.00007987741,0.00009513435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014290458,0.0002979491,0.00036982878,0.00026345826,0.0002021622,0.0004980642,0.0002090084,0.00022104135,0.00048617244],"category_scores_gemma":[0.0008501646,0.000055205503,0.000495437,0.00034199678,0.00024891715,0.00019314796,0.00021417958,0.00037328302,0.00014751713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038490996,0.004790933,0.4128561,0.0006719975,0.0019406554,0.0017080161,0.00058499357,0.0013042165,0.05267624,0.00026741903,0.009128533,0.47557995],"study_design_scores_gemma":[0.005572238,0.06495434,0.8721603,0.00016615563,0.002334627,0.0046984204,0.00047296833,0.0018322731,0.030984042,0.00022064715,0.016528653,0.000075389675],"about_ca_topic_score_codex":0.0015137518,"about_ca_topic_score_gemma":0.0022100536,"teacher_disagreement_score":0.0015137518,"about_ca_system_score_codex":0.0005186811,"about_ca_system_score_gemma":0.00065026135,"threshold_uncertainty_score":0.0075576305},"labels":[],"label_agreement":null},{"id":"W4388084134","doi":"10.1136/jitc-2023-sitc2023.0741","title":"741 TWT-101: a first-in-clinic study of CFI-402411, a hematopoietic progenitor Kinase-1 (HPK1) inhibitor, as single agent or combined with pembrolizumab in subjects with advanced solid malignancies","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University Health Network; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Adverse effect; Gastroenterology; Oncology; Toxicity; Cancer; Immunotherapy","score_opus":0.022824699747663726,"score_gpt":0.2716791618740001,"score_spread":0.24885446212633638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388084134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914068,0.0011807191,0.00038320216,0.00046028005,0.00015378992,0.0021107614,0.0010632949,0.00013188075,0.003109373],"genre_scores_gemma":[0.9847594,0.0012774243,0.0013954621,0.001146518,0.00028941777,0.0022257522,0.0020723254,0.000048023452,0.0067857434],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995351,0.0002039621,0.000017210621,0.00007370164,0.000041018993,0.00012914493],"domain_scores_gemma":[0.99927634,0.000091417045,0.00007475488,0.000038839018,0.000039618648,0.00047888604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012124527,0.0017866021,0.001943802,0.0005340847,0.00061446027,0.0011428496,0.0009526636,0.0016941089,0.0066914186],"category_scores_gemma":[0.00063213747,0.0007980342,0.0012224126,0.00035885154,0.0011275816,0.0010025988,0.00030976092,0.0044540637,0.0018547791],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5388648,0.25887203,0.006685676,0.00068898476,0.0012298503,0.0005415369,0.00028930872,0.0020682313,0.07183265,0.00030222035,0.009352356,0.10927239],"study_design_scores_gemma":[0.22878815,0.7517119,0.009956421,0.0000200697,0.00033399297,0.00022926906,0.000058407022,0.0008988043,0.0055063954,0.00008874874,0.0023759557,0.00003198015],"about_ca_topic_score_codex":0.0018146348,"about_ca_topic_score_gemma":0.0050281947,"teacher_disagreement_score":0.0066914186,"about_ca_system_score_codex":0.0013127025,"about_ca_system_score_gemma":0.0018976053,"threshold_uncertainty_score":0.02238506},"labels":[],"label_agreement":null},{"id":"W4388087237","doi":"10.1136/jitc-2023-sitc2023.0839","title":"839 TALL<sup>TM</sup> (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncolytic virus; Immunotherapy; Adoptive cell transfer; Tumor microenvironment; Medicine; Cancer research; Chimeric antigen receptor; Cancer; Immune system; Tumor-infiltrating lymphocytes; Antigen; Immunology; T cell; Internal medicine","score_opus":0.046547665589573975,"score_gpt":0.31310218700715103,"score_spread":0.2665545214175771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388087237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9330011,0.0041526686,0.04671487,0.0007693254,0.0002080196,0.0002970216,0.0023772179,0.0009230123,0.011556756],"genre_scores_gemma":[0.95531166,0.0018942415,0.025174664,0.0003741109,0.000038447666,0.00019636424,0.0024715138,0.00013323911,0.0144056715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991894,0.000010076107,0.000006780163,0.000016194434,0.000025798894,0.000022273189],"domain_scores_gemma":[0.9999615,0.000004295244,0.00001173487,0.0000047333915,0.000008243892,0.000009561595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012930737,0.00033366823,0.0001502288,0.00019406802,0.00013023397,0.00035805092,0.0001875494,0.00034223194,0.0032620013],"category_scores_gemma":[0.00005786685,0.00013521049,0.00023385025,0.00009956032,0.00016212417,0.00027810782,0.0002468247,0.0004957632,0.0013651216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009997965,0.000034631936,0.0001952705,0.000042858766,0.000004715145,0.000034136014,0.000006739374,0.00013270756,0.99462503,0.00026567836,0.00032633927,0.004231885],"study_design_scores_gemma":[0.000012030399,0.00023093015,0.00084191305,0.000005688018,0.0000078058465,0.00013946733,0.000007781661,0.0007259887,0.99154234,0.00007174824,0.0064099235,0.0000043140135],"about_ca_topic_score_codex":0.0003912801,"about_ca_topic_score_gemma":0.0006156904,"teacher_disagreement_score":0.0032620013,"about_ca_system_score_codex":0.00028329313,"about_ca_system_score_gemma":0.00021821605,"threshold_uncertainty_score":0.010912538},"labels":[],"label_agreement":null},{"id":"W4388089028","doi":"10.1136/jitc-2023-sitc2023.0119","title":"119 Uncovering spatial biology of mouse tumor immune microenvironment using imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada); Canadian Standards Association","funders":"","keywords":"Mass cytometry; Tumor microenvironment; Immune system; Cancer research; Context (archaeology); Pathology; Medicine; Biology; Immunology; Phenotype","score_opus":0.01232713183653427,"score_gpt":0.2271004150665001,"score_spread":0.21477328322996583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388089028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82455987,0.0012833169,0.1561218,0.0004496344,0.0000769028,0.00027743948,0.005303278,0.0019930867,0.009934675],"genre_scores_gemma":[0.84091485,0.0012753982,0.13881247,0.00041173334,0.000053923854,0.0005300268,0.0068062926,0.00036789765,0.010827467],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998584,0.000012148561,0.000012504731,0.000040677583,0.000048499103,0.000027800112],"domain_scores_gemma":[0.9998883,0.000025547199,0.000029651894,0.0000138129435,0.000025312444,0.000017421511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020175012,0.00022708796,0.0001442959,0.00078877044,0.00020686284,0.00041025502,0.00024695488,0.0003045976,0.003539929],"category_scores_gemma":[0.00010854649,0.00016909333,0.00020102679,0.00029480923,0.00019853126,0.00015885555,0.00017143779,0.00045087634,0.0010393254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020429328,0.000010265852,0.0003637227,0.000014360633,0.0000017446648,0.000020192572,0.000008138014,0.0001390126,0.99740297,0.00017463011,0.00015721949,0.0016872282],"study_design_scores_gemma":[0.000005232791,0.000044266162,0.0046594744,0.0000046797672,0.000006641707,0.000116795985,0.000017295164,0.0043163737,0.9867115,0.000120770055,0.0039914255,0.0000056455715],"about_ca_topic_score_codex":0.0013468722,"about_ca_topic_score_gemma":0.0016035464,"teacher_disagreement_score":0.003539929,"about_ca_system_score_codex":0.0003651602,"about_ca_system_score_gemma":0.00017610086,"threshold_uncertainty_score":0.011842191},"labels":[],"label_agreement":null},{"id":"W4388089593","doi":"10.1136/jitc-2023-sitc2023.0865","title":"865 Combining radiotherapy with novel TLR-based immunotherapy for improved tumor control in lung cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Sting; Cancer research; Cancer immunotherapy; Immunotherapy; Immune system; Prostate cancer; Cancer; Chemistry; Pharmacology; Medicine; Immunology; Internal medicine","score_opus":0.011441972537060655,"score_gpt":0.2562417504485607,"score_spread":0.24479977791150004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388089593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660503,0.015033537,0.009005269,0.00040408975,0.00017348734,0.000262514,0.0005604979,0.0004230126,0.008087389],"genre_scores_gemma":[0.98707086,0.0034683608,0.004846886,0.0001877946,0.00003289757,0.00013941702,0.0004993949,0.000030794636,0.003723633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993277,0.000009458377,0.0000048490797,0.000015380963,0.000015208137,0.000022210246],"domain_scores_gemma":[0.9999845,0.0000020368552,0.0000036480255,0.0000022324405,0.000002355623,0.0000051637994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011632073,0.0002107074,0.00031765076,0.0002006017,0.00009999103,0.000248496,0.00030997122,0.00034099727,0.0023651482],"category_scores_gemma":[0.00004653826,0.00011948732,0.00039185234,0.00016941366,0.00012484298,0.0002302965,0.00020361888,0.00044816927,0.0005824177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010630022,0.00051778933,0.00032445564,0.00026512227,0.00003194405,0.000082056744,0.00002288019,0.00066093385,0.9681189,0.0002702611,0.00049215317,0.02815051],"study_design_scores_gemma":[0.00043609494,0.007209861,0.005445679,0.0000315278,0.00014521457,0.0007005452,0.00003567835,0.0044243364,0.96610516,0.00019960741,0.015242017,0.000024241352],"about_ca_topic_score_codex":0.00043288973,"about_ca_topic_score_gemma":0.00071607163,"teacher_disagreement_score":0.0023651482,"about_ca_system_score_codex":0.00019150834,"about_ca_system_score_gemma":0.00022710311,"threshold_uncertainty_score":0.007912159},"labels":[],"label_agreement":null},{"id":"W4404052762","doi":"10.1136/jitc-2024-sitc2024.1011","title":"1011 Metabolic reprogramming alters natural killer cell responses in chronic graft-versus-host disease","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reprogramming; Disease; Host (biology); Graft-versus-host disease; Cell; Biology; Immunology; Medicine; Ecology; Genetics; Internal medicine","score_opus":0.013706992167502747,"score_gpt":0.24671118888038512,"score_spread":0.2330041967128824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404052762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980141,0.0005059314,0.00034846002,0.000042959342,0.000022783834,0.000012638204,0.00032776085,0.000015554971,0.0007096608],"genre_scores_gemma":[0.99814117,0.000263914,0.00024575827,0.0000968553,0.000008137989,0.000032390246,0.0005467841,0.000009177621,0.0006558269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989724,0.000018471592,0.000011739657,0.000026457314,0.000015324356,0.00003070165],"domain_scores_gemma":[0.99996066,0.0000063195826,0.000011250328,0.0000050053027,0.0000036254578,0.000013214207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009898146,0.00015694913,0.00015251494,0.00017613378,0.0001089261,0.00024691958,0.00010091396,0.00024308819,0.0024482775],"category_scores_gemma":[0.00008669494,0.0000687335,0.00018910787,0.00013534748,0.00019094038,0.00015053496,0.00012430144,0.0002986991,0.00039815882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010072435,0.000120657016,0.0045624725,0.000043773485,0.000014536057,0.00015927668,0.000031610147,0.00007745325,0.98955464,0.00011149078,0.00010546277,0.004211396],"study_design_scores_gemma":[0.00018211394,0.0045201336,0.25976846,0.000026971236,0.00010434911,0.002408387,0.0003740686,0.0015806763,0.7221356,0.0006487955,0.00822643,0.000024006518],"about_ca_topic_score_codex":0.0002033816,"about_ca_topic_score_gemma":0.0002082932,"teacher_disagreement_score":0.0024482775,"about_ca_system_score_codex":0.0001569557,"about_ca_system_score_gemma":0.00010268063,"threshold_uncertainty_score":0.008190334},"labels":[],"label_agreement":null},{"id":"W4404052940","doi":"10.1136/jitc-2024-sitc2024.0103","title":"103 A deep-learning approach to guide acquisition region selection for Imaging Mass Cytometry","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Computer science; Selection (genetic algorithm); Artificial intelligence; Deep learning; Machine learning; Chemistry","score_opus":0.01268774742898928,"score_gpt":0.24808452451177052,"score_spread":0.23539677708278123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404052940","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033124092,0.000103691964,0.9913901,0.00017266831,0.00003118024,0.00010028657,0.00015405934,0.0035555302,0.0011800193],"genre_scores_gemma":[0.07037037,0.00015796907,0.91949093,0.00051303074,0.000048843656,0.0005157298,0.0009054326,0.0006091357,0.0073885554],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994282,0.00010963064,0.000034259672,0.00019291743,0.00014663402,0.00008825424],"domain_scores_gemma":[0.99928766,0.00022483303,0.000059993254,0.000075168646,0.00029598223,0.00005631557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015193664,0.0013117753,0.000863544,0.0011891299,0.00065950176,0.0016795109,0.002672133,0.0019740758,0.009324846],"category_scores_gemma":[0.002641374,0.00077571726,0.0011255405,0.00097243645,0.0005855374,0.0007759413,0.0016708083,0.0021610712,0.0038049188],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026307124,0.00016738435,0.0014633633,0.00015089531,0.00011309753,0.00013760627,0.000116461946,0.2143347,0.02323237,0.011071595,0.021464331,0.7274852],"study_design_scores_gemma":[0.000012788834,0.000032699656,0.00018135845,0.00001100248,0.0000090278845,0.000029633298,0.000015407399,0.988675,0.0047055096,0.0029828516,0.0033360012,0.000008843338],"about_ca_topic_score_codex":0.012415376,"about_ca_topic_score_gemma":0.01713706,"teacher_disagreement_score":0.012415376,"about_ca_system_score_codex":0.0019062725,"about_ca_system_score_gemma":0.0023930955,"threshold_uncertainty_score":0.031194746},"labels":[],"label_agreement":null},{"id":"W4404053084","doi":"10.1136/jitc-2024-sitc2024.0716","title":"716 A randomized phase II window of opportunity clinical trial of PD-1 +/- IL-4 inhibition in early-stage ER+ HER2- breast cancer","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Stage (stratigraphy); Oncology; Window of opportunity; Window (computing); Internal medicine; Medicine; Cancer; Computer science; Biology; Real-time computing","score_opus":0.045850144807708965,"score_gpt":0.3498682161185697,"score_spread":0.3040180713108608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404053084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98566705,0.0013793122,0.00048524275,0.0009127798,0.00060251716,0.006137727,0.0015058299,0.000104754916,0.0032048814],"genre_scores_gemma":[0.9765728,0.0012279369,0.0016424264,0.0018719088,0.0005499713,0.008587977,0.0018579669,0.000039118022,0.00764986],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996613,0.0001498787,0.00001281487,0.000056707373,0.000022376507,0.000096826],"domain_scores_gemma":[0.99951327,0.00009073329,0.00007537758,0.000042517848,0.000026875372,0.00025112828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001120101,0.0013787518,0.0015903428,0.00031917437,0.00040927532,0.00102304,0.00055994064,0.0013338901,0.009839482],"category_scores_gemma":[0.0007167247,0.0005304726,0.0010593211,0.00022691829,0.0009411478,0.00079855527,0.0003861278,0.002406598,0.0013289903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96660465,0.013620042,0.00045548717,0.00017616233,0.00021816758,0.00003916602,0.000037351314,0.00032787523,0.005587717,0.0001753213,0.0015434677,0.011214536],"study_design_scores_gemma":[0.8509102,0.14538549,0.0010937989,0.000012050218,0.00013158882,0.00003404807,0.000020069941,0.00036267476,0.000629476,0.00027090107,0.0011360977,0.000013541475],"about_ca_topic_score_codex":0.000677912,"about_ca_topic_score_gemma":0.001803071,"teacher_disagreement_score":0.009839482,"about_ca_system_score_codex":0.00058937026,"about_ca_system_score_gemma":0.0013330461,"threshold_uncertainty_score":0.032916307},"labels":[],"label_agreement":null},{"id":"W4404053144","doi":"10.1136/jitc-2024-sitc2024.0677","title":"677 A phase 1, open-label, dose escalation study of the safety and tolerability of ANK-101 in advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Tolerability; Medicine; Pharmacology; Adverse effect","score_opus":0.04145467211093979,"score_gpt":0.37129023927340876,"score_spread":0.329835567162469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404053144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900095,0.00094781886,0.0010090541,0.00031915496,0.00017045556,0.004333887,0.0014314258,0.00016125776,0.0016174032],"genre_scores_gemma":[0.98095644,0.0012016881,0.003852806,0.0011447893,0.00018532026,0.0051570577,0.0023386194,0.00007780247,0.0050855004],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99954516,0.00015536793,0.000020716552,0.00008374233,0.000075953816,0.00011903535],"domain_scores_gemma":[0.99933076,0.00010130968,0.000118151605,0.00007324295,0.000050071445,0.00032649218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014006818,0.0014436425,0.0017217359,0.00047637688,0.0004769617,0.00089479086,0.00087928865,0.001311684,0.0052506584],"category_scores_gemma":[0.0005929117,0.00059604325,0.0011019664,0.00034147207,0.0010599328,0.00096821017,0.00028271895,0.0036175477,0.0011315957],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4309519,0.2930311,0.0030660327,0.0010386528,0.0008705719,0.0003161593,0.00029591002,0.0040164706,0.1580335,0.0004497401,0.0087001445,0.0992298],"study_design_scores_gemma":[0.17022376,0.80836934,0.004520206,0.000024914048,0.00017357456,0.00021520196,0.00005547427,0.0014046888,0.011909383,0.00023852964,0.0028262818,0.000038712584],"about_ca_topic_score_codex":0.001036023,"about_ca_topic_score_gemma":0.002651388,"teacher_disagreement_score":0.0052506584,"about_ca_system_score_codex":0.00094938267,"about_ca_system_score_gemma":0.0020791346,"threshold_uncertainty_score":0.01756519},"labels":[],"label_agreement":null},{"id":"W4404064195","doi":"10.1136/jitc-2024-sitc2024.0172","title":"172 The application of single-cell resolved spatial transcriptomics to prostate adenocarcinoma reveals tumor microenvironmental signatures that correlate with distinct histological features","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Prostate cancer; Transcriptome; Prostate; Adenocarcinoma; Prostatic adenocarcinoma; Prostate adenocarcinoma; Pathology; Biology; Cancer research; Medicine; Internal medicine; Cancer; Gene; Gene expression; Genetics","score_opus":0.009365542690208811,"score_gpt":0.21832421762146423,"score_spread":0.20895867493125542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7745613,0.0027189085,0.16130291,0.0010042707,0.0005546371,0.00044266044,0.03703965,0.004810887,0.017564781],"genre_scores_gemma":[0.7902509,0.0022707686,0.15161872,0.001024719,0.00010309948,0.00068396016,0.033672266,0.0012385007,0.019137098],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997472,0.000019364425,0.000013583021,0.00008212392,0.00009813934,0.00003967181],"domain_scores_gemma":[0.9998313,0.000030945776,0.00002537171,0.00003354407,0.00005744833,0.000021324817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029173752,0.00028002803,0.00026019663,0.00036470706,0.00042647796,0.0005326109,0.00033042827,0.00037340974,0.0048370655],"category_scores_gemma":[0.00030621272,0.00025894164,0.00044016214,0.000392585,0.0004868931,0.00021323025,0.0003677213,0.00052914576,0.002425656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058937985,0.0000114974955,0.0015539713,0.000096356634,0.000008359639,0.00006309551,0.000036964528,0.00028291502,0.9913189,0.00026083243,0.0013400293,0.004968124],"study_design_scores_gemma":[0.000013205513,0.00012924365,0.03813019,0.000022691132,0.000022351402,0.00041870069,0.00014082374,0.004765553,0.9326009,0.00040321884,0.023322454,0.00003069381],"about_ca_topic_score_codex":0.003212822,"about_ca_topic_score_gemma":0.008380339,"teacher_disagreement_score":0.0048370655,"about_ca_system_score_codex":0.00041520514,"about_ca_system_score_gemma":0.0005931177,"threshold_uncertainty_score":0.016181588},"labels":[],"label_agreement":null},{"id":"W4404064202","doi":"10.1136/jitc-2024-sitc2024.0057","title":"57 It’s about time: rapid on-site fixation of whole blood samples prior to high-dimensional flow cytometric analysis","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blood flow; Fixation (population genetics); Flow (mathematics); Computer science; Biomedical engineering; Medicine; Physics; Mechanics; Cardiology","score_opus":0.01145368257426029,"score_gpt":0.22626985665778512,"score_spread":0.21481617408352482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064202","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37083292,0.015715858,0.49373093,0.008396871,0.008715312,0.0036572744,0.008635885,0.010990204,0.07932473],"genre_scores_gemma":[0.46467507,0.014020446,0.38926345,0.009219045,0.0015666592,0.006395817,0.016847853,0.003147369,0.09486429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985359,0.00029499168,0.0001629708,0.00035279596,0.00043884525,0.00021451077],"domain_scores_gemma":[0.99928814,0.0001248992,0.000096663294,0.00020098999,0.00021899556,0.000070486334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013007034,0.0009046351,0.00054655067,0.0007605188,0.00070276455,0.001531681,0.0010099361,0.0009054741,0.023260882],"category_scores_gemma":[0.0009888267,0.0006402172,0.0006315109,0.0006151209,0.000785145,0.0008469034,0.00091845915,0.0017958943,0.011800436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007349204,0.00016346623,0.0021075872,0.00039841025,0.000052389998,0.0002571675,0.00013592171,0.00022345509,0.9319474,0.0013176956,0.019507417,0.043154083],"study_design_scores_gemma":[0.00011555019,0.00063203496,0.013603239,0.00016229306,0.00008582548,0.0013828164,0.00017713074,0.002278317,0.8653387,0.0012037134,0.114926875,0.00009352766],"about_ca_topic_score_codex":0.00089901756,"about_ca_topic_score_gemma":0.0024305487,"teacher_disagreement_score":0.023260882,"about_ca_system_score_codex":0.0005703328,"about_ca_system_score_gemma":0.00069029705,"threshold_uncertainty_score":0.07781541},"labels":[],"label_agreement":null},{"id":"W4404064248","doi":"10.1136/jitc-2024-sitc2024.0525","title":"525 Adenosine uptake through equilibrative nucleoside transporter-1 suppresses antitumor immunity by pyrimidine starvation","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nucleoside; Adenosine; Chemistry; Transporter; Pyrimidine; Starvation; Immunity; Biochemistry; Pharmacology; Biology; Immune system; Endocrinology; Immunology; Gene","score_opus":0.012914654672315229,"score_gpt":0.2452678759199089,"score_spread":0.23235322124759367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363166,0.0015541884,0.0019219323,0.0003239378,0.000071437666,0.00003315513,0.0007742592,0.00015335325,0.0015361483],"genre_scores_gemma":[0.9943427,0.00053771696,0.0012123256,0.00013416092,0.000014838997,0.00004615513,0.0007898769,0.000031188396,0.0028910248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998703,0.000022034263,0.000012563632,0.000023502753,0.00002846783,0.000043163174],"domain_scores_gemma":[0.9999224,0.000009736717,0.00002443209,0.000010238489,0.000009241962,0.000023941826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009833786,0.00026758868,0.00031740195,0.00011540032,0.0001222142,0.00031107845,0.00018350055,0.00027541746,0.0015735592],"category_scores_gemma":[0.00008243857,0.00011895687,0.00019995302,0.00010346426,0.00021549014,0.00015577591,0.00014016795,0.0007171258,0.00047665968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032795614,0.000058352503,0.00018519167,0.00003178303,0.0000044046083,0.000028420194,0.000007878941,0.000071733,0.9980907,0.00006295598,0.00011647469,0.0010141167],"study_design_scores_gemma":[0.00003959552,0.00054883026,0.0027999526,0.000005276307,0.000013249059,0.0001242207,0.000028534005,0.0013595608,0.99229044,0.000048538437,0.0027365685,0.000005211714],"about_ca_topic_score_codex":0.00065428804,"about_ca_topic_score_gemma":0.0011260814,"teacher_disagreement_score":0.0015735592,"about_ca_system_score_codex":0.0002532807,"about_ca_system_score_gemma":0.0002278779,"threshold_uncertainty_score":0.0052641034},"labels":[],"label_agreement":null},{"id":"W4404064319","doi":"10.1136/jitc-2024-sitc2024.0617","title":"617 Combined histone deacetylase and PD-L1 inhibition is safe and efficacious for the treatment of virus-associated cancers: results of a phase II clinical trial","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Histone deacetylase; Histone deacetylase inhibitor; Medicine; Cancer research; Virology; Pharmacology; Chemistry; Histone; Biochemistry; Gene","score_opus":0.040241847453322425,"score_gpt":0.3652573165335079,"score_spread":0.32501546908018547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890483,0.002595409,0.0007207669,0.00065446756,0.00012668082,0.004233826,0.000872368,0.000091361624,0.0016569048],"genre_scores_gemma":[0.9867176,0.0021200688,0.0022998997,0.0011499937,0.00023110294,0.004047978,0.0013985743,0.000039091934,0.0019956757],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99946195,0.00026222772,0.000033039818,0.000086451015,0.000055070643,0.00010138783],"domain_scores_gemma":[0.999288,0.00011774533,0.00013031739,0.00006315028,0.00003798885,0.00036282922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026561716,0.0012850576,0.0019627737,0.00042384048,0.00045422628,0.0010427927,0.0007809987,0.0016970388,0.0042552557],"category_scores_gemma":[0.00070964,0.0005774562,0.0014169491,0.00040711957,0.0012028454,0.0009951399,0.0004602287,0.0028974228,0.0008856762],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8056757,0.07370234,0.0029935776,0.0007149911,0.0010727879,0.0002160966,0.00020650034,0.0013648415,0.04054981,0.0003295337,0.0029829207,0.070190914],"study_design_scores_gemma":[0.61554176,0.37518433,0.0033999048,0.000030523523,0.00029016833,0.00011515382,0.00003449864,0.0007690005,0.0026979826,0.00020620786,0.0017089659,0.00002149217],"about_ca_topic_score_codex":0.0006265709,"about_ca_topic_score_gemma":0.0013819042,"teacher_disagreement_score":0.0042552557,"about_ca_system_score_codex":0.0007642203,"about_ca_system_score_gemma":0.0014997785,"threshold_uncertainty_score":0.014235258},"labels":[],"label_agreement":null},{"id":"W4404064334","doi":"10.1136/jitc-2024-sitc2024.0575","title":"575 Epigenetic modulation by KDM6B in myeloid cells regulates glioblastoma immune checkpoint therapy outcomes","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Texas MD Anderson Cancer Center; Andrew Sabin Family Foundation","keywords":"Epigenetics; Glioblastoma; Cancer research; Epigenetic therapy; Immune checkpoint; Immune system; Medicine; DNA methylation; Immunotherapy; Biology; Gene; Immunology; Genetics; Gene expression","score_opus":0.008360031046056688,"score_gpt":0.24798554494770764,"score_spread":0.23962551390165096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98265463,0.0035990037,0.0029020698,0.00032130396,0.00006409255,0.000041587893,0.0066792276,0.00018977466,0.0035484121],"genre_scores_gemma":[0.9886507,0.0013202488,0.0014696617,0.00030585326,0.000011432678,0.00006445972,0.0046497053,0.00007044117,0.0034576075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986887,0.000007985233,0.000009285055,0.000034977595,0.00004283085,0.000036090107],"domain_scores_gemma":[0.99994063,0.000004913657,0.000021805148,0.0000043581363,0.000012769852,0.00001557773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012142211,0.00013067295,0.00023649135,0.00017151904,0.00019822766,0.00036917342,0.00012358958,0.00021916187,0.003088056],"category_scores_gemma":[0.00013707032,0.00010605331,0.00024252171,0.0001574783,0.0001797011,0.00011896447,0.00023372407,0.00040353482,0.00069975783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005396231,0.000052657375,0.011702231,0.00018557612,0.000035837365,0.00006912254,0.00007227544,0.00044529582,0.97026855,0.00029817218,0.0014152026,0.014915458],"study_design_scores_gemma":[0.00009457721,0.00060313015,0.2926173,0.00008538866,0.00013767205,0.0005482787,0.00032898007,0.004388663,0.6732599,0.0005226892,0.027380269,0.000033164033],"about_ca_topic_score_codex":0.0014669738,"about_ca_topic_score_gemma":0.0032416433,"teacher_disagreement_score":0.003088056,"about_ca_system_score_codex":0.0003161975,"about_ca_system_score_gemma":0.0002693579,"threshold_uncertainty_score":0.010330558},"labels":[],"label_agreement":null},{"id":"W4404064412","doi":"10.1136/jitc-2024-sitc2024.0361","title":"361 Early differentiation and memory transcription programs drive long-term persistence of NY-ESO-1 specific TCR-T cells in adoptive cell therapy","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"T-cell receptor; Term (time); Persistence (discontinuity); Biology; Computer science; T cell; Immunology; Physics; Engineering; Immune system","score_opus":0.035798880816205,"score_gpt":0.2570067381479863,"score_spread":0.2212078573317813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971539,0.0004447937,0.001265734,0.00003407417,0.000010047937,0.000037414236,0.00015474176,0.000049909326,0.0008493361],"genre_scores_gemma":[0.99714774,0.00022200058,0.00088269444,0.00003972216,0.0000058574205,0.000039700346,0.00026064456,0.000009699584,0.0013920465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999915,0.0000100290645,0.0000075277935,0.000016074799,0.000021719,0.000029715387],"domain_scores_gemma":[0.99994576,0.0000071214936,0.000018138639,0.0000088706975,0.000005863285,0.000014338435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011547297,0.00017752121,0.00015107074,0.00009429963,0.00009746563,0.00022199262,0.00012127493,0.00018161489,0.0013429737],"category_scores_gemma":[0.000068694906,0.00007970546,0.00012319881,0.000077580706,0.0001630811,0.00014680275,0.000117377225,0.00058191194,0.00038128774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022316958,0.00014024747,0.0005115771,0.00001660474,0.0000027991225,0.000043335822,0.000023225834,0.000076960314,0.9957223,0.00010343114,0.000105136314,0.003031185],"study_design_scores_gemma":[0.00010986632,0.004738711,0.010947522,0.000009856466,0.000030234944,0.00084031903,0.000059640384,0.0013927233,0.97746974,0.00011139359,0.0042841053,0.0000059724534],"about_ca_topic_score_codex":0.00027909863,"about_ca_topic_score_gemma":0.00048728895,"teacher_disagreement_score":0.0013429737,"about_ca_system_score_codex":0.00014786498,"about_ca_system_score_gemma":0.00015136981,"threshold_uncertainty_score":0.0044927},"labels":[],"label_agreement":null},{"id":"W4404064430","doi":"10.1136/jitc-2024-sitc2024.1314","title":"1314 Immunostimulatory nanofilaments turn cancer cells into neoantigen agnostic cancer vaccines","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Cancer; Computational biology; Cancer cell; Computer science; Cancer research; Biology; Genetics","score_opus":0.01022391758609406,"score_gpt":0.2572536201186203,"score_spread":0.24702970253252624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699052,0.0010561487,0.02110878,0.00031140848,0.00019516885,0.00008781921,0.00072455895,0.0004923081,0.00611869],"genre_scores_gemma":[0.9753363,0.00056762196,0.016949091,0.00024139434,0.000024435152,0.000094688185,0.00046663842,0.000059255373,0.006260606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995184,0.000004509218,0.0000036345682,0.00001124775,0.000014969271,0.0000138596115],"domain_scores_gemma":[0.9999721,0.000004190407,0.000009562418,0.0000020779341,0.000005868429,0.0000062474883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069791924,0.00025019964,0.000085930566,0.00009067416,0.000074653195,0.00016002663,0.00011082793,0.00028798278,0.0018297344],"category_scores_gemma":[0.00006117979,0.00009698862,0.00018085368,0.000052632844,0.000119270575,0.00014484927,0.000111642126,0.0002909512,0.000420377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020069483,0.000010815075,0.00004836116,0.000020409654,0.000001777938,0.000013718292,0.0000051500538,0.00011325723,0.9983771,0.00014181435,0.00018723014,0.0010602309],"study_design_scores_gemma":[0.0000047212134,0.00009605046,0.0003823102,0.000002609426,0.000002633589,0.000032798293,0.0000061058654,0.001277606,0.9955907,0.000037035203,0.002563605,0.0000038405055],"about_ca_topic_score_codex":0.0003281335,"about_ca_topic_score_gemma":0.00047472777,"teacher_disagreement_score":0.0018297344,"about_ca_system_score_codex":0.00022938398,"about_ca_system_score_gemma":0.000086093045,"threshold_uncertainty_score":0.006121099},"labels":[],"label_agreement":null},{"id":"W4404064451","doi":"10.1136/jitc-2024-sitc2024.1291","title":"1291 Profiling bispecific T-cell engagers: strategies for enhancing potency while minimizing cytokine release","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Profiling (computer programming); Potency; Computer science; Bispecific antibody; Cytokine; Human–computer interaction; Chemistry; Medicine; Immunology; Antibody; Operating system","score_opus":0.03727982372611302,"score_gpt":0.2903729767150358,"score_spread":0.25309315298892276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729196,0.00054049713,0.023393407,0.000084899446,0.0000121845305,0.0000970347,0.0002838688,0.00015311074,0.002515351],"genre_scores_gemma":[0.9770562,0.00035773835,0.02040491,0.00012568689,0.000007780767,0.00009826872,0.00027817706,0.000049250302,0.0016218971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997305,0.000050719074,0.000020757776,0.00004227315,0.00009622385,0.000059562135],"domain_scores_gemma":[0.99986315,0.000039365128,0.00003807907,0.000012415254,0.000027805096,0.000019277999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003369795,0.00032979978,0.00021058548,0.00017763856,0.00010894064,0.00046693286,0.00021474762,0.0003030517,0.0010858275],"category_scores_gemma":[0.0002476665,0.00010926544,0.00013788046,0.00017213688,0.00016539978,0.00025938245,0.00020745579,0.00047158232,0.00041194865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060885908,0.000049522278,0.00025305484,0.00002557848,0.0000038659,0.000016568692,0.000009394097,0.00068071164,0.9960387,0.00013330451,0.00006347432,0.0026648],"study_design_scores_gemma":[0.000009640797,0.00018954804,0.00030738438,0.0000017838972,0.000004347197,0.00003348901,0.0000063287425,0.002041317,0.99654275,0.00004031683,0.00082060887,0.0000025071574],"about_ca_topic_score_codex":0.00031216908,"about_ca_topic_score_gemma":0.0008149492,"teacher_disagreement_score":0.0010858275,"about_ca_system_score_codex":0.00031108645,"about_ca_system_score_gemma":0.0001834946,"threshold_uncertainty_score":0.0036324263},"labels":[],"label_agreement":null},{"id":"W4404064955","doi":"10.1136/jitc-2024-sitc2024.0418","title":"418 Dendritic cell-activation of T cells provides metabolic signals for improved <i>in vivo</i> persistence and anti-tumour performance","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"In vivo; Persistence (discontinuity); Cell biology; Cell; Chemistry; Biology; Engineering; Biochemistry; Biotechnology","score_opus":0.013582975857025576,"score_gpt":0.21882290239331617,"score_spread":0.20523992653629058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943768,0.0007429117,0.002218073,0.00010269086,0.000029913885,0.0000276041,0.0004935655,0.00005245726,0.0019560365],"genre_scores_gemma":[0.9945252,0.00047403437,0.0019420475,0.000092474234,0.000015635895,0.00003934486,0.00068971433,0.000029344099,0.002192217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998379,0.00002231697,0.0000136240305,0.00003193352,0.0000381575,0.000056144356],"domain_scores_gemma":[0.99994457,0.0000074153913,0.000016868735,0.0000060234984,0.000009000743,0.000016050994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012178644,0.00026208936,0.00022241827,0.00011819342,0.00010803236,0.00036827108,0.00013268758,0.0002789204,0.0016913426],"category_scores_gemma":[0.00005806491,0.00008589124,0.00019922186,0.00012477157,0.00015293754,0.00013900053,0.00012415774,0.0006211498,0.0007614412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021559928,0.00004855262,0.00023757618,0.000024366156,0.0000024348071,0.000015625363,0.000007838844,0.000041787418,0.99849534,0.000051159674,0.000051105737,0.0008086654],"study_design_scores_gemma":[0.000019323104,0.00043030342,0.0020483178,0.0000035817689,0.000009894354,0.00008813756,0.000015386107,0.00042719406,0.9953987,0.00003434462,0.0015220486,0.00000272005],"about_ca_topic_score_codex":0.00022057375,"about_ca_topic_score_gemma":0.00034080294,"teacher_disagreement_score":0.0016913426,"about_ca_system_score_codex":0.0001807823,"about_ca_system_score_gemma":0.00017557356,"threshold_uncertainty_score":0.00565809},"labels":[],"label_agreement":null},{"id":"W4404065332","doi":"10.1136/jitc-2024-sitc2024.0878","title":"878 The immunomodulatory impact of chemotherapy when combined with PD-1 blockade in resectable lung cancers","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Blockade; Medicine; Chemotherapy; Lung; Oncology; Internal medicine; Cancer research; Receptor","score_opus":0.009662269831908502,"score_gpt":0.2611179576055441,"score_spread":0.25145568777363564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404065332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907032,0.001591851,0.0020554615,0.00022784724,0.00007712204,0.00007172473,0.0028833952,0.00020218476,0.002187198],"genre_scores_gemma":[0.98738617,0.0007412121,0.004117704,0.00024180846,0.00004097254,0.00017560743,0.0048315013,0.000096459225,0.0023685799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980134,0.00004480069,0.000016460252,0.00003687208,0.00006387886,0.00003673639],"domain_scores_gemma":[0.99988234,0.00002877895,0.000027059234,0.000014632039,0.000022032196,0.000025068455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041675344,0.00022497596,0.0004206911,0.00036069422,0.00012700984,0.0003492764,0.00016759265,0.00014143198,0.00436855],"category_scores_gemma":[0.00037839162,0.0001359396,0.00024361556,0.00029303404,0.00017991904,0.0001543522,0.0001707057,0.0004489894,0.0006509595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013855917,0.001372087,0.060868267,0.00065817137,0.00024625316,0.00033367754,0.0001295881,0.003162198,0.7243637,0.0003415755,0.0105677,0.18410088],"study_design_scores_gemma":[0.0013466529,0.010513242,0.39815724,0.00008267008,0.0003745202,0.00114638,0.00022998563,0.016514992,0.54778874,0.0007582566,0.023044549,0.000042936965],"about_ca_topic_score_codex":0.0007529477,"about_ca_topic_score_gemma":0.0017022007,"teacher_disagreement_score":0.00436855,"about_ca_system_score_codex":0.00023810905,"about_ca_system_score_gemma":0.00040151126,"threshold_uncertainty_score":0.014614224},"labels":[],"label_agreement":null},{"id":"W4404065577","doi":"10.1136/jitc-2024-sitc2024.1435","title":"1435 Therapeutic mRNA cancer vaccine for GBM reaches complete response in a preclinical model","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; Providence Health Care","funders":"","keywords":"Cancer; Cancer vaccine; Cancer research; Messenger RNA; Medicine; Internal medicine; Biology; Immunotherapy; Gene; Genetics","score_opus":0.05780815849520819,"score_gpt":0.32106252314046096,"score_spread":0.26325436464525276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404065577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97766405,0.0032981024,0.009550806,0.00043992797,0.00038871393,0.00035070704,0.0016124863,0.00054151966,0.0061537125],"genre_scores_gemma":[0.98241055,0.0023768824,0.0047125868,0.00023919027,0.00006398436,0.00039772273,0.0023918366,0.0000822786,0.0073249866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998654,0.000017515018,0.000009060953,0.000024227056,0.000038432903,0.00004544042],"domain_scores_gemma":[0.9999374,0.000007655208,0.0000125474235,0.0000066983375,0.000014024828,0.000021591199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021980412,0.0004864916,0.0004893316,0.00028216047,0.00011303167,0.00025375688,0.00024233888,0.00052543107,0.002672386],"category_scores_gemma":[0.00011210949,0.00012182605,0.0003085651,0.0001382326,0.00017075274,0.0003179641,0.00012142778,0.0012290535,0.00095935515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005690185,0.00093539234,0.000126667,0.000111190704,0.000018952825,0.00004835206,0.000027556218,0.0003006372,0.98956877,0.00024762313,0.0008159395,0.0072298963],"study_design_scores_gemma":[0.00017865849,0.012394766,0.0014846212,0.000023751922,0.000060549035,0.0003100005,0.000033658725,0.0021968454,0.97415304,0.00014817018,0.009006357,0.000009662506],"about_ca_topic_score_codex":0.0004583758,"about_ca_topic_score_gemma":0.0005537107,"teacher_disagreement_score":0.002672386,"about_ca_system_score_codex":0.00022920886,"about_ca_system_score_gemma":0.00031919446,"threshold_uncertainty_score":0.008939981},"labels":[],"label_agreement":null},{"id":"W4415898573","doi":"10.1136/jitc-2025-sitc2025.0164","title":"164 A 50-marker mass cytometry intracellular cytokine staining panel: unprecedented resolution enables unrivaled detection of functional diversity present among human immune cell subsets","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Immune system; Intracellular; Flow cytometry; Cytokine; Resolution (logic); Functional diversity","score_opus":0.01718002217721588,"score_gpt":0.21537268725179692,"score_spread":0.19819266507458105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7139843,0.003558617,0.2598675,0.0016148867,0.00030670935,0.00030973917,0.0038555919,0.0027888706,0.013713726],"genre_scores_gemma":[0.73614144,0.0018305597,0.24098396,0.0013271847,0.00018957279,0.0003806751,0.0069000614,0.00043148652,0.0118150655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996952,0.00005628956,0.000025924166,0.00008875214,0.00007898967,0.00005484787],"domain_scores_gemma":[0.9998467,0.00004848979,0.000020327765,0.000024355148,0.000028686542,0.000031367406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036274202,0.00048916956,0.00033134432,0.00063564273,0.000285793,0.0006699475,0.0003342429,0.0006792759,0.004114399],"category_scores_gemma":[0.00031370498,0.00033823826,0.00029023195,0.00031107964,0.00023527801,0.00029787098,0.0004106015,0.00064951525,0.0028081455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035307843,0.000008339078,0.00011509437,0.000008583866,0.0000018683191,0.000012084659,0.000005413095,0.000030325251,0.9976514,0.00008852746,0.00021663378,0.0018263361],"study_design_scores_gemma":[0.000032507764,0.00016505357,0.004418687,0.000009913352,0.000030791736,0.00036433156,0.000019472714,0.0037507254,0.9826031,0.0003171427,0.008277092,0.0000111367435],"about_ca_topic_score_codex":0.00037871697,"about_ca_topic_score_gemma":0.0011193814,"teacher_disagreement_score":0.004114399,"about_ca_system_score_codex":0.0002470446,"about_ca_system_score_gemma":0.0003181806,"threshold_uncertainty_score":0.013764024},"labels":[],"label_agreement":null},{"id":"W4415898589","doi":"10.1136/jitc-2025-sitc2025.0176","title":"176 Spatial and seromic profiling of tumor infiltrating B-cell subtypes and autoantibody production in oral cancers","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Tumor-infiltrating lymphocytes; Autoantibody; Profiling (computer programming); Gene expression profiling; Oral Cancers; Lymphocytic infiltration","score_opus":0.014191246541385222,"score_gpt":0.2703179880950271,"score_spread":0.2561267415536419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985783,0.0003345352,0.00011394379,0.000015063182,0.000005097065,0.000005355496,0.0003452164,0.000005206729,0.00059722236],"genre_scores_gemma":[0.998094,0.00023157384,0.00028796587,0.00003092487,0.000010745583,0.000010354604,0.00045929308,0.0000050941944,0.0008700927],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998795,0.000014769502,0.000009516211,0.000024290974,0.00003444925,0.000037458518],"domain_scores_gemma":[0.9998969,0.00001852405,0.00002856374,0.000010430525,0.000025937188,0.000019598088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015501076,0.00014175008,0.00021537983,0.0006905875,0.0002626354,0.00063176797,0.00010826181,0.0001718199,0.0020659785],"category_scores_gemma":[0.00025122392,0.00012404981,0.00022478234,0.0005942103,0.0001558224,0.00015580398,0.00023150202,0.00019944519,0.00046329576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010920623,0.00006986602,0.26252845,0.00010166445,0.0001261579,0.00022971457,0.00022148306,0.00021647707,0.71773636,0.00013484739,0.00041944973,0.01712347],"study_design_scores_gemma":[0.000014365098,0.00022958788,0.9695117,0.000009796464,0.00008579867,0.0006403116,0.0008836123,0.00051920075,0.025865663,0.00009582584,0.0021343853,0.000009700335],"about_ca_topic_score_codex":0.0012967767,"about_ca_topic_score_gemma":0.0019436614,"teacher_disagreement_score":0.0020659785,"about_ca_system_score_codex":0.00015212917,"about_ca_system_score_gemma":0.0001571447,"threshold_uncertainty_score":0.006911397},"labels":[],"label_agreement":null},{"id":"W4415898595","doi":"10.1136/jitc-2025-sitc2025.1251","title":"1251 Impact of intra-tumoral mammary microbiota on macrophage biology and anti-tumor immune response in breast cancer","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Immune system; Macrophage; Breast cancer; Mammary gland; Cancer; Mammary tumor","score_opus":0.0068481748058390485,"score_gpt":0.26674911915837546,"score_spread":0.2599009443525364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568176,0.0023634708,0.00014113467,0.00019178614,0.000049628667,0.00001029335,0.00012633881,0.0000073031583,0.0014283314],"genre_scores_gemma":[0.99507576,0.0014721826,0.00021177341,0.00008590629,0.000028115617,0.00001748304,0.00017522476,0.0000054387056,0.0029281462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986255,0.00002969097,0.0000053941176,0.000012722811,0.000034225566,0.000055459295],"domain_scores_gemma":[0.99992824,0.00000833373,0.000010332874,0.000003369393,0.000012407587,0.000037332597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016756708,0.00010063816,0.00018615813,0.00022496353,0.00018292424,0.00036849914,0.00010206317,0.00023212223,0.0021305943],"category_scores_gemma":[0.00016423651,0.00008364754,0.00014741588,0.00014220062,0.00015451477,0.00010028992,0.00025136216,0.0004049829,0.00039749587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047943527,0.00034102588,0.009362212,0.00009947117,0.000022867092,0.00015475668,0.00006490243,0.00008158339,0.96757674,0.000260355,0.00057306985,0.016668618],"study_design_scores_gemma":[0.00032488463,0.0065185255,0.59078056,0.000087910004,0.00019525776,0.0010922254,0.0012082643,0.0020261845,0.38093317,0.0006286333,0.016176756,0.00002768763],"about_ca_topic_score_codex":0.0009204877,"about_ca_topic_score_gemma":0.001299141,"teacher_disagreement_score":0.0021305943,"about_ca_system_score_codex":0.00033613786,"about_ca_system_score_gemma":0.0003128916,"threshold_uncertainty_score":0.007127583},"labels":[],"label_agreement":null},{"id":"W4415898627","doi":"10.1136/jitc-2025-sitc2025.1230","title":"1230 Enhancing tissue microarray design for immune profiling: tissue microarray vs whole-slide quantification of CD8 in non-small cell lung carcinoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Queen's University","funders":"","keywords":"Immune system; Microarray; Tissue microarray; Microarray analysis techniques; CD8; Lung cancer; Cytotoxic T cell","score_opus":0.013997620393194875,"score_gpt":0.26727838706133306,"score_spread":0.2532807666681382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82406676,0.001129317,0.16551301,0.00024808757,0.00016280226,0.0005349649,0.0015361756,0.001608155,0.0052008405],"genre_scores_gemma":[0.76804227,0.0007206983,0.21804877,0.00038300574,0.00006727793,0.0021082934,0.0016299125,0.00019800596,0.008801801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956375,0.000074447344,0.000022950857,0.00012648542,0.0001607417,0.000051610135],"domain_scores_gemma":[0.9997303,0.000092751005,0.000033835415,0.00003613135,0.000082507744,0.000024483043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047452372,0.00024297998,0.00035960873,0.00048032243,0.00022786987,0.00045173135,0.00033336776,0.00037437014,0.0050010174],"category_scores_gemma":[0.00058853615,0.00032582018,0.0001569225,0.00038207512,0.00016379345,0.0002496618,0.00018033588,0.00033281647,0.0016373518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008518883,0.000025811976,0.00038778014,0.000026926762,0.0000032848998,0.000009423281,0.000009688625,0.00019215183,0.99564135,0.00004247254,0.0001367167,0.0034390527],"study_design_scores_gemma":[0.000017569855,0.00034329336,0.013529866,0.000005538897,0.0000187119,0.0001245504,0.00003708233,0.014105658,0.9691887,0.00008520461,0.0025305795,0.000013215821],"about_ca_topic_score_codex":0.00044293253,"about_ca_topic_score_gemma":0.0011791611,"teacher_disagreement_score":0.0050010174,"about_ca_system_score_codex":0.0003112876,"about_ca_system_score_gemma":0.00022161682,"threshold_uncertainty_score":0.01673001},"labels":[],"label_agreement":null},{"id":"W4415898651","doi":"10.1136/jitc-2025-sitc2025.1224","title":"1224 Glioblastoma: bridging mouse model insights to human tumor microenvironment using imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Tumor microenvironment; Bridging (networking); Flow cytometry; Mass cytometry; Tumor cells","score_opus":0.01079983947566746,"score_gpt":0.23531166254559555,"score_spread":0.2245118230699281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77522147,0.0057114596,0.17421922,0.0034923642,0.00041951498,0.0006455784,0.013423077,0.0042267884,0.022640541],"genre_scores_gemma":[0.88175476,0.0051673073,0.076467514,0.0005251073,0.00006683514,0.00052620773,0.005679303,0.0006865727,0.029126422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998241,0.00002032184,0.000012865219,0.000035525365,0.00007526912,0.000031897012],"domain_scores_gemma":[0.99992836,0.00000867292,0.000017860248,0.000010528437,0.000015368669,0.000019211824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039476505,0.00037787578,0.00023830369,0.0013820154,0.0002601626,0.00048132797,0.00026450047,0.00045624172,0.006121896],"category_scores_gemma":[0.00010002184,0.00021708816,0.00025821413,0.00040926674,0.0002652452,0.0002604669,0.0002736285,0.0008407075,0.001886057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078744124,0.000034746336,0.00019287078,0.000044070173,0.00000461034,0.000055891647,0.000021417112,0.000103562495,0.99437743,0.0007051211,0.0006935658,0.0036879645],"study_design_scores_gemma":[0.00003854345,0.00026020515,0.007555018,0.00003797297,0.000033133914,0.0010048113,0.00009442818,0.0044930363,0.9535014,0.00063890807,0.032328464,0.0000140183865],"about_ca_topic_score_codex":0.0016576003,"about_ca_topic_score_gemma":0.0027642197,"teacher_disagreement_score":0.006121896,"about_ca_system_score_codex":0.00044938587,"about_ca_system_score_gemma":0.00029078755,"threshold_uncertainty_score":0.020479798},"labels":[],"label_agreement":null},{"id":"W4415898660","doi":"10.1136/jitc-2025-sitc2025.0128","title":"128 Enabling sensitive and reproducible functional profiling for immuno-oncology research on the CyTOF XT PRO mass cytometer","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Profiling (computer programming); Mass spectrometry; Tandem mass spectrometry","score_opus":0.08514801184976346,"score_gpt":0.3306256824787652,"score_spread":0.24547767062900178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898660","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17388366,0.0016271088,0.7381389,0.0024996751,0.0008992028,0.0014822154,0.013434613,0.018220756,0.049813837],"genre_scores_gemma":[0.22365694,0.0025540397,0.69053787,0.001226077,0.00027619454,0.0037660252,0.0126563525,0.0025597836,0.062766686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989028,0.00017170246,0.00008254747,0.00023565156,0.0005118921,0.00009536705],"domain_scores_gemma":[0.99930906,0.00025685885,0.000055228462,0.00014291794,0.00018472745,0.000051109157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094184576,0.00086241175,0.0006494026,0.001283061,0.00054100977,0.0014183153,0.0009441053,0.0011078966,0.025631],"category_scores_gemma":[0.0012945406,0.00069361465,0.00038771244,0.00093350944,0.00050956313,0.0010139028,0.0006650115,0.0018211917,0.013893361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006464741,0.000037914542,0.00029966727,0.00006411086,0.0000050215267,0.000023816088,0.000024059806,0.00014652846,0.98080796,0.001255802,0.0042565134,0.013013875],"study_design_scores_gemma":[0.000042933018,0.00012567782,0.002473285,0.00003338949,0.00001782856,0.00027125783,0.000023103754,0.012401987,0.9533251,0.0016818657,0.029558476,0.00004501698],"about_ca_topic_score_codex":0.0004261841,"about_ca_topic_score_gemma":0.0013671161,"teacher_disagreement_score":0.025631,"about_ca_system_score_codex":0.00043291078,"about_ca_system_score_gemma":0.00072010723,"threshold_uncertainty_score":0.08574426},"labels":[],"label_agreement":null},{"id":"W4415898666","doi":"10.1136/jitc-2025-sitc2025.1196","title":"1196 TriTCE Co-stim: a differentiated T cell engager platform with conditional <i>cis</i> CD28 co-stimulation is transferable to diverse targeting strategies","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"T cell; CD28; Cell; T-cell receptor; Ubiquitin-Protein Ligases","score_opus":0.02448960916072105,"score_gpt":0.2953962097737661,"score_spread":0.27090660061304506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493613,0.0016032094,0.023628809,0.0005367188,0.00030046963,0.00020221039,0.003023749,0.0010144642,0.020329108],"genre_scores_gemma":[0.96476626,0.00061907736,0.009608202,0.00025163527,0.000030537973,0.00015604853,0.0031412577,0.00019142014,0.021235546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999521,0.000045219032,0.000030294272,0.00011934859,0.00014515368,0.00013900945],"domain_scores_gemma":[0.9999043,0.000014040382,0.000017010718,0.000015637863,0.000013100285,0.000035836143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002057787,0.00040476304,0.00029407963,0.00027050058,0.0002640973,0.00062801235,0.00033383336,0.0005334614,0.0069517638],"category_scores_gemma":[0.00013021597,0.00024368944,0.00026768973,0.00021552402,0.00024113324,0.0002867163,0.00041482731,0.0014564276,0.0034817527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009475535,0.000033335044,0.000086580534,0.00002390197,0.000006687398,0.00002981075,0.000011423199,0.000090492016,0.9971008,0.00026385396,0.00044830752,0.0018101683],"study_design_scores_gemma":[0.000017926031,0.00012007574,0.00065675366,0.0000035113283,0.000012243579,0.0001312105,0.000015586842,0.0008879261,0.9920229,0.00004657052,0.0060800323,0.000005240188],"about_ca_topic_score_codex":0.00046859268,"about_ca_topic_score_gemma":0.0012365987,"teacher_disagreement_score":0.0069517638,"about_ca_system_score_codex":0.00036678987,"about_ca_system_score_gemma":0.000363284,"threshold_uncertainty_score":0.023255944},"labels":[],"label_agreement":null},{"id":"W4415898701","doi":"10.1136/jitc-2025-sitc2025.0078","title":"78 Exploratory radiomics analysis in unresectable hepatocellular carcinoma treated with durvalumab alone or combined with tremelimumab or bevacizumab","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Tremelimumab; Bevacizumab; Radiomics; Hepatocellular carcinoma; Nivolumab; Exploratory analysis","score_opus":0.015160175798743708,"score_gpt":0.25031871104562703,"score_spread":0.23515853524688332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962069,0.0006275329,0.00044381138,0.00011722622,0.000016018317,0.000056281544,0.0005100705,0.000030026786,0.0019921635],"genre_scores_gemma":[0.99805284,0.00020060928,0.00033581656,0.000065882494,0.000027428629,0.00003964342,0.00062036695,0.000015754033,0.00064166787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998902,0.000018325269,0.000007208496,0.000024623201,0.000021842343,0.00003782551],"domain_scores_gemma":[0.99980193,0.00005456333,0.00003579142,0.000018885772,0.000022737702,0.000066085384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002482003,0.00038794568,0.0006876421,0.00045594285,0.00020458706,0.00040827112,0.00022627681,0.00029842186,0.002744624],"category_scores_gemma":[0.00052708085,0.00016579988,0.0006382123,0.00030745508,0.00027635385,0.00022432802,0.00021763219,0.00030212363,0.00042419217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13928752,0.002048724,0.42666155,0.000551762,0.00096669904,0.05751487,0.0005056323,0.005270365,0.21386755,0.00075057906,0.0048257275,0.14774907],"study_design_scores_gemma":[0.0026743168,0.02411316,0.8664974,0.00006848943,0.002136597,0.032812126,0.0007210953,0.009087406,0.050007567,0.0008274465,0.010942875,0.00011140547],"about_ca_topic_score_codex":0.0020432314,"about_ca_topic_score_gemma":0.0013459714,"teacher_disagreement_score":0.002744624,"about_ca_system_score_codex":0.00073221134,"about_ca_system_score_gemma":0.0003258363,"threshold_uncertainty_score":0.009181678},"labels":[],"label_agreement":null},{"id":"W4415898738","doi":"10.1136/jitc-2025-sitc2025.0718","title":"718 Global quantitative patient chart review of multidisciplinary team (MDT) care and treatment use in early-stage non-small-cell lung cancer (NSCLC)","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montfort Hospital","funders":"AstraZeneca","keywords":"Multidisciplinary approach; Lung cancer; Chart; MEDLINE; Patient care; Lung disease","score_opus":0.019939317980088075,"score_gpt":0.30876162806235,"score_spread":0.28882231008226195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721733,0.0009226114,0.0003437799,0.000469339,0.000038944283,0.0002075087,0.021749318,0.00006637261,0.004028854],"genre_scores_gemma":[0.99194556,0.00026497373,0.0006662852,0.00014682458,0.000021809212,0.00011277795,0.0062748147,0.000010117677,0.000556858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754936,0.0010866844,0.0004118807,0.00028304392,0.0004571416,0.00021189652],"domain_scores_gemma":[0.9851141,0.003310713,0.006974055,0.00039886308,0.0029522362,0.001250037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001983742,0.00013753786,0.00032585402,0.0024611074,0.00044547842,0.0007345396,0.00029038973,0.00029604376,0.0028866972],"category_scores_gemma":[0.010123156,0.0001577434,0.00046802775,0.0027029058,0.00021243842,0.0006124965,0.0008833724,0.00038759323,0.00033780403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010429941,0.000038210583,0.99253654,0.000059461294,0.000051564246,0.000022748336,0.00015834403,0.00008276549,0.00005742722,0.000020633894,0.0017298871,0.005138169],"study_design_scores_gemma":[0.000007894523,0.00006605215,0.99851984,0.000025594652,0.000018729575,0.000035627225,0.0003745622,0.000149071,0.000052474014,0.000009922568,0.00073491316,0.0000052014266],"about_ca_topic_score_codex":0.035099383,"about_ca_topic_score_gemma":0.053422403,"teacher_disagreement_score":0.035099383,"about_ca_system_score_codex":0.0015240925,"about_ca_system_score_gemma":0.0023063987,"threshold_uncertainty_score":0.069790184},"labels":[],"label_agreement":null},{"id":"W4415898748","doi":"10.1136/jitc-2025-sitc2025.0082","title":"82 AI-guided spatial profiling of tertiary lymphoid structures in human lung cancer by imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Lung cancer; Human lung; Profiling (computer programming); Flow cytometry","score_opus":0.006854862872212871,"score_gpt":0.26774149573051886,"score_spread":0.260886632858306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606797,0.0020138319,0.026997877,0.0003124906,0.0000406295,0.00011463733,0.0010520009,0.00020878614,0.008580083],"genre_scores_gemma":[0.9706072,0.00080299994,0.020542575,0.00013064957,0.000014271932,0.00010460072,0.0007991122,0.000052055413,0.006946467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999292,0.000006878834,0.0000032803514,0.00002298957,0.000017984145,0.000019610537],"domain_scores_gemma":[0.99995446,0.00001485765,0.000006332382,0.000005055866,0.000013094909,0.000006181723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015087913,0.00009023684,0.00011110537,0.00030685303,0.0002126072,0.00036572854,0.00014787145,0.00029570638,0.0018082276],"category_scores_gemma":[0.00013837463,0.00011476712,0.00010850407,0.00022043753,0.00015679012,0.00014729785,0.00016558629,0.00032050017,0.0007359091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053684387,0.000009039986,0.00039542618,0.000017739872,0.0000015937558,0.000019489627,0.000022126993,0.00015215212,0.9962274,0.00014178256,0.00009011413,0.0028695462],"study_design_scores_gemma":[0.00001775985,0.000092198636,0.016571762,0.000005138549,0.000014084492,0.00016684592,0.00013711196,0.006203617,0.9722288,0.00016007999,0.0043954602,0.000007112044],"about_ca_topic_score_codex":0.0026893269,"about_ca_topic_score_gemma":0.0032835838,"teacher_disagreement_score":0.0026893269,"about_ca_system_score_codex":0.00031894684,"about_ca_system_score_gemma":0.0002185344,"threshold_uncertainty_score":0.0060490966},"labels":[],"label_agreement":null},{"id":"W4415898803","doi":"10.1136/jitc-2025-sitc2025.0400","title":"400 New ICD code-based case definition correctly identifies ICI-IA from administrative health data","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Vancouver Coastal Health; University of Manitoba; University of Calgary; McGill University; Alberta Health Services; University of Alberta","funders":"","keywords":"Health data; Data collection; Data quality; MEDLINE; Health care","score_opus":0.3509173051807121,"score_gpt":0.45081514445663345,"score_spread":0.09989783927592133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82562935,0.0016898343,0.025256399,0.006632589,0.003910689,0.00088482053,0.045965012,0.0013892053,0.088641986],"genre_scores_gemma":[0.9450956,0.0004428439,0.018132105,0.0031757972,0.0006322263,0.00025475657,0.026351683,0.00020939742,0.0057055117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602675,0.0005142769,0.0007420065,0.00060131936,0.0016601774,0.00045549456],"domain_scores_gemma":[0.98442984,0.004169717,0.0040781437,0.002433802,0.004215135,0.0006734869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024015983,0.00046802752,0.00047419794,0.004167653,0.0007535927,0.001812915,0.0010623033,0.0010005087,0.0069465484],"category_scores_gemma":[0.028284533,0.00030336244,0.00094327313,0.0017432675,0.0003441166,0.0007187082,0.00090517994,0.0013130208,0.0027937775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035443157,0.00026704397,0.9086703,0.00011151197,0.00010405522,0.0006124274,0.00016751153,0.000598285,0.002743627,0.001283556,0.04165229,0.04343507],"study_design_scores_gemma":[0.00010915382,0.00011987116,0.9478333,0.00046135407,0.00017870958,0.0029596915,0.000437558,0.008196877,0.0039663278,0.0018745551,0.033819906,0.000042686916],"about_ca_topic_score_codex":0.015283488,"about_ca_topic_score_gemma":0.01839616,"teacher_disagreement_score":0.015283488,"about_ca_system_score_codex":0.0014869191,"about_ca_system_score_gemma":0.002119376,"threshold_uncertainty_score":0.03038907},"labels":[],"label_agreement":null},{"id":"W4415898806","doi":"10.1136/jitc-2025-sitc2025.0441","title":"441 Reimagining bladder cancer immunotherapy: local non-viral gene delivery of DNA-encoded immune checkpoint inhibitors","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Saint-Laurent","funders":"","keywords":"Bladder cancer; Immune system; Gene; Immune checkpoint; Gene delivery","score_opus":0.01088837622101589,"score_gpt":0.25748898297937334,"score_spread":0.24660060675835746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94832385,0.01563007,0.019576564,0.0010933146,0.0005446757,0.00020525188,0.00040619628,0.0004460234,0.013774074],"genre_scores_gemma":[0.9698601,0.004584106,0.0068564164,0.00020235332,0.000056130753,0.000069750415,0.00030562864,0.000061006456,0.01800454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998708,0.000015262796,0.000004361457,0.000031723877,0.0000363766,0.000041411306],"domain_scores_gemma":[0.99996984,0.000005712631,0.000007991647,0.0000033897254,0.000004646153,0.00000837749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016817533,0.00025679727,0.00030837453,0.00018190934,0.00018731027,0.00069144665,0.00021356823,0.00053898775,0.003338971],"category_scores_gemma":[0.00010071266,0.00013226402,0.000293981,0.00016922332,0.000203956,0.00037264248,0.00022626302,0.0007968556,0.0006564263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022563139,0.0001367554,0.0001232089,0.00009280395,0.000012250339,0.00004049489,0.000027656444,0.00042571122,0.97414976,0.0008336484,0.0006518141,0.023280352],"study_design_scores_gemma":[0.00011096694,0.0016983035,0.0018167027,0.000017101118,0.000056927558,0.00031350675,0.000054063847,0.002625165,0.97354865,0.00022190288,0.019519215,0.000017542976],"about_ca_topic_score_codex":0.0006438881,"about_ca_topic_score_gemma":0.0011749488,"teacher_disagreement_score":0.003338971,"about_ca_system_score_codex":0.00036647773,"about_ca_system_score_gemma":0.00034754173,"threshold_uncertainty_score":0.01116997},"labels":[],"label_agreement":null},{"id":"W4415898841","doi":"10.1136/jitc-2025-sitc2025.0384","title":"384 Features of neoantigen-reactive T cells with <i>ex vivo</i> expansion capacity","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"T cell; T lymphocyte; Work (physics); Population","score_opus":0.008710869836876198,"score_gpt":0.20621346275863206,"score_spread":0.19750259292175587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926001,0.00031356068,0.00076567667,0.00006363031,0.00001214839,0.000032022133,0.0005936376,0.00004583102,0.0055733393],"genre_scores_gemma":[0.9963581,0.00010385718,0.0005001536,0.00005961202,0.000018421559,0.000040467126,0.001134446,0.000017701452,0.001767314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998641,0.000023514242,0.000014257213,0.00002089833,0.000027084297,0.000050076294],"domain_scores_gemma":[0.99985015,0.000048100264,0.000018959736,0.000021282898,0.000026539612,0.00003492128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001319774,0.00030601106,0.00014361356,0.0004219677,0.00017959184,0.00046208705,0.0002343768,0.00035589025,0.004282887],"category_scores_gemma":[0.00019688068,0.00014102393,0.00023051727,0.0002535796,0.00015460393,0.0002331959,0.00024603689,0.00044751313,0.0012121969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057293347,0.00007714961,0.0016820447,0.00002131556,0.0000049103455,0.00018043237,0.000043923243,0.00012811898,0.9943293,0.00030470605,0.00009715956,0.002558009],"study_design_scores_gemma":[0.00018143683,0.0023559646,0.11002185,0.000024558178,0.00007320971,0.0029382566,0.00032089825,0.0030385505,0.87316275,0.0010003058,0.0068502156,0.000032046893],"about_ca_topic_score_codex":0.00036340643,"about_ca_topic_score_gemma":0.00018298163,"teacher_disagreement_score":0.004282887,"about_ca_system_score_codex":0.00016174385,"about_ca_system_score_gemma":0.00010110988,"threshold_uncertainty_score":0.014327705},"labels":[],"label_agreement":null},{"id":"W4415898865","doi":"10.1136/jitc-2025-sitc2025.0320","title":"320 Integrated efficacy and safety analysis of letetresgene autoleucel, a T-cell receptor T-cell therapy, across clinical trials of patients with synovial sarcoma and myxoid/round cell liposarcoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Soft tissue sarcoma; Synovial sarcoma; Liposarcoma; Sarcoma; Receptor","score_opus":0.043261942524745856,"score_gpt":0.3526277013207987,"score_spread":0.3093657587960528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596965,0.001422289,0.0004790251,0.000110933724,0.00004768516,0.0003915704,0.0006334315,0.000043178337,0.00090223964],"genre_scores_gemma":[0.99644214,0.0005308878,0.0005488936,0.00015074476,0.0000546002,0.00031847728,0.0011457012,0.000021819022,0.00078669924],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99778134,0.0012346271,0.00017412104,0.00027193155,0.0002868398,0.00025105875],"domain_scores_gemma":[0.99875486,0.0003501496,0.00033542377,0.00016888168,0.00014691232,0.00024382777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042284722,0.0006203348,0.001795444,0.0006475158,0.00026130912,0.0012036745,0.00045943816,0.00074835523,0.0020801567],"category_scores_gemma":[0.0023615337,0.00038083037,0.0015706576,0.0005486094,0.00078194105,0.001059319,0.0003615954,0.0015307071,0.0005006729],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7737965,0.016023178,0.012846712,0.0005307731,0.0038756994,0.00010806313,0.00022418593,0.0041468986,0.060787898,0.00040771716,0.0013640639,0.12588832],"study_design_scores_gemma":[0.15969399,0.7545114,0.05866751,0.000054254473,0.0037639658,0.00028224709,0.00014082984,0.003183734,0.014027265,0.0003986788,0.005205862,0.000070308466],"about_ca_topic_score_codex":0.00051167374,"about_ca_topic_score_gemma":0.0008708477,"teacher_disagreement_score":0.0042284722,"about_ca_system_score_codex":0.0010979119,"about_ca_system_score_gemma":0.0009159388,"threshold_uncertainty_score":0.02236259},"labels":[],"label_agreement":null},{"id":"W4415898942","doi":"10.1136/jitc-2025-sitc2025.0283","title":"283 Functional profiling of CAR T cells using high-dimensional CyTOF: integrating cytokine, transcription factor and immune checkpoint marker signatures","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Transcription factor; Profiling (computer programming); Immune system; Immune checkpoint; Transcription (linguistics); Gene expression profiling","score_opus":0.023002610327908395,"score_gpt":0.26604151805324533,"score_spread":0.24303890772533693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97582924,0.0005831692,0.016849047,0.0001598135,0.000021108895,0.00007810675,0.003198795,0.0002452476,0.003035424],"genre_scores_gemma":[0.9744819,0.00044399,0.017412188,0.000116392184,0.000014564174,0.00012304056,0.0033361202,0.00011432004,0.0039576283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984205,0.000015556896,0.000008229178,0.000032593653,0.000050636092,0.000050903407],"domain_scores_gemma":[0.999918,0.000026166184,0.000009936082,0.00000980463,0.000022056547,0.000014047217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014158405,0.00017608206,0.00023314363,0.00061787275,0.00031068246,0.00088968786,0.00018756978,0.0003725681,0.002188592],"category_scores_gemma":[0.00017845191,0.00013179041,0.00023338028,0.00038909406,0.00018189165,0.00020578224,0.00015425847,0.0005283147,0.0011797942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011928585,0.000021241885,0.0010374477,0.000017349044,0.0000033717956,0.000024929337,0.000037293397,0.00023456622,0.9955318,0.00012793954,0.00008927267,0.0027555344],"study_design_scores_gemma":[0.00001146607,0.00012767907,0.019628197,0.0000054781203,0.000019162448,0.00015442834,0.00016985499,0.0072790813,0.96950454,0.00016040787,0.0029278048,0.000011857263],"about_ca_topic_score_codex":0.001181403,"about_ca_topic_score_gemma":0.0017525486,"teacher_disagreement_score":0.002188592,"about_ca_system_score_codex":0.00027770246,"about_ca_system_score_gemma":0.00018103137,"threshold_uncertainty_score":0.007321596},"labels":[],"label_agreement":null},{"id":"W4415898972","doi":"10.1136/jitc-2025-sitc2025.0406","title":"406 Imaging mass cytometry detects true dynamic range of low-abundance T cell exhaustion biomarkers in human cancers","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; T cell; Flow cytometry; Dynamic range; Range (aeronautics); Cell","score_opus":0.005140404900735351,"score_gpt":0.23085852397252465,"score_spread":0.2257181190717893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709447,0.0035046795,0.01802807,0.00079589617,0.00007297034,0.000044772172,0.0007209514,0.00033425033,0.005553751],"genre_scores_gemma":[0.97621834,0.0013361013,0.0139217125,0.0005080132,0.0000691626,0.00009716502,0.00096557435,0.00009578039,0.0067882305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997907,0.00003527641,0.000008234643,0.00006908045,0.00005128323,0.000045517263],"domain_scores_gemma":[0.9998827,0.000036929912,0.000018843615,0.000010597482,0.000030324776,0.000020658394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033332867,0.00023904328,0.0002482907,0.00054222345,0.0002718214,0.0007602735,0.00024479814,0.0006678114,0.0026638538],"category_scores_gemma":[0.0004238191,0.00024402773,0.00017049504,0.0003322753,0.00028274537,0.00032596278,0.00022296183,0.0006932007,0.0010317389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011040608,0.000019883548,0.0021966456,0.000023498607,0.0000057996026,0.000026642194,0.000033913428,0.00007955604,0.9931069,0.0001731287,0.00029638116,0.0039271857],"study_design_scores_gemma":[0.000027051577,0.00027480948,0.04231652,0.000016615733,0.000039648472,0.000579649,0.0001748909,0.005147565,0.9443534,0.00077103946,0.006280433,0.000018488154],"about_ca_topic_score_codex":0.0005182368,"about_ca_topic_score_gemma":0.00087144744,"teacher_disagreement_score":0.0026638538,"about_ca_system_score_codex":0.00030066306,"about_ca_system_score_gemma":0.0002110798,"threshold_uncertainty_score":0.00891149},"labels":[],"label_agreement":null},{"id":"W4415898975","doi":"10.1136/jitc-2025-sitc2025.0407","title":"407 Relationships between lymphocyte counts and clinical outcomes in patients with recurrent glioblastoma treated with pembrolizumab","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Pembrolizumab; Lymphocyte; Glioblastoma; Immunotherapy; Immune system","score_opus":0.018150357305015703,"score_gpt":0.2713920643638617,"score_spread":0.253241707058846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868447,0.00046149458,0.000023038028,0.000088701396,0.000013643698,0.0000034841985,0.00011505313,0.0000031411014,0.0006068807],"genre_scores_gemma":[0.99935526,0.0001289659,0.000015239587,0.00005594386,0.000025973299,0.0000060191446,0.00021685791,0.0000013308471,0.0001944725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997806,0.00004687476,0.000020099536,0.000031538402,0.000046332323,0.000074467906],"domain_scores_gemma":[0.9993716,0.00014066137,0.00022502267,0.000019347184,0.000076707445,0.00016669229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002609546,0.00017998372,0.00042787183,0.00035041088,0.00026095685,0.000539778,0.00021927369,0.00038444012,0.001048696],"category_scores_gemma":[0.0013081653,0.00011862124,0.0003902724,0.00047840693,0.0001570596,0.00032838134,0.00020253881,0.0006045327,0.00022392241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003727857,0.0001915246,0.9843464,0.000019090921,0.00026056333,0.00029468085,0.00004795911,0.00025012795,0.001173227,0.000027237142,0.0004853265,0.009175859],"study_design_scores_gemma":[0.00006392002,0.00062913675,0.9976131,0.0000068518807,0.00014148682,0.0003111907,0.00008797037,0.0004973783,0.00018408432,0.000056768535,0.00039930517,0.000008731754],"about_ca_topic_score_codex":0.002438377,"about_ca_topic_score_gemma":0.0035405753,"teacher_disagreement_score":0.002438377,"about_ca_system_score_codex":0.000553816,"about_ca_system_score_gemma":0.00039124058,"threshold_uncertainty_score":0.004848361},"labels":[],"label_agreement":null},{"id":"W4415899041","doi":"10.1136/jitc-2025-sitc2025.0853","title":"853 Design of a next generation tumor targeted masked IL-12Fc for enhanced tolerability and localized anti-tumor activity","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Tolerability; Tumor cells; Clinical trial; Context (archaeology); Solid tumor","score_opus":0.054974113793201766,"score_gpt":0.30744779321598054,"score_spread":0.25247367942277876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96834356,0.0012246303,0.026151456,0.00029188246,0.00010167836,0.00022007541,0.00057236286,0.00020633753,0.002888116],"genre_scores_gemma":[0.98002565,0.00031512362,0.015350974,0.00017371125,0.000013798283,0.00013192036,0.0004804654,0.000017036835,0.003491404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999014,0.000008566627,0.0000044395383,0.000022604287,0.000024096928,0.000038903734],"domain_scores_gemma":[0.99995077,0.0000035563137,0.000011073316,0.000004202768,0.000014957612,0.000015519348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014436623,0.0002727375,0.0001868955,0.000113096896,0.00013627042,0.00027814257,0.00035788692,0.00037294315,0.0010901827],"category_scores_gemma":[0.000110699926,0.00009410909,0.00021467455,0.0000837073,0.00012833683,0.00012219533,0.00013435812,0.00038465147,0.00041372175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016655319,0.00005101237,0.00007657973,0.000024690587,0.000005583408,0.000033959503,0.000008360197,0.00060119387,0.9954951,0.00012704167,0.0001762568,0.0032337701],"study_design_scores_gemma":[0.000067569585,0.00076115533,0.00055292196,0.0000041004428,0.0000246313,0.00013423945,0.000008468446,0.0036269308,0.9889263,0.000037475063,0.0058475104,0.000008655211],"about_ca_topic_score_codex":0.0014377026,"about_ca_topic_score_gemma":0.0017184281,"teacher_disagreement_score":0.0014377026,"about_ca_system_score_codex":0.00052593165,"about_ca_system_score_gemma":0.00035620696,"threshold_uncertainty_score":0.003815949},"labels":[],"label_agreement":null},{"id":"W4415899043","doi":"10.1136/jitc-2025-sitc2025.0982","title":"982 Targeting glycans for cancer immunotherapy","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"","score_opus":0.012602089408156391,"score_gpt":0.29857917280003904,"score_spread":0.28597708339188266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899043","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5589102,0.06703948,0.027252084,0.021897277,0.00605841,0.0006380973,0.0022268447,0.0007995599,0.31517813],"genre_scores_gemma":[0.58919966,0.045281846,0.013710292,0.002241617,0.0013076646,0.0001954171,0.0028347317,0.00017055428,0.3450581],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999236,0.000013380995,0.0000022160984,0.000007352031,0.00003059892,0.0000227496],"domain_scores_gemma":[0.9999639,0.000003248824,0.0000031373606,0.0000023285554,0.0000075632784,0.000019912148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033761616,0.000362699,0.00015983373,0.00032315106,0.00020390566,0.00058274006,0.00024865055,0.0004844238,0.015769662],"category_scores_gemma":[0.00010456263,0.0001297681,0.00019115934,0.00026919256,0.00012602819,0.00026391432,0.00040237396,0.00068585534,0.0048745433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091137836,0.00043236025,0.0009770792,0.00023231801,0.000037936017,0.00025562794,0.000053043364,0.0004201231,0.7182863,0.011269314,0.05224425,0.21488032],"study_design_scores_gemma":[0.0003516103,0.0013485693,0.008896883,0.000070613656,0.000058435304,0.0014107157,0.00009657829,0.0028665555,0.3015047,0.0044316985,0.67894,0.000023683671],"about_ca_topic_score_codex":0.0002929103,"about_ca_topic_score_gemma":0.0005558997,"teacher_disagreement_score":0.015769662,"about_ca_system_score_codex":0.00031666536,"about_ca_system_score_gemma":0.00026655893,"threshold_uncertainty_score":0.05275476},"labels":[],"label_agreement":null},{"id":"W4415899076","doi":"10.1136/jitc-2025-sitc2025.0854","title":"854 Amplification &amp; redirection of endogenous IL-15 activity with a bispecific antibody","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Acuitas Therapeutics (Canada)","funders":"","keywords":"Bispecific antibody; Endogeny; Antibody; Antibody response; Cell culture","score_opus":0.02288873498355517,"score_gpt":0.25139613198913935,"score_spread":0.22850739700558417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899076","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88846684,0.0019258064,0.0787404,0.00079057517,0.00055012456,0.0011649835,0.002592336,0.0011562958,0.024612637],"genre_scores_gemma":[0.89012676,0.0015773148,0.071353704,0.0006556147,0.00012540759,0.001050094,0.0052447547,0.000375983,0.029490335],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989078,0.00016362198,0.00013102798,0.0002131769,0.00019151124,0.0003929061],"domain_scores_gemma":[0.99964464,0.00011848247,0.000037528338,0.00006117969,0.000057067744,0.00008112749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078537327,0.0009571307,0.00047080466,0.0007914776,0.00042337432,0.00071158085,0.00066445966,0.000679283,0.006807615],"category_scores_gemma":[0.00040213275,0.0004609577,0.0006466139,0.00054792094,0.0005148901,0.00034391848,0.0008242257,0.0018781215,0.0027861295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028152327,0.0000920274,0.00012492438,0.000058622947,0.000012536541,0.00004272543,0.000021274225,0.00012998332,0.9956631,0.00059985,0.00025687707,0.002716453],"study_design_scores_gemma":[0.000042579064,0.0001182542,0.00052795216,0.0000049395476,0.00001183357,0.00006480704,0.000007541254,0.000813768,0.99495465,0.000051405335,0.0033981132,0.0000040999603],"about_ca_topic_score_codex":0.0013650053,"about_ca_topic_score_gemma":0.0020895666,"teacher_disagreement_score":0.006807615,"about_ca_system_score_codex":0.0008772501,"about_ca_system_score_gemma":0.00088496256,"threshold_uncertainty_score":0.022773802},"labels":[],"label_agreement":null},{"id":"W4415899080","doi":"10.1136/jitc-2025-sitc2025.0016","title":"16 Automated tertiary lymphoid structure detection and prognostic value in colorectal liver metastases","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Polytechnique Montréal","funders":"","keywords":"Value (mathematics); Colorectal cancer; Lymphatic system; Metastasis","score_opus":0.014902788863567617,"score_gpt":0.22608262810304677,"score_spread":0.21117983923947917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915366,0.0009809202,0.004176021,0.00015224487,0.0000448348,0.000048713548,0.00073753524,0.00026942784,0.0020537402],"genre_scores_gemma":[0.99341136,0.00017936465,0.0036634502,0.00002511394,0.000050769457,0.000021299884,0.0010137269,0.000016896098,0.0016179809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971014,0.000081536695,0.000025581065,0.000044286615,0.000080357226,0.00005808478],"domain_scores_gemma":[0.99899536,0.00039372678,0.000109890316,0.0000810183,0.00029616756,0.00012374378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011196363,0.00025668906,0.0003400508,0.0022787796,0.0002619492,0.0010289513,0.00039571492,0.0005033257,0.0038788512],"category_scores_gemma":[0.0027795592,0.00019888423,0.000335722,0.0007236997,0.000160894,0.0004255638,0.00052424445,0.00024235387,0.0011984954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003871793,0.00023045597,0.6865618,0.00013660564,0.000132416,0.00036888677,0.00008021975,0.004671133,0.047548275,0.0002810206,0.003394063,0.25272328],"study_design_scores_gemma":[0.00024255582,0.0012059951,0.82728624,0.00004338869,0.00032995894,0.002108063,0.00019725272,0.13307303,0.029898038,0.0010815285,0.004486601,0.000047332032],"about_ca_topic_score_codex":0.002466354,"about_ca_topic_score_gemma":0.003208361,"teacher_disagreement_score":0.0038788512,"about_ca_system_score_codex":0.0004988508,"about_ca_system_score_gemma":0.00036792297,"threshold_uncertainty_score":0.01297611},"labels":[],"label_agreement":null},{"id":"W4415899119","doi":"10.1136/jitc-2025-sitc2025.0248","title":"248 Exploitation of endogenous TCR signaling using an oncolytic virus for modulation of CAR T phenotype and function against solid tumors","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncolytic virus; Function (biology); Phenotype; Endogeny; Virus; T-cell receptor; Signal transduction","score_opus":0.0456889959017081,"score_gpt":0.3014719377498376,"score_spread":0.2557829418481295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899119","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894248,0.001078917,0.0047283187,0.0001738738,0.000047829843,0.000049751823,0.00021682531,0.00008306561,0.0041965432],"genre_scores_gemma":[0.99476117,0.00040416585,0.0022785317,0.000026270081,0.000014988482,0.000017724138,0.00013720542,0.000023652126,0.0023363803],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998779,0.000022501981,0.000008506477,0.000015536192,0.000032696316,0.00004294773],"domain_scores_gemma":[0.9999503,0.000015134468,0.000009251735,0.000007310194,0.0000063740945,0.000011641354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013635399,0.00019991299,0.00014037607,0.00019170676,0.00013253203,0.0004658652,0.0002424371,0.00027425273,0.0016739531],"category_scores_gemma":[0.00010636921,0.00011126972,0.00020911008,0.0000980045,0.00019961224,0.0001658709,0.00015250476,0.0005481845,0.00041699805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010990849,0.000029239314,0.00007086622,0.000010156031,0.0000023197879,0.000033898054,0.000007432664,0.00010443955,0.99715877,0.00043918475,0.00005793174,0.0019757804],"study_design_scores_gemma":[0.000028766724,0.0003351957,0.0006691357,0.0000021805372,0.000007862502,0.00016738668,0.000010471262,0.0013791741,0.995411,0.00006363197,0.0019229131,0.0000023942166],"about_ca_topic_score_codex":0.00059237756,"about_ca_topic_score_gemma":0.0005776773,"teacher_disagreement_score":0.0016739531,"about_ca_system_score_codex":0.0003243567,"about_ca_system_score_gemma":0.00020124926,"threshold_uncertainty_score":0.0055999756},"labels":[],"label_agreement":null},{"id":"W4415899151","doi":"10.1136/jitc-2025-sitc2025.0744","title":"744 Mapping immune cell responses in whole blood and solid tumor tissue biopsies of renal cancer with CyTOF and imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Immune system; Cancer; Whole blood; Whole body imaging; Solid tumor; Kidney cancer; Cell","score_opus":0.007189278954605434,"score_gpt":0.23233414959018844,"score_spread":0.225144870635583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899151","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855928,0.0009003604,0.009872332,0.00012333486,0.00001927198,0.000073406794,0.00067553023,0.00012862815,0.0026144648],"genre_scores_gemma":[0.982255,0.0005799585,0.01241381,0.00020427092,0.000029435343,0.00015756843,0.00085374084,0.000039609393,0.003466666],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998154,0.000031710173,0.000008183037,0.000055608572,0.000042360443,0.00004679894],"domain_scores_gemma":[0.99989986,0.00003350829,0.000013901249,0.000011631134,0.000024813487,0.000016304135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029792296,0.00014934814,0.00018330994,0.0006533671,0.00027688,0.0003444098,0.00016484744,0.00043625204,0.0018207862],"category_scores_gemma":[0.00023837708,0.00013672245,0.0001655615,0.00027253787,0.00023913263,0.00019330272,0.00016425106,0.00032135687,0.00047500638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035186822,0.000027600285,0.0042799455,0.000030260011,0.000008788362,0.00006540377,0.000060800856,0.000088429304,0.9910114,0.00011210131,0.00010872198,0.0038548233],"study_design_scores_gemma":[0.000046796213,0.000489526,0.19536461,0.000013278667,0.00006674962,0.00080275466,0.0006142731,0.006931622,0.79185253,0.00045365334,0.0033475307,0.000016671514],"about_ca_topic_score_codex":0.0019909742,"about_ca_topic_score_gemma":0.0025784099,"teacher_disagreement_score":0.0019909742,"about_ca_system_score_codex":0.0002525007,"about_ca_system_score_gemma":0.0001871621,"threshold_uncertainty_score":0.006091118},"labels":[],"label_agreement":null},{"id":"W4415899250","doi":"10.1136/jitc-2025-sitc2025.1219","title":"1219 High-plex spatial profiling of tumor metabolic reprogramming and cell signaling dynamics in breast cancer using imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Breast cancer; Reprogramming; Mass cytometry; Flow cytometry; Cell; Dynamics (music); Human breast","score_opus":0.0077330287408000934,"score_gpt":0.23356212491651593,"score_spread":0.22582909617571584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899250","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87434393,0.0015434028,0.10494252,0.0009870357,0.00014267942,0.00013740857,0.005652989,0.0015833415,0.0106666265],"genre_scores_gemma":[0.8912321,0.0015271264,0.083848864,0.00041331805,0.00006674375,0.00029017613,0.004427258,0.00026092888,0.017933534],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996069,0.000038858092,0.000019939274,0.00011017202,0.00015721192,0.00006705783],"domain_scores_gemma":[0.9998179,0.00004906848,0.000034817265,0.000027289165,0.00004482203,0.000026146505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004983803,0.00027364053,0.0003315232,0.0006947208,0.0005162642,0.0013550144,0.00039074573,0.0006138155,0.003500796],"category_scores_gemma":[0.0003450826,0.00025231155,0.00031325757,0.0006253226,0.00023860882,0.0004849669,0.00037328535,0.0008459162,0.0015865896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008545974,0.000043306158,0.0013066438,0.000028091146,0.000008737466,0.000017791483,0.000025883714,0.00035897736,0.9906501,0.00042646084,0.00047188462,0.006576722],"study_design_scores_gemma":[0.000012849315,0.00008074611,0.020977007,0.0000066046728,0.000019125036,0.00011940821,0.00007394685,0.012694543,0.9605443,0.0004280477,0.0050239787,0.000019470877],"about_ca_topic_score_codex":0.0014998048,"about_ca_topic_score_gemma":0.0035885845,"teacher_disagreement_score":0.003500796,"about_ca_system_score_codex":0.0008791739,"about_ca_system_score_gemma":0.000446336,"threshold_uncertainty_score":0.011711299},"labels":[],"label_agreement":null},{"id":"W4415899263","doi":"10.1136/jitc-2025-sitc2025.0189","title":"189 Baseline NKT cells as a potential predictive biomarker for treatment with an anchored IL-12 drug conjugate in patients with solid tumors","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biomarker; Conjugate; Baseline (sea); Drug; Clinical trial","score_opus":0.005950676006228926,"score_gpt":0.21808261094360482,"score_spread":0.2121319349373759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899263","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489367,0.0018478378,0.00030006043,0.0002421568,0.000078092984,0.000038060316,0.00040909566,0.000028655826,0.0021624512],"genre_scores_gemma":[0.9980433,0.0003627545,0.0002511026,0.0001315742,0.00006655829,0.000025065245,0.00048672408,0.000005127209,0.0006277811],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998202,0.000044545315,0.00001999472,0.000030577645,0.000043229804,0.00004148462],"domain_scores_gemma":[0.99958855,0.00014611686,0.00011446868,0.000020886833,0.000052538195,0.0000773572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023118574,0.00021059853,0.0005933088,0.00030351113,0.00019204667,0.00068645464,0.0001515665,0.0003520692,0.0017155829],"category_scores_gemma":[0.0009953992,0.00011844119,0.0002485349,0.00028238384,0.00019016149,0.000258158,0.0001939232,0.000658086,0.00055920705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060931863,0.0003740324,0.91716385,0.000106380874,0.00012284305,0.00059641124,0.00006832481,0.00032105527,0.016783124,0.0000930474,0.001624185,0.056653623],"study_design_scores_gemma":[0.00023167106,0.00489804,0.9778105,0.00004974079,0.00020977296,0.0023446842,0.00023664648,0.0018374773,0.008143727,0.0002330625,0.0039846767,0.000020096502],"about_ca_topic_score_codex":0.00041899795,"about_ca_topic_score_gemma":0.0005023757,"teacher_disagreement_score":0.0017155829,"about_ca_system_score_codex":0.00027751428,"about_ca_system_score_gemma":0.00024220237,"threshold_uncertainty_score":0.0057391524},"labels":[],"label_agreement":null},{"id":"W4415899279","doi":"10.1136/jitc-2025-sitc2025.1036","title":"1036 KAN-004, a metabolically complete live biotherapeutic product for the treatment of immune-related colitis","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Product (mathematics); Colitis; Ulcerative colitis; Inflammatory bowel disease; Inflammation","score_opus":0.012490885317736301,"score_gpt":0.24919964792937513,"score_spread":0.23670876261163884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899279","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8958486,0.02283301,0.014827364,0.0017865645,0.00092412834,0.0005877182,0.004033048,0.0016266652,0.05753299],"genre_scores_gemma":[0.93667746,0.007800138,0.007809013,0.00048738284,0.000060281174,0.00017112019,0.0036933457,0.00008889535,0.043212365],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992144,0.000015255463,0.0000037165435,0.000011871793,0.000024587318,0.000023116336],"domain_scores_gemma":[0.9999536,0.0000070223955,0.000007791371,0.000005100927,0.0000055953788,0.000020880101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001331078,0.0003252981,0.00025894484,0.0002584668,0.00015260454,0.00026564737,0.00038070988,0.0005212792,0.010117004],"category_scores_gemma":[0.000103063096,0.00013492753,0.00028028685,0.00018569845,0.00019509364,0.00019467443,0.00022054031,0.00094845233,0.002030932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003819811,0.0006514824,0.00035035308,0.0002955824,0.000039466704,0.0003767414,0.000035929428,0.00055171497,0.8771853,0.001244481,0.0036292905,0.11181996],"study_design_scores_gemma":[0.0039162324,0.023646327,0.009402603,0.00008283947,0.00016260408,0.004229213,0.00007815829,0.0022930566,0.83006346,0.0005279191,0.12554127,0.000056399876],"about_ca_topic_score_codex":0.00060405815,"about_ca_topic_score_gemma":0.0008023691,"teacher_disagreement_score":0.010117004,"about_ca_system_score_codex":0.0002261571,"about_ca_system_score_gemma":0.00044558034,"threshold_uncertainty_score":0.03384471},"labels":[],"label_agreement":null},{"id":"W4415900069","doi":"10.1136/jitc-2025-sitc2025.0064","title":"64 A novel application of selective exo-enzymatic glycan labeling to co-quantify cell-surface glycans and protein-based biomarkers of the tumour immune microenvironment","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glycan; Immune system; Tumor microenvironment; Cell","score_opus":0.007676710676286933,"score_gpt":0.2483286297433944,"score_spread":0.24065191906710745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.544313,0.0036264488,0.44000342,0.0007799102,0.0003929652,0.00060182787,0.0009701137,0.00090942916,0.00840286],"genre_scores_gemma":[0.7695642,0.002633885,0.21165834,0.0006099218,0.00011665939,0.00060160045,0.00090127066,0.00011556326,0.013798531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996123,0.00008162082,0.000019683303,0.00012093219,0.000107721506,0.000057844834],"domain_scores_gemma":[0.99976593,0.00007368633,0.000046220648,0.000048092366,0.000038272137,0.000027767945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005400566,0.00069464993,0.00034901797,0.0004556904,0.00026349167,0.0007007719,0.00054431,0.0008386153,0.0014410246],"category_scores_gemma":[0.00033307928,0.00043610382,0.00043524476,0.0002900361,0.00045976453,0.0004339977,0.00065970985,0.0009658645,0.0006863003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019460871,0.000016489583,0.000056189212,0.000024009663,0.0000032223804,0.000017571576,0.0000062496797,0.000024215982,0.99758863,0.00017367731,0.000056292996,0.0020140477],"study_design_scores_gemma":[0.000009642325,0.00012902061,0.0010231027,0.00000568684,0.000010933835,0.00039365262,0.000010319853,0.0014775221,0.99327314,0.00012968639,0.0035278972,0.000009532814],"about_ca_topic_score_codex":0.0002509929,"about_ca_topic_score_gemma":0.000596896,"teacher_disagreement_score":0.0014410246,"about_ca_system_score_codex":0.00039330593,"about_ca_system_score_gemma":0.00025574028,"threshold_uncertainty_score":0.0048207045},"labels":[],"label_agreement":null},{"id":"W4415900112","doi":"10.1136/jitc-2025-sitc2025.0167","title":"167 Assessment of pathologic complete response following neoadjuvant therapy in patients with resectable lung cancer is equivalent across scoring systems","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Complete response; Neoadjuvant therapy; Lung cancer; Lung; Cancer; Scoring system","score_opus":0.02213456210844184,"score_gpt":0.3351564247441748,"score_spread":0.31302186263573295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95818937,0.0058285603,0.0067644953,0.0012050612,0.0006606595,0.0003687466,0.0021470734,0.00017784802,0.024658157],"genre_scores_gemma":[0.99356914,0.0005652885,0.002456492,0.00021254919,0.00014825992,0.00009916889,0.0015209522,0.000032935222,0.0013951906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937039,0.0028133292,0.000909518,0.00039653646,0.0018561439,0.0003205397],"domain_scores_gemma":[0.9827756,0.0064719585,0.0035581142,0.0013804006,0.004917572,0.0008962351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077832895,0.00032767645,0.0009991832,0.0017393007,0.00034166683,0.0018151685,0.00060340133,0.00052239385,0.00282887],"category_scores_gemma":[0.026705863,0.00020150463,0.0012618983,0.0012416228,0.00047482533,0.0012480891,0.0012852687,0.0005492276,0.0010145738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044562095,0.00013096104,0.8722323,0.00026861107,0.00066320715,0.00011515814,0.00018200076,0.00068263605,0.0020072497,0.00033532863,0.0032228795,0.11570348],"study_design_scores_gemma":[0.00014564172,0.0019217094,0.9860556,0.00011451671,0.00032845422,0.0006088405,0.00032784083,0.0032723874,0.0010273062,0.00067420886,0.0054871417,0.00003636171],"about_ca_topic_score_codex":0.0013256675,"about_ca_topic_score_gemma":0.0033251797,"teacher_disagreement_score":0.0077832895,"about_ca_system_score_codex":0.00077646907,"about_ca_system_score_gemma":0.00070453825,"threshold_uncertainty_score":0.04116249},"labels":[],"label_agreement":null},{"id":"W4415900166","doi":"10.1136/jitc-2025-sitc2025.1037","title":"1037 Non-infectious sarcoid-like inflammatory granulomatous conditions (NSIGC) associated with Immune checkpoint inhibitors (ICIs) for cancer: updated results from the international ICARUS consortium","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"ICARUS; Immune system; Inflammation; Immunotherapy; Inflammatory response","score_opus":0.01564778829486315,"score_gpt":0.27336484578651404,"score_spread":0.2577170574916509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900166","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13950388,0.7198144,0.001638564,0.012041231,0.0097359205,0.00073032774,0.05698389,0.00031782358,0.05923395],"genre_scores_gemma":[0.32626018,0.4911398,0.006515529,0.011704979,0.01875763,0.0005348288,0.132014,0.00017542673,0.012897637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976259,0.00038502834,0.00043934627,0.0001650709,0.0011369414,0.0002478187],"domain_scores_gemma":[0.98855186,0.0026502882,0.0031449278,0.00040032354,0.00444945,0.00080314314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049317894,0.0007597169,0.0014039516,0.0039855754,0.00040457037,0.002617676,0.000724223,0.00092993275,0.004189805],"category_scores_gemma":[0.005382267,0.00021321888,0.001821933,0.0054743635,0.000298322,0.00090613484,0.00079476525,0.0010952262,0.0013253012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065319655,0.0005324845,0.18844178,0.0070542702,0.0029938933,0.0012741337,0.00015979396,0.0005316855,0.0021258509,0.0003801351,0.14128047,0.64869344],"study_design_scores_gemma":[0.0010496043,0.00087726157,0.728382,0.0032151188,0.006761894,0.0027777262,0.0002999791,0.00023340248,0.0012331482,0.00024198512,0.2548539,0.00007394148],"about_ca_topic_score_codex":0.007683454,"about_ca_topic_score_gemma":0.014791063,"teacher_disagreement_score":0.007683454,"about_ca_system_score_codex":0.001092955,"about_ca_system_score_gemma":0.0027013046,"threshold_uncertainty_score":0.026082098},"labels":[],"label_agreement":null},{"id":"W4415900229","doi":"10.1136/jitc-2025-sitc2025.1235","title":"1235 Abemaciclib differentially reshapes the immunopeptidome of breast cancer subtypes","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Breast cancer; Cancer; Human breast; Clinical trial","score_opus":0.009399993672740354,"score_gpt":0.2676627313144038,"score_spread":0.25826273764166346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847157,0.004561064,0.000544319,0.00035516504,0.0002969712,0.00010278105,0.00075729395,0.00012971621,0.008536986],"genre_scores_gemma":[0.98782325,0.0020558755,0.00070513267,0.00029427258,0.000069780974,0.000057812736,0.0014169033,0.000023467912,0.0075534387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998853,0.000015971316,0.0000069593484,0.000014797672,0.0000188701,0.000058107926],"domain_scores_gemma":[0.99994624,0.0000067468523,0.0000075851617,0.0000056181266,0.0000063251287,0.000027495787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015724737,0.000258387,0.00047430734,0.00023621666,0.00020445349,0.0005316751,0.00023132552,0.00031528057,0.0064544715],"category_scores_gemma":[0.00022965447,0.00015598489,0.00028537834,0.00018415012,0.00018407853,0.00021662499,0.00018504339,0.00091563206,0.0011550318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015483407,0.0015047475,0.0016924479,0.00030868626,0.00015891535,0.00017362295,0.00004324509,0.0004057993,0.8901534,0.0007976669,0.0055541513,0.08372384],"study_design_scores_gemma":[0.0054801335,0.023935717,0.054690894,0.0000914047,0.00044020463,0.0025215107,0.00024097139,0.002856326,0.83410877,0.00060193264,0.07495903,0.00007304591],"about_ca_topic_score_codex":0.0009875585,"about_ca_topic_score_gemma":0.0020757506,"teacher_disagreement_score":0.0064544715,"about_ca_system_score_codex":0.00035053986,"about_ca_system_score_gemma":0.00048859126,"threshold_uncertainty_score":0.021592319},"labels":[],"label_agreement":null},{"id":"W4415900237","doi":"10.1136/jitc-2025-sitc2025.0614","title":"614 Treatment with diacylglycerol kinase (DGK) alpha specific inhibitor BAY2862789 exhibits combination potential with DGK zeta inhibition in biomarker assays during FIH monotherapy trial","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Diacylglycerol kinase; Biomarker; Alpha (finance); Kinase; In vivo","score_opus":0.008923470580566912,"score_gpt":0.22727474598230546,"score_spread":0.21835127540173854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918134,0.0041646897,0.00048737423,0.00055169885,0.00025198367,0.00027200318,0.0007351482,0.00018204674,0.0041737775],"genre_scores_gemma":[0.99148655,0.0019893257,0.00077999645,0.00030141958,0.00010152795,0.00021946001,0.0010982632,0.000016222193,0.0040072626],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999008,0.00001857383,0.000008778294,0.000017652223,0.00001546907,0.000038674803],"domain_scores_gemma":[0.9999219,0.000010756211,0.00001280962,0.000008006964,0.000006683934,0.000039900842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025135378,0.000436676,0.0010009931,0.00022023584,0.00019863635,0.0004370737,0.00026709598,0.00047948505,0.003929925],"category_scores_gemma":[0.00019773234,0.0001249852,0.00044818118,0.0002071917,0.00020390798,0.00025380938,0.00016734259,0.0011475846,0.0009660306],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27115408,0.011962652,0.007859455,0.0009903802,0.000825006,0.00076585775,0.00014778407,0.0017505165,0.37710544,0.00059025944,0.0103929285,0.3164557],"study_design_scores_gemma":[0.117355354,0.41307533,0.10415213,0.00019920577,0.001992608,0.0024106142,0.00024399546,0.0063377814,0.30899137,0.0010001934,0.044052046,0.00018937411],"about_ca_topic_score_codex":0.00030925512,"about_ca_topic_score_gemma":0.0011831068,"teacher_disagreement_score":0.003929925,"about_ca_system_score_codex":0.0002897009,"about_ca_system_score_gemma":0.00044389477,"threshold_uncertainty_score":0.013146877},"labels":[],"label_agreement":null},{"id":"W4415900261","doi":"10.1136/jitc-2025-sitc2025.0658","title":"658 KAN-001, a defined live biotherapeutic product (LBP) for NSCLC, enhances ICI response in preclinical models and demonstrates manufacturing consistency and strain-resolved viability","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"University of Texas MD Anderson Cancer Center","keywords":"Consistency (knowledge bases); Product (mathematics); New product development; Selection (genetic algorithm); Manufacturing process","score_opus":0.025380657972440542,"score_gpt":0.2998519849065107,"score_spread":0.27447132693407017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499334,0.001753839,0.0053930185,0.00026904047,0.000078595534,0.00008605662,0.0009109341,0.0003482137,0.0061669783],"genre_scores_gemma":[0.98483753,0.0008623237,0.005500181,0.00012094267,0.000014126873,0.000049828373,0.0017058749,0.000060451242,0.006848756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989426,0.000012665491,0.0000066634266,0.000019548534,0.000041467327,0.000025311145],"domain_scores_gemma":[0.9999119,0.000014451878,0.000023557206,0.000010140199,0.000014385311,0.000025510115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012836303,0.00025825843,0.00017829392,0.00017653056,0.00011792403,0.00028713178,0.00023324435,0.0003288268,0.00277751],"category_scores_gemma":[0.0001019272,0.00010954483,0.00019906448,0.000116721174,0.00020196434,0.00017258094,0.00013550023,0.00076672045,0.0010132756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002004706,0.00010589568,0.000111005764,0.000033001194,0.000003424665,0.000018911705,0.000012924575,0.0000691896,0.9947601,0.00006452453,0.00019159271,0.0044288905],"study_design_scores_gemma":[0.00006380738,0.0017665919,0.002191793,0.000007839731,0.000015305974,0.00020112102,0.00002785306,0.00053575373,0.991217,0.00002762155,0.003940039,0.000005202508],"about_ca_topic_score_codex":0.0008561837,"about_ca_topic_score_gemma":0.0014643645,"teacher_disagreement_score":0.00277751,"about_ca_system_score_codex":0.00029364205,"about_ca_system_score_gemma":0.00031118077,"threshold_uncertainty_score":0.0092917085},"labels":[],"label_agreement":null},{"id":"W4415900298","doi":"10.1136/jitc-2025-sitc2025.0097","title":"97 Statistical and systematic uncertainties affect biomarker reliability: a case study in multiplex immunofluorescence","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Reliability and Agreement in Measurement","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiplex; Biomarker; Immunofluorescence; Affect (linguistics)","score_opus":0.06942844363114892,"score_gpt":0.3442540651931056,"score_spread":0.27482562156195667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8545428,0.0014111073,0.13434702,0.0036661457,0.00008733787,0.00020151441,0.0002238051,0.00032271762,0.005197569],"genre_scores_gemma":[0.9847878,0.00012937743,0.0144543415,0.00017504847,0.000025063191,0.000029369936,0.000046754503,0.00005953203,0.00029278782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96168435,0.02369821,0.0019281793,0.002891989,0.0086306,0.0011667899],"domain_scores_gemma":[0.39443314,0.5604943,0.0154414065,0.012168824,0.016446892,0.00101539],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0695259,0.0005897869,0.0010473003,0.001678359,0.0018112693,0.0030892233,0.001995228,0.003145894,0.001317838],"category_scores_gemma":[0.25462022,0.00067639345,0.0015363591,0.002093664,0.002837423,0.0019390464,0.0014597825,0.0023452265,0.0002976884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025687376,0.0007804587,0.6043283,0.00077455613,0.001518563,0.023544421,0.009267254,0.14717335,0.012116229,0.018979447,0.0044218716,0.17452686],"study_design_scores_gemma":[0.0003366755,0.0031603237,0.25903326,0.00061531324,0.0020149157,0.030422173,0.010304481,0.54597175,0.04559229,0.088812165,0.012975884,0.00076084957],"about_ca_topic_score_codex":0.0076374887,"about_ca_topic_score_gemma":0.005959797,"teacher_disagreement_score":0.9304741,"about_ca_system_score_codex":0.0026653998,"about_ca_system_score_gemma":0.002424189,"threshold_uncertainty_score":0.36769247},"labels":[],"label_agreement":null},{"id":"W4415900317","doi":"10.1136/jitc-2025-sitc2025.0597","title":"597 A phase 1 trial of the oncolytic virus SVV-001 in combination with nivolumab and ipilimumab in patients with high grade neuroendocrine neoplasms","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seneca Polytechnic","funders":"","keywords":"Nivolumab; Ipilimumab; Oncolytic virus; Immunotherapy; Virus; Melanoma","score_opus":0.008464327826013815,"score_gpt":0.2554905428203701,"score_spread":0.24702621499435629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920845,0.00233185,0.00037896555,0.00062668865,0.00032749726,0.0006626639,0.0005584989,0.00007922314,0.00295015],"genre_scores_gemma":[0.9896192,0.0020504866,0.0010496813,0.000796419,0.00015532231,0.0006346764,0.0013895856,0.00004056236,0.0042639445],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997688,0.00008211458,0.000010715415,0.000049839793,0.000024973748,0.00006355346],"domain_scores_gemma":[0.9997315,0.00006067182,0.000029808445,0.000018869681,0.000016094396,0.00014311724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006990717,0.0010087519,0.0016344648,0.00031480571,0.00041614423,0.0012004675,0.0005442475,0.0010614333,0.0049587055],"category_scores_gemma":[0.00053403684,0.000512006,0.0014425389,0.0002592744,0.00071820186,0.00068907085,0.00024433737,0.0031194256,0.0012250947],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6755549,0.03915133,0.0047898684,0.0012048183,0.0024675385,0.00036959126,0.0003621183,0.0048915306,0.06408724,0.0008819521,0.008322107,0.19791709],"study_design_scores_gemma":[0.5815051,0.3887511,0.010173998,0.000071176306,0.0010097225,0.00037142585,0.00014921621,0.0034572016,0.007204341,0.0006032978,0.0066467393,0.00005665553],"about_ca_topic_score_codex":0.0014120014,"about_ca_topic_score_gemma":0.003477538,"teacher_disagreement_score":0.0049587055,"about_ca_system_score_codex":0.0009895788,"about_ca_system_score_gemma":0.0011428626,"threshold_uncertainty_score":0.016588569},"labels":[],"label_agreement":null},{"id":"W4415900318","doi":"10.1136/jitc-2025-sitc2025.0957","title":"957 Modulation of the tumor immune microenvironment by low dose antibody-based radiopharmaceutical therapy (RPT) and direct visualization of RPT analog microdistribution by imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Immune system; Visualization; Tumor microenvironment; Flow cytometry; Immune modulation","score_opus":0.0081256481701865,"score_gpt":0.2888037388252827,"score_spread":0.2806780906550962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96980536,0.002643481,0.016343402,0.0002787617,0.000044857687,0.00009708231,0.0005279791,0.00027695237,0.009982083],"genre_scores_gemma":[0.9784127,0.00090240646,0.01377442,0.000078278,0.000019249243,0.0000809133,0.00043836967,0.00003235663,0.00626135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990845,0.000020164201,0.000005204221,0.000018990502,0.000025282674,0.000021815866],"domain_scores_gemma":[0.99995995,0.000014265232,0.000006515279,0.0000041417775,0.000005836004,0.0000092597775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013619818,0.00019232447,0.000126749,0.00027486187,0.00013565666,0.00036819087,0.00015765213,0.00026512184,0.0044198846],"category_scores_gemma":[0.0000714526,0.00010532427,0.00013603763,0.00015628041,0.00016635367,0.00017945524,0.00014525036,0.0004965317,0.0008605623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005328532,0.000015443553,0.000082743325,0.000013725645,0.0000016842732,0.000020469493,0.000005102554,0.00004564002,0.99831414,0.000095542186,0.00007726557,0.0012750244],"study_design_scores_gemma":[0.000012412548,0.00021060651,0.0017612791,0.0000021570183,0.000004318913,0.00017944053,0.0000103833345,0.0012789259,0.9947476,0.000026968506,0.00176349,0.000002426624],"about_ca_topic_score_codex":0.00074887316,"about_ca_topic_score_gemma":0.0006632038,"teacher_disagreement_score":0.0044198846,"about_ca_system_score_codex":0.00032560187,"about_ca_system_score_gemma":0.00014152277,"threshold_uncertainty_score":0.014786005},"labels":[],"label_agreement":null},{"id":"W4415900319","doi":"10.1136/jitc-2025-sitc2025.0173","title":"173 Androgen receptor stratifies immune-cold triple negative breast cancer: meta-analysis of chemotherapy response to guide precision immunotherapy","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemotherapy; Immunotherapy; Complete response; Androgen receptor; Androgen suppression; Androgen","score_opus":0.0224521765230527,"score_gpt":0.30189445328839937,"score_spread":0.27944227676534666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900319","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010136142,0.98184055,0.0031610476,0.0011717614,0.0005489652,0.00040908493,0.0018934703,0.000082532475,0.0007565099],"genre_scores_gemma":[0.6711863,0.3077939,0.009256303,0.0032009021,0.0012637896,0.0022739146,0.003500457,0.00016274671,0.0013616938],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98147845,0.012048064,0.0033184416,0.0016804314,0.0010484977,0.0004261542],"domain_scores_gemma":[0.9761841,0.018480664,0.0025101805,0.0014250997,0.001141598,0.0002583355],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02165021,0.0022390117,0.011569366,0.0060752127,0.00043127371,0.0034504577,0.0020870962,0.0021373862,0.004939286],"category_scores_gemma":[0.041155588,0.0012070471,0.04367722,0.0054276926,0.00062451436,0.0013609877,0.0014373283,0.0016996526,0.00058564846],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022932747,0.000018126344,0.009157173,0.107889034,0.8650286,0.000083465835,0.00006143618,0.0013404551,0.00025961632,0.00033240317,0.0014388119,0.012097613],"study_design_scores_gemma":[0.00084122125,0.0001738047,0.007046658,0.010744101,0.9762067,0.00006785525,0.00003836532,0.0007498385,0.0001552575,0.00096097705,0.0029865082,0.000028634995],"about_ca_topic_score_codex":0.006256494,"about_ca_topic_score_gemma":0.009443438,"teacher_disagreement_score":0.9884306,"about_ca_system_score_codex":0.0018623777,"about_ca_system_score_gemma":0.0026252412,"threshold_uncertainty_score":0.114498615},"labels":[],"label_agreement":null},{"id":"W4415900334","doi":"10.1136/jitc-2025-sitc2025.1231","title":"1231 A scalable, proteome-wide protein profiling platform with absolute quantification of 1000 proteins","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Profiling (computer programming); Quantitative proteomics; Peptide mapping; Quantitative analysis (chemistry); Proteomics","score_opus":0.013973822773747941,"score_gpt":0.250930916148302,"score_spread":0.23695709337455403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900334","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26506013,0.0036423549,0.58125186,0.0022921416,0.0013277922,0.0018542432,0.061162498,0.068530686,0.014878363],"genre_scores_gemma":[0.2344318,0.0020270315,0.65659547,0.0024213998,0.00038991982,0.0033692608,0.07731838,0.002655657,0.020791104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767023,0.00016195574,0.0001005211,0.0007389979,0.001175616,0.00015264418],"domain_scores_gemma":[0.999443,0.00010281323,0.00006582199,0.00008497398,0.00018694,0.000116506875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012915512,0.0014770321,0.0017532369,0.0014411617,0.0010052746,0.0020459255,0.001346767,0.0013425504,0.0047597624],"category_scores_gemma":[0.00085287873,0.0009473645,0.0008457413,0.0013341068,0.0004840442,0.0011532377,0.0017017195,0.0021454839,0.0057677394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004908662,0.0002087417,0.0011656509,0.00017145457,0.000117227006,0.000070694805,0.00004163113,0.0006010027,0.9554524,0.0006207387,0.013179822,0.027879765],"study_design_scores_gemma":[0.00026583075,0.0006955954,0.010459766,0.000057507536,0.0001455813,0.00061691843,0.00005472508,0.06406496,0.8608981,0.002063731,0.060446203,0.00023113536],"about_ca_topic_score_codex":0.0010830672,"about_ca_topic_score_gemma":0.0030971311,"teacher_disagreement_score":0.0047597624,"about_ca_system_score_codex":0.00060958206,"about_ca_system_score_gemma":0.0013786999,"threshold_uncertainty_score":0.015922964},"labels":[],"label_agreement":null},{"id":"W4415900344","doi":"10.1136/jitc-2025-sitc2025.0588","title":"588 Selective inhibition of Diacylglycerol kinase zeta exhibits increased T cell activation and anti-tumor immunity, demonstrating pharmacodynamic proof of mechanism in the FIH trial of BAY2965501","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Diacylglycerol kinase; Pharmacodynamics; Mechanism (biology); T cell; Kinase; Protein kinase C; Mechanism of action; Cell","score_opus":0.007561693293307385,"score_gpt":0.23947799589209692,"score_spread":0.23191630259878954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938791,0.00090284273,0.0005198839,0.000688736,0.00013458663,0.00012239852,0.00031191594,0.00012198948,0.0033184618],"genre_scores_gemma":[0.99611795,0.00045748847,0.00038367207,0.0002490412,0.000052016607,0.000053836546,0.0003526336,0.000012106796,0.0023212705],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99989617,0.000016064903,0.0000063866732,0.00001589151,0.000018794011,0.000046639645],"domain_scores_gemma":[0.9999156,0.00001532876,0.000013386199,0.000010212772,0.0000054890183,0.00004000846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029303238,0.00037328372,0.000619093,0.00016457793,0.00018499506,0.00047494008,0.0002900599,0.0004800098,0.002814957],"category_scores_gemma":[0.0002252915,0.00015790714,0.00029161794,0.00012904513,0.00041584863,0.00033097778,0.00014139463,0.0020514599,0.0006431488],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08221979,0.008945085,0.0027422726,0.0003401913,0.00032955068,0.0005839498,0.00012371369,0.0017487014,0.7249031,0.0015195588,0.0061176503,0.17042632],"study_design_scores_gemma":[0.11301988,0.3558539,0.048974726,0.00006239473,0.0008115699,0.0024235705,0.0001711104,0.007959182,0.44508705,0.0017290317,0.023783036,0.00012454852],"about_ca_topic_score_codex":0.00057241233,"about_ca_topic_score_gemma":0.0016541721,"teacher_disagreement_score":0.002814957,"about_ca_system_score_codex":0.00037458807,"about_ca_system_score_gemma":0.00043675554,"threshold_uncertainty_score":0.009416938},"labels":[],"label_agreement":null},{"id":"W4415900424","doi":"10.1136/jitc-2025-sitc2025.0116","title":"116 Application of a comprehensive multi-omic immune profiling strategy achieves superior checkpoint immunotherapy response prediction in lung cancer","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Lung cancer; Profiling (computer programming); Immunotherapy; Cancer immunotherapy; Nivolumab; Immune checkpoint","score_opus":0.0161937421815287,"score_gpt":0.2976826542388666,"score_spread":0.2814889120573379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94575346,0.008364295,0.031035783,0.0012514656,0.00032129264,0.0002265056,0.007409588,0.00094718975,0.0046904683],"genre_scores_gemma":[0.96584177,0.0012086355,0.022429548,0.0007432859,0.00016662196,0.000101195,0.0076738694,0.00007553798,0.0017595356],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989378,0.0001878301,0.00009185204,0.0003576811,0.00029003187,0.00013485934],"domain_scores_gemma":[0.99935657,0.00018207503,0.00015957611,0.000082661245,0.00015523599,0.00006393014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014379442,0.0006694398,0.0012523339,0.0016591807,0.00045371524,0.0023078355,0.00035782586,0.00067657564,0.0014766318],"category_scores_gemma":[0.001974304,0.00027809883,0.0010349286,0.0013435136,0.00023695742,0.00047135653,0.00088373694,0.00070177537,0.00088176026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020424144,0.00075264956,0.25685823,0.00058331166,0.0013553947,0.0002440014,0.000118730255,0.00627415,0.47103545,0.0006418724,0.007152551,0.25294134],"study_design_scores_gemma":[0.0003048834,0.002375689,0.6017509,0.00026450082,0.0031851474,0.0015069108,0.00045431696,0.12513836,0.23146638,0.0042092428,0.029150404,0.00019328386],"about_ca_topic_score_codex":0.0011236052,"about_ca_topic_score_gemma":0.002436087,"teacher_disagreement_score":0.0023078355,"about_ca_system_score_codex":0.00034736833,"about_ca_system_score_gemma":0.0008075686,"threshold_uncertainty_score":0.0076046586},"labels":[],"label_agreement":null},{"id":"W4416074353","doi":"10.1136/jitc-2025-sitc2025.0107","title":"107 Multi-omic assessment of blood and tissue of renal cell carcinoma patients provides a comprehensive characterization of the systemic and local immune response","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Renal cell carcinoma; Immune system; Kidney cancer; Kidney; Cell","score_opus":0.011548335764911235,"score_gpt":0.2403977365315683,"score_spread":0.22884940076665705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416074353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97820514,0.004865823,0.0053583067,0.00032232024,0.000089619294,0.00013081105,0.0014408003,0.00014934261,0.0094378395],"genre_scores_gemma":[0.9903993,0.0012175549,0.0045353943,0.00040947404,0.00012481643,0.00007188313,0.0010315737,0.000035362766,0.0021745851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997297,0.00006693042,0.000033247037,0.000051510127,0.000068720685,0.000049812472],"domain_scores_gemma":[0.9997565,0.000048805243,0.000049906146,0.000025726404,0.000068870286,0.000050145452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040499252,0.00033060374,0.00066111755,0.0014659837,0.00038281872,0.0007674902,0.00018366754,0.00045234172,0.0023373975],"category_scores_gemma":[0.00045760747,0.00014842831,0.00026479244,0.000701756,0.0001879135,0.0003524744,0.00040880818,0.00037308555,0.0007470748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011815713,0.000246455,0.58098,0.00023711314,0.00014008647,0.001970002,0.00030028386,0.00029623095,0.34220308,0.00019898324,0.0017217601,0.070524365],"study_design_scores_gemma":[0.00002027095,0.0008744004,0.9281946,0.000059991293,0.00018866254,0.005070605,0.0010054635,0.0015051564,0.056670547,0.00032654125,0.006060539,0.000023263068],"about_ca_topic_score_codex":0.0009759909,"about_ca_topic_score_gemma":0.0014988305,"teacher_disagreement_score":0.0023373975,"about_ca_system_score_codex":0.00018435041,"about_ca_system_score_gemma":0.00021503367,"threshold_uncertainty_score":0.0078193545},"labels":[],"label_agreement":null},{"id":"W4416074415","doi":"10.1136/jitc-2025-sitc2025.0106","title":"106 Spatial multi-omic characterization of tumor microenvironment heterogeneity in hepatocellular carcinoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Tumor microenvironment; Hepatocellular carcinoma; Tumor heterogeneity; Tumor cells; Cancer","score_opus":0.028865828059463857,"score_gpt":0.2299068720586562,"score_spread":0.20104104399919234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416074415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96488166,0.0027679931,0.021809759,0.00035207233,0.000050058723,0.000050105627,0.0056661824,0.000488496,0.003933611],"genre_scores_gemma":[0.96156704,0.0011411023,0.026020918,0.00020842845,0.000029221217,0.00007294205,0.0069927997,0.00013655545,0.003831002],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998487,0.0000137184825,0.000010146553,0.000038025508,0.000056618028,0.00003276625],"domain_scores_gemma":[0.999889,0.00002027426,0.00002033991,0.000017153749,0.000035758716,0.00001744673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020011686,0.0002242983,0.00021127994,0.0011587903,0.00023810224,0.0005462382,0.000105622574,0.0002446768,0.002070533],"category_scores_gemma":[0.00019858805,0.00016104718,0.00020873478,0.00074251957,0.00013554393,0.00019829119,0.00026486212,0.00031182403,0.00075269764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068327376,0.000011171682,0.003187312,0.000054520962,0.000016673479,0.000057453577,0.000018305058,0.000115067975,0.9930641,0.00006427173,0.00023273849,0.0031101778],"study_design_scores_gemma":[0.000015351034,0.000116252086,0.21593523,0.00002763795,0.00010235386,0.0011832189,0.00036154705,0.008355188,0.7653007,0.00025119816,0.008320778,0.000030524752],"about_ca_topic_score_codex":0.0015788354,"about_ca_topic_score_gemma":0.0026230025,"teacher_disagreement_score":0.002070533,"about_ca_system_score_codex":0.00023817149,"about_ca_system_score_gemma":0.00019351442,"threshold_uncertainty_score":0.006926656},"labels":[],"label_agreement":null},{"id":"W4416075617","doi":"10.1136/jitc-2025-sitc2025.1069","title":"1069 Real-world experience with durvalumab amongst older patients","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Durvalumab; Disease; MEDLINE; Population; Incidence (geometry)","score_opus":0.00956199840565414,"score_gpt":0.25784839890166195,"score_spread":0.2482864004960078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416075617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939989,0.0014470535,0.00015748468,0.0007140756,0.000037997557,0.000015129569,0.000109268556,0.0000051342017,0.0035149506],"genre_scores_gemma":[0.99717253,0.0011846063,0.00013957593,0.0005419565,0.00008833294,0.000010619993,0.00016208133,0.0000062624267,0.0006939888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974924,0.00007858683,0.000027335736,0.000033007957,0.000050769922,0.0000610826],"domain_scores_gemma":[0.9990736,0.00024570234,0.00022690228,0.00003085707,0.000058892798,0.00036405792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004649001,0.00009881915,0.00024011092,0.00011563451,0.00062555086,0.00074305007,0.00011150296,0.00034282953,0.0024301775],"category_scores_gemma":[0.0023217262,0.00007805682,0.0002301637,0.00022293122,0.00021595972,0.0003818703,0.00036493764,0.0005544355,0.00041378645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045848344,0.0016242911,0.83155066,0.0002794835,0.00025470962,0.01746557,0.005606394,0.0005929738,0.0038892566,0.00073987956,0.008363148,0.12504882],"study_design_scores_gemma":[0.000754052,0.01286449,0.8332364,0.00038811308,0.0005085542,0.05302071,0.012309162,0.0015745526,0.0020392372,0.00072223356,0.08248359,0.00009900419],"about_ca_topic_score_codex":0.0016242763,"about_ca_topic_score_gemma":0.0026558833,"teacher_disagreement_score":0.0024301775,"about_ca_system_score_codex":0.00059525215,"about_ca_system_score_gemma":0.00035163783,"threshold_uncertainty_score":0.008129716},"labels":[],"label_agreement":null},{"id":"W4416075644","doi":"10.1136/jitc-2025-sitc2025.1091","title":"1091 Decoding clinical and molecular determinants of tertiary lymphoid structure heterogeneity in pancreatic cancer by integrating multimodal spatial transcriptomics, proteomics, and histopathology imaging","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Histopathology; Pancreatic cancer; Disease; Cancer; Pancreas; Molecular imaging","score_opus":0.008576981915853005,"score_gpt":0.26860253141103707,"score_spread":0.2600255494951841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416075644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98362863,0.0017417772,0.009228964,0.0005044914,0.00002441203,0.000043174798,0.00074018294,0.0001488804,0.003939509],"genre_scores_gemma":[0.99279904,0.0006017949,0.004664687,0.0001165698,0.000022867867,0.000033043514,0.0006229112,0.000044897064,0.0010942959],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998041,0.000038827082,0.00001604176,0.00004431723,0.000042915362,0.00005383763],"domain_scores_gemma":[0.9997725,0.000065602755,0.000048696438,0.000027175836,0.00005235133,0.00003371666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061778596,0.00018162475,0.0003509983,0.0008232857,0.00023412623,0.0015640424,0.00029086744,0.00050663593,0.0030167932],"category_scores_gemma":[0.0008117987,0.00026913485,0.0001787092,0.0005723523,0.00033667858,0.0005353767,0.00039785737,0.00059674814,0.00085850747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001128625,0.00009893085,0.08587136,0.00017987605,0.000039531842,0.00084202806,0.00014817172,0.001098639,0.8681731,0.001144473,0.0015696492,0.039705668],"study_design_scores_gemma":[0.00009872512,0.00048210897,0.47593027,0.00009209814,0.000258422,0.00629189,0.0023273046,0.025905957,0.4708563,0.0036171589,0.014083106,0.000056610243],"about_ca_topic_score_codex":0.0012722549,"about_ca_topic_score_gemma":0.0015665598,"teacher_disagreement_score":0.0030167932,"about_ca_system_score_codex":0.00052563165,"about_ca_system_score_gemma":0.0004483782,"threshold_uncertainty_score":0.010092199},"labels":[],"label_agreement":null},{"id":"W4416076158","doi":"10.1136/jitc-2025-sitc2025.1150","title":"1150 MaaT034, a new co-cultured microbiome ecosystem therapy candidate, potentiates anti-PD1 mediated antitumoral activity in germ-free mice","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Microbiome; Ecosystem; Bacteria; Immune system","score_opus":0.00941429106082356,"score_gpt":0.2657198795771739,"score_spread":0.2563055885163503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416076158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98108494,0.004629713,0.0033775936,0.0007775306,0.00047654807,0.00010372108,0.0019203457,0.00057832,0.0070513254],"genre_scores_gemma":[0.98427063,0.0021048423,0.0031209178,0.00031337017,0.000037942737,0.00010333556,0.0018424876,0.000050594343,0.008155847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998852,0.00001551022,0.000005905375,0.000021299767,0.00003604687,0.000036041027],"domain_scores_gemma":[0.99994814,0.0000034797285,0.000012798063,0.0000040505615,0.0000056291797,0.00002598105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014101171,0.00038034056,0.00029529168,0.00024260588,0.00017373139,0.00042763655,0.00028875037,0.00043973475,0.0035970667],"category_scores_gemma":[0.000074491414,0.00012585957,0.00033676717,0.00019089997,0.00024306479,0.00021934687,0.00019283606,0.0011193991,0.00074759935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002448683,0.0005687926,0.00048834254,0.00011872016,0.000042533433,0.0000591803,0.000017935075,0.00029150076,0.9748925,0.0003153877,0.0015238796,0.019232452],"study_design_scores_gemma":[0.000774552,0.009065472,0.0065604616,0.000026282241,0.000154894,0.00035122148,0.000084227744,0.001933529,0.9535467,0.00024953904,0.027228361,0.000024705756],"about_ca_topic_score_codex":0.00067347666,"about_ca_topic_score_gemma":0.0017444894,"teacher_disagreement_score":0.0035970667,"about_ca_system_score_codex":0.00029966235,"about_ca_system_score_gemma":0.00046964016,"threshold_uncertainty_score":0.0120334625},"labels":[],"label_agreement":null},{"id":"W4416076177","doi":"10.1136/jitc-2025-sitc2025.1161","title":"1161 Novel cyclophilin inhibitors could serve as an NK cell-stimulating immunotherapy for triple negative breast cancer","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; International Seafood Sustainability Foundation","keywords":"Immunotherapy; Triple-negative breast cancer; Cyclophilin A; Cancer immunotherapy; Breast cancer","score_opus":0.012852219179175036,"score_gpt":0.2814946952335048,"score_spread":0.2686424760543297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416076177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93920845,0.038539667,0.005967276,0.0009725887,0.000416049,0.000297765,0.00088238483,0.00023910057,0.013476653],"genre_scores_gemma":[0.976661,0.011173992,0.0026577031,0.00031652985,0.00006485014,0.00014676692,0.0009742844,0.000017070857,0.007987783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996614,0.0000058319124,0.000002910959,0.0000055087626,0.000008825741,0.000010830316],"domain_scores_gemma":[0.9999832,0.000002499465,0.0000039583906,0.0000013229048,0.0000037116793,0.0000053532603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059316935,0.00024854625,0.00020582325,0.0001433677,0.00007949884,0.0002608909,0.00012931676,0.00024234857,0.0025593245],"category_scores_gemma":[0.00005399651,0.000058918078,0.00019949426,0.0000915619,0.00009183884,0.00012569274,0.000119198616,0.00034633695,0.0005137745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069396757,0.00018390143,0.00090519886,0.00037935536,0.000037428385,0.00021931336,0.000020897201,0.00043701753,0.9562891,0.0004406413,0.0013377833,0.03905539],"study_design_scores_gemma":[0.00035158504,0.003618633,0.009936897,0.0000711414,0.00017779341,0.0017472868,0.000043264405,0.0029969325,0.92306656,0.00030189386,0.057670407,0.000017680248],"about_ca_topic_score_codex":0.00020413558,"about_ca_topic_score_gemma":0.0005242837,"teacher_disagreement_score":0.0025593245,"about_ca_system_score_codex":0.00015595232,"about_ca_system_score_gemma":0.000120312325,"threshold_uncertainty_score":0.00856185},"labels":[],"label_agreement":null},{"id":"W4416076231","doi":"10.1136/jitc-2025-sitc2025.1166","title":"1166 Avidity engineered multifunctional antibodies that strongly activate and expand anti-tumor immunity in situ, turning cold patient tumor tissue hot and exerting durable tumor control in mice","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immunity; Antibody; Avidity; Immune system; Humoral immunity; Tumor cells; Immunotherapy","score_opus":0.010206595566446732,"score_gpt":0.24623540699914992,"score_spread":0.23602881143270318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416076231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96899575,0.0018123406,0.021052215,0.00033488212,0.00019163164,0.00012504481,0.00046065578,0.00052072003,0.0065067513],"genre_scores_gemma":[0.9836121,0.0005289349,0.0085449945,0.00013467223,0.000027941815,0.000054021508,0.00039028152,0.00006634185,0.0066407965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996996,0.000039160514,0.0000178762,0.00006292104,0.00007542947,0.00010509382],"domain_scores_gemma":[0.9998604,0.000020654346,0.000049653587,0.000017152342,0.000012848545,0.00003914381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003159841,0.0006074055,0.00027003212,0.0003160498,0.000111405934,0.00035382767,0.00030021166,0.00064704724,0.0024209598],"category_scores_gemma":[0.00014417172,0.00028641138,0.0002932439,0.00016015791,0.0002471273,0.00021663183,0.00021589857,0.000995782,0.0006481208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012229053,0.000037841695,0.000054463,0.000017385337,0.000005139954,0.000016747115,0.000006757888,0.00016406813,0.9975981,0.00027367246,0.00009863987,0.0016049893],"study_design_scores_gemma":[0.000060556482,0.00051101774,0.0005987773,0.0000031826607,0.000016165164,0.00018377314,0.000005082706,0.0011728008,0.99503434,0.00005741799,0.002352296,0.000004611309],"about_ca_topic_score_codex":0.00029369324,"about_ca_topic_score_gemma":0.00044345533,"teacher_disagreement_score":0.0024209598,"about_ca_system_score_codex":0.0002999207,"about_ca_system_score_gemma":0.00017736066,"threshold_uncertainty_score":0.0080989},"labels":[],"label_agreement":null},{"id":"W4416088080","doi":"10.1136/jitc-2025-sitc2025.0599","title":"599 The MATRiX trial: a multicenter, randomized, phase II study of ATR inhibition (via tuvusertib) with or without avelumab in patients with advanced anti-PD-(L)1-refractory merkel cell carcinoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; EMD Serono","keywords":"Avelumab; Merkel cell carcinoma; Merkel cell; Phase (matter); Carcinoma; Matrix (chemical analysis)","score_opus":0.008445985497383852,"score_gpt":0.25578565912241846,"score_spread":0.24733967362503462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416088080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98866606,0.0031561411,0.00064545765,0.00094140175,0.00051464053,0.0014519972,0.0013055425,0.00017503301,0.0031436894],"genre_scores_gemma":[0.9830215,0.0028357815,0.001737758,0.001425344,0.00042215202,0.0020986937,0.0022427563,0.00005818496,0.006157862],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996929,0.00013729281,0.000012871042,0.000059223563,0.000022000855,0.000075675525],"domain_scores_gemma":[0.99969804,0.00006433885,0.000051920848,0.00002754352,0.000012954823,0.00014518271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011071749,0.0016122313,0.0023072052,0.00035682262,0.00041658862,0.0012529859,0.00084791234,0.0011914666,0.005707141],"category_scores_gemma":[0.00073559704,0.00056269194,0.0014277413,0.00038973053,0.0010495901,0.0012092394,0.0003774434,0.0030894761,0.0013930048],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9166513,0.010732519,0.0013889335,0.0006507755,0.0011812708,0.00009608648,0.00009991508,0.0013003284,0.015541245,0.0005680589,0.0038049412,0.04798462],"study_design_scores_gemma":[0.9116752,0.08280786,0.0022217538,0.000018110284,0.00032161459,0.00006515429,0.00003364276,0.00064716284,0.00077162473,0.0002134665,0.0012015424,0.000022936158],"about_ca_topic_score_codex":0.0009222127,"about_ca_topic_score_gemma":0.0025272474,"teacher_disagreement_score":0.005707141,"about_ca_system_score_codex":0.0006342573,"about_ca_system_score_gemma":0.0008868906,"threshold_uncertainty_score":0.019092321},"labels":[],"label_agreement":null},{"id":"W4416088167","doi":"10.1136/jitc-2025-sitc2025.0427","title":"427 Mapping the expression of therapeutically targetable molecules in the tumor microenvironment of malignant pleural mesothelioma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Queen's University","funders":"","keywords":"Tumor microenvironment; Mesothelioma; Tumor cells; In vitro; Immunohistochemistry","score_opus":0.016306256658325368,"score_gpt":0.2343329296337351,"score_spread":0.21802667297540973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416088167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948285,0.00080662407,0.0012231277,0.00005677959,0.000010028369,0.000016606013,0.00012210694,0.000013841906,0.002922423],"genre_scores_gemma":[0.99562055,0.0005977178,0.00125574,0.000034761684,0.000009368069,0.000028038285,0.00019735236,0.00000631757,0.0022502353],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991155,0.000018384808,0.0000034414643,0.000013306759,0.00002769315,0.00002568406],"domain_scores_gemma":[0.99996793,0.000008284992,0.0000054431757,0.0000030043536,0.000005669418,0.000009590488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008622203,0.000103308696,0.00010942842,0.00023200695,0.00020300032,0.00030194194,0.000082149396,0.00024454013,0.0016878889],"category_scores_gemma":[0.00011024862,0.0001081015,0.000121974255,0.00018534782,0.00012562252,0.00013706379,0.00014289614,0.00019842054,0.0004057095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010834699,0.00001959417,0.00074189954,0.000020944473,0.0000033461847,0.000060835315,0.000021334074,0.000087708846,0.9973392,0.0001130048,0.000042066873,0.0014418303],"study_design_scores_gemma":[0.000036974376,0.0007237234,0.07564718,0.0000121481235,0.00004946888,0.00077807513,0.00050845713,0.0032056111,0.91221106,0.00028581847,0.0065328013,0.000008650219],"about_ca_topic_score_codex":0.0004925989,"about_ca_topic_score_gemma":0.0005748626,"teacher_disagreement_score":0.0016878889,"about_ca_system_score_codex":0.00014168806,"about_ca_system_score_gemma":0.00012940668,"threshold_uncertainty_score":0.005646527},"labels":[],"label_agreement":null},{"id":"W4416088438","doi":"10.1136/jitc-2025-sitc2025.0057","title":"57 High-throughput quantitative characterization of cytotoxic antibody-drug conjugates using spheroid models reveals important considerations in potential molecular mechanisms of ADC resistance","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Cytotoxic T cell; Conjugate; Spheroid; Cytotoxicity; Cell culture","score_opus":0.026555963767107112,"score_gpt":0.3195329329115008,"score_spread":0.2929769691443937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416088438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8529826,0.0016354833,0.13370538,0.00052604877,0.00009293361,0.0003301441,0.0032415108,0.0010592758,0.006426598],"genre_scores_gemma":[0.9362757,0.0012629658,0.05043783,0.00014265963,0.000011832579,0.0002492381,0.0023210032,0.00016757425,0.009131235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996915,0.000040929313,0.000021762908,0.00005816485,0.00014597827,0.000041693645],"domain_scores_gemma":[0.9998129,0.00008219577,0.000020033953,0.000030942752,0.00004390297,0.000010099878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004206927,0.00030562154,0.0006980757,0.0002645204,0.00029566773,0.00090726954,0.00028385792,0.00041353563,0.0016520686],"category_scores_gemma":[0.00037975307,0.00020116274,0.00030567776,0.00038341986,0.00026065225,0.00037671422,0.00016245981,0.00060568965,0.0006937142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006213253,0.00004291376,0.0005371036,0.000043483764,0.000008947327,0.00002874145,0.000039090643,0.0007922865,0.99369365,0.0005191476,0.00033337838,0.0038990008],"study_design_scores_gemma":[0.0000045576394,0.00006139162,0.0016001995,0.000002419524,0.00000823736,0.000030202129,0.000028234183,0.006830738,0.98990273,0.00010281761,0.0014228811,0.000005505863],"about_ca_topic_score_codex":0.0032339706,"about_ca_topic_score_gemma":0.0054835454,"teacher_disagreement_score":0.0032339706,"about_ca_system_score_codex":0.00072853937,"about_ca_system_score_gemma":0.00039956433,"threshold_uncertainty_score":0.0064302683},"labels":[],"label_agreement":null}]}